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Abstract 
Bacillus thuringiensis (Bt) crystal (Cry) proteins, used for decades as insecticidal toxins 
worldwide, are well known to be toxic to certain insects, but not to mammals. The 
three domain Cry toxins represent the biggest group with pore formation as a widely 
accepted model for insect killing. A novel group of Cry proteins has been identified 
known as parasporins. They do not show insecticidal or hemolytic activity, but exert a 
strong cytocidal effect against some human cancer cells. The preferential activity of 
parasporins has potential for anticancer drug design but at the same time the 
knowledge that some Bt toxins are able to kill mammalian cells may raise concerns 
about the use of Bt-based pesticides in the future. Out of 19 parasporins Parasporin-3 
(PS-3) most closely resembles the commercially used insecticidal toxins and is toxic to 
a narrow range of human cancer cell lines. In this study the effect of recombinant PS-3 
on the human hepatic cancer cell line HepG2 was investigated to elucidate its mode of 
action. Results are consistent with PS-3 being a pore forming toxin. The toxin induced: 
pore formation in artificial and biological membranes, irreparable membrane damage, 
cell swelling, rapid decrease in ATP levels and drop in metabolic activity. The toxin did 
not induce activation of caspases or oxidative stress. In response to the toxin, cells 
activated p38 MAPK, a conserved signalling pathway induced in host cells by pore 
forming toxins. PS-3 induced very stable lesions and p38 MAPK did not facilitate cell 
recovery. Identification of a proteinous receptor was unsuccessful, but the toxin 
interaction with the membrane was prevented by EGTA facilitated chelation of 
membrane associated cations, suggesting the existence of a cation dependent 
receptor. 
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1. Introduction 
1.1 Bt and its toxins 
Bacillus thuringiensis (Bt) is a gram positive bacterium belonging to the Bacillus cereus 
group, which among others includes: B. cereus, B. thuringiensis and B. anthracis (Rasko 
et al., 2005). What distinguishes Bt from other Bacillus species is the presence of a 
parasporal crystal produced during sporulation (Vilas-Boas et al., 2007). Bt was first 
isolated in Japan in 1901, but is ubiquitously present worldwide in many environments, 
mainly in soil. Thousands of strains have been isolated (Martin and Travers, 1989), and 
over 80 different serovars have been described (Lecadet et al., 1999). 
Bt was initially recognised as an insect pathogen due to its parasporal crystal 
inclusions, which are toxic to insects in their larval stages. For this reason Bt toxins 
have been used as bio-pesticides across the world, both in the form of sprays and 
transgenically expressed in crop plants (Bravo et al., 2011). However studies have 
shown that some Bt toxins also possess toxic activity towards mites, protozoa, 
nematodes (Schnepf et al., 1998) and also to human cancer cells (Mizuki et al., 1999b). 
Insecticidal properties of Bt toxins are mainly attributed to the δ-endotoxins within the 
crystal inclusions produced during bacterial sporulation and classified into two 
families: Cry and Cyt (Hofte and Whiteley, 1989).  
In 1989, Höfte and Whiteley proposed a nomenclature and classification for 
crystal proteins based on amino acid sequence homology as well as their host range 
(Höfte and Whiteley, 1989). This was later revised by Crickmore et al. A four rank 
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system was devised for Bt toxin classification by the Bacillus thuringiensis Toxin 
Nomenclature Committee. Proteins are classified based on the degree of pairwise 
amino acid identity and not structure, target specificity or mode of action. A different 
primary (e.g. Cry1, Cry2), secondary (e.g. Cry1A, Cry1B), tertiary (e.g. Cry1Aa, Cry1Ab), 
and quaternary (e.g. Cry1Aa1, Cry1Aa2) rank mean that proteins share less than 45%, 
78%, 95%, and ≤100% pairwise identity respectively (Crickmore et al., 1998, Crickmore, 
2016). 
The family of Cry toxins represent around 300 different crystal proteins 
(Crickmore, 2016), which are speciﬁcally toxic to insects from different orders such as: 
Lepidoptera, Diptera, Coleoptera, and Hymenoptera (Palma et al., 2014a) and will be 
discussed more in section 1.2. 
Cyt toxins have been classified into four families (Crickmore, 2016). In vivo they 
are mostly toxic to dipteran insects, but some of them are able to kill coleopteran 
species (Soberón et al., 2013). A synergistic mosquitocidal effect was demonstrated 
between Cyt and Cry toxins, indicating an important role of Cyt toxins in the 
pathogenicity of Bt strains (Crickmore et al., 1995). In vitro Cyt toxins possess a general 
cytolytic activity against various cultured cells including erythrocytes (Thomas and 
Ellar, 1983a). Cyt protoxins are solubilised and activated in the insect midgut 
environment to an active 25 kDa toxin (Thomas and Ellar, 1983b). Crystal structure 
data indicate the presence of a single domain comprising of α-helical layers wrapped 
around a β-sheet (Cohen et al., 2011, Cohen et al., 2008, Li et al., 1996). Cyt toxins 
associate with membranes via interaction with lipids rather than proteins (Thomas and 
Ellar, 1983b). Two modes of action were proposed, reviewed by Soberón et al. One 
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involves oligomerisation and formation of a β-barrel pore. In the second, called the 
detergent model, toxin does not insert into a membrane but aggregates near the cell 
surface and causes damage by affecting lipid packing (Soberón et al., 2013).  
Apart from Cyt and Cry toxins, the third family of Bt toxins - called the 
vegetative insecticidal proteins (Vip) - represents proteins secreted from cells into the 
medium in a non-crystal form during vegetative growth rather than sporulation (de 
Maagd et al., 2003). Vips are classified into four families (Crickmore, 2016), reviewed 
recently by Chakroun et al. (Chakroun et al., 2016). Vip1 and Vip2 represent an A+B 
type binary toxin highly toxic to some coleopteran species (Warren et al., 1998). Vip3 
toxins are active against a wide range of lepidopterans (Donovan et al., 2006), while 
the target of Vip4 remains unknown. Vip toxins undergo proteolytic cleavage in the 
insect midgut followed by different mechanisms of action. Vip1 binds to cell 
membrane and translocates toxic component Vip2 into the cytoplasm, most likely by 
receptor mediated endocytosis or via a pore created by Vip1, where it facilitates ADP-
ribosylation of actin (Chakroun et al., 2016). Vip3 was demonstrated to induce pore 
formation in planar lipid bilayers (Lee et al., 2003).  
The classification of Bt toxins based on sequence homology is presented 
graphically in Figure 1. Figure 2 shows the arrangement of Bt δ-endotoxins based on 
target specificity.  
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Figure 1 Classification of Bt toxins based on protein sequence homology. 
The main virulence factors produced by Bt are δ endotoxins called Cry and Cyt. Some Bt strains additionally produce 
insecticidal non-crystal forming proteins Vips. Cry family consists of four phylogenetically different families: three 
domain, Bin, ETX/MTX2 and unrelated toxins.  
 
 
Figure 2 Diversity of hosts and Bt toxin organisation based on target specificity. 
Host range and their pathogens showing Bt δ endotoxins (Cry and Cyt) grouped based on target specificity. Figure 
taken from Palma et al. (Palma et al., 2014a).  
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1.2 Introduction to Cry toxins 
The name Cry derives from the fact that the proteins are contained in a parasporal 
crystal. They are synthesised during sporulation usually as protoxins which are then 
digested at the N- and/or C- terminus to form a toxic core (Schnepf et al., 1998). In 
some Bt, crystals can account for up to 25% of the dry weight of the sporulated cell 
(Agaisse and Lereclus, 1995). Although the Cry toxins are mainly found in parasporal 
crystals, some proteins have been found within the spore coat (Aronson et al., 1982). 
Genes encoding Cry toxins are thought to reside on large plasmids with many Bt strains 
containing multiple cry genes (Gonzalez et al., 1981).  
To date, Cry toxins have been classified into 74 different types (Crickmore, 
2016), which represent the largest group of insecticidal Bt toxins, with documented 
toxicity towards: lepidopterans (moths and butterflies), dipterans (flies), coleopterans 
(beetles), hemipterans (bugs, aphids and cicadas), hymenopterans (wasps, bees and 
ants), nematodes (worms), snails and cancer cells (Palma et al., 2014a). The main 
families within this group include: three domain, binary (Bin) and ETX/MTX2 toxins. 
Figure 3 shows a list of Bt toxins with colour coded families (list last updated August 
2014). 
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Figure 3 A list of Bt toxins. 
The figure lists Bt toxins according to their primary rank (proteins with the same quaternary rank are not listed) with 
colour-coded families. The majority of Cry toxins belong to the three domain Cry toxin family - depicted in blue. Two 
other families: Bin and ETX/MTX2 are coloured in pink and orange respectively. Cry toxins highlighted with other 
colours represent toxins unrelated to other Cry toxins and not classified into existing Cry toxin families. Additionally, 
parasporins are written in red. Figure was taken from Adang et al. (Adang et al., 2014).   
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The three domain Cry toxins represent the largest group of insecticidal Bt proteins, 
active mostly against Lepidoptera, Diptera, Coleoptera, Hemiptera and nematodes 
(Palma et al., 2014a). They share the five conserved blocks of amino acids in the 
sequence of the toxic core and a distinct three domain structure. Protoxins generally 
have two different lengths: around 70 and 130 kDa. The C-terminus of the protoxin 
often contains additional three conserved blocks 6-8, but is not required for toxicity 
(Schnepf et al., 1998). It is rich in cysteine residues and believed to be essential for 
crystal formation by facilitating the creation of the disulﬁde bonds between these 
residues within the crystals (Bietlot et al., 1990, Du et al., 1994).  
Several crystal structures of the three domain toxins have been solved by X-ray 
crystallography: Cry1Aa, Cry1Ac, Cry2Aa, Cry3Aa, Cry3Bb, Cry4Aa, Cry4Ba, Cry5B and 
Cry8Ea (Li et al., 1991, Grochulski et al., 1995, Morse et al., 2001, Galitsky et al., 2001, 
Boonserm et al., 2006, Guo et al., 2009, Hui et al., 2012, Derbyshire et al., 2001, 
Boonserm et al., 2005). Examples of the three domain structure are shown in Figure 4. 
 
Figure 4 Architecture of the three domain Cry toxins.  
Crystal structures of Cry1Aa, Cry2Aa, Cry3Aa and Cry4Ba showing the three domain structure common in some Bt 
Cry toxins. Domain I, II, and III are represented in red, green, and blue, respectively. Figure taken from Pigott and 
Ellar et al. (Pigott and Ellar, 2007).  
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Domain I, located at the N-terminus, is made up of 7-8 α-helices with a central 
hydrophobic α-helix 5. It is involved in membrane insertion and pore formation (Li et 
al., 1991). An umbrella model was postulated where α-helices 4 and 5 insert into the 
membrane by forming a hydrophobic hairpin, whereas the other α-helices lay flat on 
the surface of the cell membrane (Li et al., 1991). The middle domain II is comprised of 
three antiparallel β-sheets and plays an important role in receptor binding and 
specificity (Schnepf et al., 1998). At the base of domain II there are three flexible loops, 
with the second and the third one being principally involved in receptor recognition 
and binding (Adang et al., 2014). Domain III is a two antiparallel β-sheet sandwich that 
is also involved in receptor binding and possibly in pore formation (Li et al., 1991). It 
resembles a galactose binding domain and contains conserved blocks 3-5 (Adang et al., 
2014). 
The mechanism of action of the three domain Cry toxins is discussed in section 
1.4. Cry toxin receptors are described in section 1.6. 
The ETX/MTX2 family includes 11 members structurally very different from the 
three domain Cry toxins. They show sequence similarity to ETX - epsilon toxin from 
Clostridium perfringens and MTX2 - a mosquitocidal toxin from Lysinibacillus  
sphaericus (formerly Bacillus sphaericus) (Adang et al., 2014). Structurally this group is 
also related to aerolysin type β-pore forming toxins (PFTs) with elongated structures 
rich in β-sheets (Knapp, 2010); presented in section 1.3, Figure 5. Some toxins in this 
group, e.g. Cry23 and Cry37 exist as binary toxins, despite the lack of homology to Bin 
toxins (Palma et al., 2014a). MTX toxins are widely present in L. sphaericus strains and 
have mosquitocidal activities, but MTX related proteins found in Bt show toxicity 
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against some lepidopteran and coleopteran species (de Maagd et al., 2003). ETX forms 
β-barrel pores in the membranes of susceptible cells (Popoff, 2011). Due to structural 
homology ETX/MTX2 Cry proteins are believed to share a similar mode of action 
(Adang et al., 2014).  
The class of binary toxins (Bin) comprises of 13 proteins. They resemble Bin 
toxins found in the mosquitocidal strains of L. sphaericus, which are composed of two 
homologous components: Bin A and Bin B, both required for full toxicity. After 
solubilisation and proteolytic activation in insect midgut, Bin B is required for receptor 
binding, which is followed by cell death facilitated most likely by pore formation (de 
Maagd et al., 2003). However toxin internalization was also observed (Opota et al., 
2011) and the exact mode of action remains to be clarified (Berry, 2012). Contrary to 
Bin toxins from L. sphaericus, Bins found in B. thuringiensis strains show little 
homology between each other and their mechanism of action is unclear (Adang et al., 
2014). E.g. Cry35 is toxic towards the coleopteran Diabrotica virgifera virgifera only in 
the presence of unrelated Cry34 (Ellis et al., 2002).  
1.3 Introduction to parasporins 
There are a great number of Bt strains with no known insecticidal activity (Meadows et 
al., 1992). Therefore researchers in the past began to look for other activities 
associated with these strains. In 1999 Mizuki et al. screened the activated toxins from 
1744 Bt strains against human leukemic T-cells (MOLT-4). Hemolytic activity against 
sheep erythrocytes was tested as well. Out of 1684 strains with no hemolytic activity, 
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42 showed cytotoxic activity against these cancer cells. These strains did not show 
significant insecticidal activity when tested against 11 insect species of five orders: 
Lepidoptera, Diptera, Orthoptera (grasshoppers and crickets), Dictyoptera 
(cockroaches), and Isoptera (termites). Furthermore, a few proteins showed 
preferential activity, being able to discriminate between cancerous and healthy T cells, 
killing the former (Mizuki et al., 1999b). The results of this study revealed for the first 
time cytocidal activity of Bt Cry proteins against cancerous cells. After that report, 
further toxins with human cancer cell activity have been identified. A new group of Bt 
toxins was devised - named parasporins – described as: ‘B. thuringiensis and related 
bacterial parasporal proteins that are non-hemolytic but capable of preferentially 
killing cancer cells’ (Katayama et al., 2005b) and their application in the medical field 
was suggested (Ohba et al., 2009, Mizuki et al., 1999a). 
To date 19 parasporins have been discovered. They were classified into 6 
families, parasporin (PS) 1-6, by the Committee of Parasporin Classification and 
Nomenclature based on the primary amino acid sequence of protoxins 
(http://parasporin.fitc.pref.fukuoka.jp/intro.html). Similarly to other Cry toxins, a novel 
parasporin is assigned a four rank name based on the degree of sequence identity to 
previously identified toxins (Crickmore et al., 1998). In addition to already classified 
parasporins, many Bt strains showing anticancer activities have been isolated around 
the world, e.g. LDC-391 from India (Poornima et al., 2010), 64-1-94 from Caribbean 
Islands (Gonzalez et al., 2011a), and Bt18 isolated in Malaysia (Nadarajah et al., 2008).  
Anticancer activity of parasporins however does not mean that they do not 
affect normal cells at all. Initial studies on PS-1 reported low to moderate activity of 
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the native toxin against normal lung cells (Mizuki et al., 2000). Some cytopathic effects 
were observed in normal T-cells after exposure to recombinant PS-2 (Ito et al., 2004). 
Cytotoxicity was also induced in normal T-cells (Saitoh et al., 2006) and normal uterine 
UtSMC cells by recombinant PS-4 (Okumura et al., 2005), as well as UtSMC and normal 
lung MRC-5 cells by recombinant PS-5 (Ekino et al., 2014). Also, parasporins are not 
expected to have evolved to kill cancer cells, therefore their target insect(s), although 
currently unknown, may be present in nature. For example, Palma et al. already 
reported a novel Cry toxin related to PS-3 (40% pairwise identity), which possess 
speciﬁc toxic activity against the aphid Myzus persicae (Palma et al., 2014b). 
Parasporins differ in many aspects. Some of them share the five conserved 
blocks and the three domain structure. However, in general homology with each other 
or with other proteins is low. Based on their molecular weight size parasporins can be 
divided into two groups. Parasporins processed to the active form of around 60 kDa 
include: PS-1, PS-3 and PS-6, which with varying degrees contain the five conserved Cry 
toxin blocks characteristic of three domain toxins. Parasporins 2, 4 and 5 are cleaved to 
a smaller mass fragment of around 30 kDa (details in Table 1). Parasporins target 
different cell lines and different levels are required for cytotoxicity. They also have 
different cytotoxic spectra; some are cytotoxic to a wide range of cancer cell lines, 
whereas others affect only a few of them. Sensitive cells do not seem to possess any 
obvious common characteristics responsible for susceptibility towards parasporin(s). 
More importantly, the mechanism of cell killing seems to be different. Also, different 
morphological effects have been observed after treatment with the same parasporin 
depending on the cell type. At present, only the cytotoxic effects of parasporins: 1, 2 
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and 4 have been closely examined, and each toxin appears to have a distinct mode of 
action (Ito et al., 2004, Ohba et al., 2009).  
Parasporin-1 (Cry31Aa1 from strain A1190) 
PS-1 presents cytocidal activity towards HeLa, HL-60, MOLT-4 and HepG2 cells 
(Katayama et al., 2005a). The toxin shows low (<25%) amino acid sequence homology 
to existing Bt proteins. It contains the five blocks conserved in three domain Cry toxins 
but sequence homology is low, particularly within the third block (Mizuki et al., 2000). 
Proteolytic cleavage resulted in two tightly associated polypeptides of 15 and 56 kDa 
(Katayama et al., 2005a). Its crystal structure was resolved at 1.76 Å resolution, but 
only incomplete data was released into the public domain. The protein showed a three 
domain structure common to insecticidal Cry toxins with an additional N-terminal 
region resembling that seen with Cry2Aa (PDB ID: 1I5P) (Akiba et al., 2005, Akiba and 
Okumura, 2016). 
A novel mechanism of action was proposed for PS-1. The toxin seems to 
activate apoptotic signalling in HeLa cells causing rapid Ca2+ influx, without alterations 
in membrane permeability (Katayama et al., 2007). PS-1 decreased cell viability 
gradually. Cytopathic effects, like cell ballooning were observed only after 8 – 10 hours 
in susceptible HeLa and MOLT-4 cells, despite a relatively high toxin dose being used 
(10 µg/ml). This is the first parasporin reported that did not effectively compromise 
membrane integrity. The membrane of susceptible cells stayed polarized and 
impermeable to a small DNA binding dye within 30 minutes of PS-1 treatment. Also, 
there was no significant release of a big cytosolic marker (LDH) within 4 hours 
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(Katayama et al., 2007). Instead, within the first few minutes of treatment levels of 
intracellular Ca2+ increased, indicated by the intracellular calcium probe Fura-2. 
Calcium influx was from extracellular space as cytotoxicity was reduced in medium 
with low Ca2+ and it correlated with toxin dose and sensitivity levels of four cell lines 
tested. A set of various Ca2+ influx inhibitors were tested on PS-1 activity including 
voltage dependent Ca2+ channel antagonists. However only suramin, which inhibits G 
protein coupled receptors (GPCR), substantially reduced calcium influx and PS-1 
cytotoxicity. Toxin also activated apoptotic signalling as indicated by increased 
caspase-3 levels and PARP cleavage in treated cells and inhibited protein and DNA 
synthesis. The authors proposed that PS-1 is not a pore forming toxin and its action 
involves the activation of GPCR, calcium influx and apoptosis resulting from disrupted 
calcium homeostasis (Katayama et al., 2007). 
However, it is worth mentioning that a close homolog of PS-1 - designated as 
PS-1Aa2 or Cry31Aa2 (94% sequence identity) - was demonstrated to form pores in 
artificial membranes. Conductance values were not as big as the ones recorded for 
other Cry toxins (section 4.7), but the presence of ionic channels formed in the 
absence of cellular content and protein receptors may be a strong evidence of pore 
forming capacity of this group (Cry31A) of Cry toxins. Moreover, the same research 
group also reported Cry31Aa2 induced calcium oscillations, even in the absence of 
extracellular calcium and in non-cancer cell line HEK 293 (Gabriel Narvaez, 2014). 
Interestingly, the authors that revealed the PS-1 crystal structure proposed that the 
presence of the additional N-terminal region, which locks domain I, may be responsible 
for hindered pore formation of this particular toxin (Akiba et al., 2005, Akiba and 
Okumura, 2016). 
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In 2011 a patent application was published regarding the identification of a PS-
1 receptor. In this document a tumor suppressor protein – beclin-1 – was reported as 
the PS-1 receptor in HeLa cells, based on experiments where anti-beclin-1 antibody 
suppressed toxin binding and cytotoxicity (Katayama et al., 2011). 
Parasporin-2 (Cry46Aa1 from strain A1547) 
PS-2 is highly cytotoxic to a wide range of cancer cell lines (Table 1), like MOLT-4, 
Jurkat, and HepG2 cells (Kitada et al., 2006); however the main cell line used in PS-2 
research was HepG2. The activity of PS-2 was additionally tested in tumor slices. 
Tissues isolated from differentiated hepatocellular carcinoma and colon cancer were 
incubated with PS-2 resulting in cancerous but not non-neoplastic cells showing a 
cytopathic appearance (Ito et al., 2004, Kitada et al., 2006). 
Immunofluorescence established toxin association with the plasma membrane 
of susceptible cells (Kitada et al., 2006). PS-2 induced rapid cell swelling and blebbing, 
disintegration of organelles and cytoskeleton in HepG2 cells. Swelling was observed in 
toxin treated MOLT-4 cells. Cell permeability assays measuring LDH release and PI 
staining demonstrated rapid membrane damage. Experiments with osmoprotective 
PEGs indicate that PS-2 induced the formation of large, up to 3 nm in diameter, pores 
(Kitada et al., 2006). Low doses of PS-2 induced caspase activation and DNA 
fragmentation in HepG2 cells; however a caspase inhibitor did not prevent cytotoxicity, 
indicating that the mode of action is primarily non-apoptotic (Ito et al., 2004). 
PS-2 was targeted to the lipid rafts in HepG2 cells, where it required GPI - 
anchored proteins for oligomerization and cytotoxicity (Kitada et al., 2009, Okumura et 
32 
 
al., 2011). PS-2 formed ~200 kDa SDS-resistant membrane embedded oligomers in 
susceptible cells, a temperature dependent process that correlated with membrane 
permeability and was significantly inhibited by cholesterol depletion or membrane 
solubilisation (Abe et al., 2008). Further experiments that examined the effect of 
cholesterol depletion on cell viability showed only small contribution of cholesterol in 
cytotoxicity. Conversely, depletion of GPI-linked proteins with PI-PLC treatment 
significantly inhibited PS-2 activity due to decreased efficiency in binding and 
oligomerisation (Kitada et al., 2009). 
The crystal structure of activated PS-2 was solved. The toxin is extremely 
elongated with dimensions of 115 x 30 x 29 Å. It has a track of serine and threonine 
residues exposed along the long axis, which is thought to play a role in oligomerisation 
and pore formation (Akiba et al., 2009b). The structure is different from the ones 
resolved for other three domain Cry and Cyt toxins. Based on primary amino acid 
sequence homology it does not belong to the ETX/MTX2 Cry toxin family (Figure 3), 
however structurally resembles one of them, as well as the proteins in the Toxin_10 
family (which possess an additional beta trefoil motif in the head domain) and 
aerolysin-type β-PFTs (Figure 5), which supports a proposed pore formation activity of 
PS-2. It also shares structural similarity with hydralysin (Sher et al., 2005).  
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Figure 5 Crystal structure of PS-2 (Cry46) and its structural homologues.  
PS-2 (Cry46) crystal structure was resolved at a resolution of 2.38 Å (PDB ID: 2ZTB). Its structural homologues 
include: Cry45 - a non-toxic protein related to PS-4 from A1470 Bt strain (PDB 2D42), Cry51 (PDB 4PKM) from Bt, 
BinB (PDB 3WA1) from L. sphaericus, Cry35 (PDB 4JP0) from Bt, lectin (Lsulph) from L. sulphureus (PDB 1W3A), and 
proaerolysin (PDB 1PRE) from A. hydrophila. Head domains are presented in light blue and tail domains in dark blue, 
with the extra domain in proaerolysin in green. Figure was edited from Berry et al. (Berry and Crickmore, in press). 
 
Parasporin-3 (Cry41Aa and Cry41Ab from strain A1462) 
Protein inclusions containing PS-3 were originally isolated from Bt strain designated 
89-T-26-17 (later named A1462), from a soil sample in Tokyo, Japan (Mizuki et al., 
1999b). This strain produced bi-pyramidal shaped crystals of differing sizes: 0.6-2 µm 
long, 0.4-1.1 µm wide (Yamashita et al., 2000). Genes encoding PS-3 were first 
identified and characterised in 2005 (Yamashita et al., 2005). DNA cloning and 
sequencing revealed the existence of two gene complexes, each comprised of three 
ORFs: ORF1, ORF2 and ORF3, located close to each other and orientated in the same 
direction. Putative ribosome binding sites were identified upstream of each ORF and 
no transcriptional terminator sequence was present in between the ORFs (Yamashita 
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et al., 2005). ORF1 encodes a hypothetical protein of 19 kDa (predicted MW). ORF2 
codes for the 93 kDa (predicted MW) protein with cytocidal activities and contains the 
five conserved blocks (1-5) commonly found in Cry toxins and accountable for the 
three domain fold (Schnepf et al., 1998). Additionally, the C-terminus of the protein 
coded by ORF2 contains a sequence belonging to ricin superfamily (Yamashita et al., 
2005), similar to that of Clostridium botulinum hemagglutinin HA-33 (Tsuzuki et al., 
1990). 82 kDa (predicted MW) protein coded by ORF3 includes the additional three 
conserved blocks (6-8), lying outside the active toxic core in 130-140 kDa Cry protoxins, 
and believed to help facilitating crystallization and expression (Schnepf et al., 1998). 
The two encoded toxins were designated as Cry41Aa1 and Cry41Ab1 by the Bt 
Toxin Nomenclature Committee (Crickmore, 2016). The deduced amino acid sequence 
of these two proteins uncovered a high degree of homology between them (87%, 88% 
and 99% homology between the proteins coded by ORFs: 1, 2 and 3 respectively). SDS 
PAGE analysis revealed that alkali solubilisation in the presence of DTT resulted in five 
major bands ranging from 88-180 kDa, while in the absence of DTT, solubilisation 
yielded only two 88 kDa proteins, indicating that the others stayed insoluble. 
Solubilized proteins did not possess cytocidal activity, unless treated with a protease. 
Proteinase K treatment cleaved 88 kDa protoxin to 64 kDa active toxin. N-terminal 
sequencing detected ORF2 sequence in the 88 and 64 kDa bands, whereas ORF3 
sequence was found in 120 kDa band (Yamashita et al., 2005). Digests with other 
proteases (trypsin, chymotrypsin) resulted in two bands (around 64 and 80 kDa) and a 
lower cytocidal activity against MOLT-4 cells compared to activation with proteinase K 
(Yamashita et al., 2000). 
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In the initial screen of 1744 Bt parasporal proteins against human cells 124 
µg/ml of activated PS-3 (in the study addressed as 89-T-26-17) showed cytotoxic 
activity against human leukemic T-cells (MOLT-4), but not to normal T-cells or human 
erythrocytes. It also showed little or no insecticidal activity against 11 insect species 
from five different orders (Mizuki et al., 1999b). In the succeeding study, dose 
response experiments with activated protein inclusions from A1462 against HeLa and 
MOLT-4 showed that EC50 for HeLa was 37.6, and >130 µg/ml for MOLT-4, whereas 
normal T-cells were unaffected even at a high 130 µg/ml dose (Yamashita et al., 2000). 
In the 2005 study, the cytopathic effect of purified Cry41Aa and Cry41Ab was tested 
individually using a broad range of mammalian cell lines (Figure 6).  
 
Figure 6 Cytotoxicity of purified Cry41Aa and Cry41Ab proteins on mammalian cells. 
Cytotoxicity of proteinase K activated, purified Cry41Aa and Cry41Ab was tested on various cell lines using an MTT 
cell viability assay 24 hours after toxin treatment. Figure was edited from Yamashita et al. (Yamashita et al., 2005). 
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Cry41Aa and Cry41Ab exhibited strong cytocidal activity only against HL-60 (myeloid 
leukaemia cancer) and HepG2 (liver cancer) cells with EC50 of 1.25 and 1.86 µg/ml 
respectively (for Cry41Aa). The other cells tested, including four human non-cancer cell 
types, were not affected by this toxin treatment. Decrease in viability (tested in an 
MTT assay) and membrane damage (assessed by LDH efflux assay) were more rapid in 
Cry41Aa treated cells, suggesting Cry41Aa was more toxic than Cry41Ab (Yamashita et 
al., 2005). 
Morphological observations of compromised HepG2 cells (Figure 7) showed 
widespread swelling within one hour and a serious membrane damage within 24 hours 
detected with Trypan Blue staining (Yamashita et al., 2005). In the previous study, 
following application of high doses of PS-3, rapid cell swelling was also noted in HeLa 
and MOLT-4 cells, two cell lines reported later as non-susceptible to the toxin 
(Yamashita et al., 2005, Yamashita et al., 2000). 
 
Figure 7 Morphological changes in HepG2 cells following PS-3 treatment.  
The effect of Cry41Aa and Cry41Ab was recorded 1 and 24 hours post-treatment. Cells stained with Trypan Blue 
point to membrane damage (bar = 50 μm). Figure edited from Yamashita et al. (Yamashita et al., 2005). 
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As mentioned earlier, the cry41Aa gene exists as part of a three gene operon in the 
native A1462 strain. cry41Aa was expressed by Krishnan, et al. (Krishnan, 2013). PCR 
primers were designed to amplify the ORF2 and ORF3 and incorporate suitable 
restriction sites: a BamHI 22 bp upstream from the ORF2 start codon and an XbaI 16 bp 
downstream of ORF3. These two ORFs and their ribosome binding sites  were cloned 
into the E. coli - Bt expression vector pSVP27A (Crickmore and Ellar, 1992). This vector 
places cloned genes under the control of the promoter for the Bt cyt1Aa toxin gene. 
The resulting vector (pSVP2741Aa) was introduced into the acrystalliferous Bt strain 
4D7 (Krishnan, 2013). In this work, the name Parasporin-3 (or PS-3) refers to the 
Cry41Aa protein, encoded by cry41Aa gene, expressed in the Bt 4D7 strain by 
Krishnan, et al. (Krishnan, 2013). Amino acid sequence of PS-3 ORF2 with conserved 
blocks and domains is presented in Figure 8. 
 
Figure 8 Deduced amino acid sequence of PS-3 protoxin encoded by ORF2.  
Putative domains marked with coloured boxes were identified based on sequence comparison with other three 
domain Cry toxins (Elhigazi et al. unpublished). Conserved blocs written in red are based on sequence comparison 
by Yamashita et al. (Yamashita et al., 2005). N- and C-terminal regions of the protoxin, incorporating a ricin type 
domain and most probably cleaved off by proteinase K, are positioned outside coloured boxes. Extra loop region in 
a blue box represents a region not found in other three domain Cry toxins.    
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According to Yamashita et al. cleavage by proteinase K occurs after alanine at position 
60 and is prerequisite for toxicity (Yamashita et al., 2005). The N-terminal sequence 
analysis of trypsin cleaved PS-3 (upper band sequenced) may indicate that the 
cleavage takes place after arginine at position 63 (Souissi, unpublished). Similarly to 
many insecticidal Cry toxins, only a small portion of PS-3 is cleaved at the N-terminus 
with majority of processing done at the C-terminus (Schnepf et al., 1998).  
Figure 9 shows predicted three dimensional structure of PS-3 protoxin 
generated by Phyre2 (Kelley et al., 2015), viewed using UCSF Chimera 1.10.1 (Pettersen 
et al., 2004).  
 
Figure 9 Structural model of PS-3 protoxin showing the three domain Cry toxin organisation.  
Based on 13 templates 792 residues of PS-3 protoxin (96%) were modelled at >90% accuracy by Phyre
2
. Domain I is 
represented by the blue helix bundle, domain II by the light green β-sheets and domain III by the yellow β-sandwich. 
C-terminal ricin domain is depicted in red and the unstructured extra loop of domain I is presented in light blue. 
 
One notable aspect of this protein is that it is the only parasporin identified so far in 
which the five blocks are well conserved and is the most closely related to the 
insecticidal three domain Cry toxins. This poses a question whether similarity is also 
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reflected in their mode of action. Another feature of PS-3 is the presence of a ricin-
type domain, which is not normally present in Cry toxins, as well as a short 
unstructured region located within domain I named the extra loop (Figure 8 and Figure 
9). Whereas deletion of the 111 amino acids from the C-terminus containing the ricin 
domain did not abolish or decrease protein toxicity against HepG2 cells (Krishnan, 
2013), the removal of 31 amino acids encoding  the extra loop resulted in an unstable 
protein (Banani et al., unpublished). Furthermore, sequence comparison of PS-3 and 
insecticidal toxins identified a putative binding site, loop 3 in domain II of PS-3, which 
in insecticidal Cry toxins plays a major role in receptor binding (Pardo-Lopez et al., 
2013a). Alanine scanning experiments, involving changing hydrophobic to alanine 
residues in this putative loop revealed that F509A and W511A mutations (but not 
Y514A) completely abolished PS-3 cytotoxicity. Further mutagenesis experiments 
showed that F509Y and W511F remained toxic contrary to F509W, F509S, and F509L. 
These results may indicate that amino acid with a single aromatic ring at position 509 
and amino acid with aromatic rings at position 511 are important for the function of 
the toxin (Elhigazi et al., unpublished). 
Parasporin-4 (Cry45Aa1 from strain A1470) 
PS-4 exhibits toxicity mainly towards CACO-2, Sawano, and MOLT-4 cells (Okumura et 
al., 2005). Similar to PS-2, it does not contain the five conserved Cry blocks and showed 
low homology (<25%) to existing proteins. Structure of a close PS-4 homolog is 
presented in Figure 5. The authors suggested that PS-4 is an aerolysin type β-PFT due 
to high amount of β structure (51%) measured by a CD spectrum and a weak sequence 
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identity to β-PFTs like: α toxin from C. septicum, epsilon from C. perfringens, and 
aerolysin from A. hydrophila (Okumura et al., 2011).  
A novel method of toxin activation in acidic conditions was described by 
Okumura et al. Toxin was solubilised in 10 mM HCl and activated with pepsin. While 
cytotoxic activity remained the same, the efficiency of a protein yield was 27 times 
higher compared to activation in alkaline conditions (Okumura et al., 2008, Okumura 
et al., 2006).  
Within the first 10 minutes of PS-4 treatment swelling and membrane blebbing 
were observed in susceptible MOLT-4 cells. Over time shrinkage and disintegration of 
the nucleus occurred as early as 1 hour post-treatment and the cell burst within 24 
hours. PS-4 induced membrane damage and formation of large pores in the membrane 
of MOLT-4 cells, as evidenced by the passage of 70 kDa dextrans and LDH efflux. 
Despite non-specific monomer binding observed in non-susceptible cells, SDS-resistant 
90-200 kDa oligomers were detected only in susceptible cells, which increased in a 
time dependent manner after toxin treatment. Further research found little caspase 
activation following treatment with low or high doses of PS-4 and cholesterol 
independence (Okumura et al., 2011).  
Interestingly, strain A1470 produces multiple proteins including PS-4 (Okumura 
et al., 2005), and a protein designated as PS-2Aa2, which differs from PS-2 (from strain 
1547) by four amino acids (Okumura et al., 2013). It is consistent with the observation 
that inclusion proteins from A1470 strain were more toxic than recombinant PS-4 with 
EC50 towards MOLT-4 of 0.13 and 0.47 µg/ml respectively (Saitoh et al., 2006). 
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Parasporin-5 (Cry64Aa1 from strain A1100) 
Out of 18 mammalian cell lines tested, PS-5 showed strong cytocidal activity (EC50 
values below 0.1 μg/ml) against 5 human: MOLT-4, HepG2, TCS (uterus cervix cancer), 
HeLa, Sawano and 2 monkey kidney cell lines: COS7 and Vero. The 34 kDa protoxin was 
cleaved by proteinase K at the C-terminal to produce a 30 kDa toxin. Similarly to PS-2 
and PS-4, the protein showed slight homology to aerolysin type β-PFTs (<35%). 
Microscopic observation revealed rapid cell swelling (MOLT-4) within the first hour of 
treatment. The mode of action is unknown, but it is predicted to act as a β-PFT, 
similarly to PS-4 (Ekino et al., 2014). 
Parasporin-6 (Cry63Aa1, CP84 from strain M019) 
Three cytotoxic proteins were isolated from strain M019. CP78A and CP78B were 
added into the PS-1 family based on sequence similarities. CP84 was assigned to a new 
parasporin-6 class. Trypsin activation of the 84 kDa protoxin produces two fragments 
(14 and 59 kDa), which together are toxic to HeLa and HepG2 cells. Interestingly, the 
N-terminus of the protoxin that shows structural homology to PS-1 is cleaved during 
the digestion step, and the resistant core partially resembles the three domain 
structure. It shows 56% sequence similarity with Cry2A toxin in the region of the five 
conserved blocks. After PS-6 treatment, cell swelling was apparent in both susceptible 
cell lines, with additional vacuole formation in HepG2 cells (Nagamatsu et al., 2010).  
Table 1 presents a comparison of the best characterised parasporins so far: PS-
1, PS-2, PS-3 and PS-4.  
Table 1 Comparison of parasporins 1-4. 
Human cell line origins: Jurkat (leukemic T-cell), HepG2 (liver cancer), Sawano (cervical cancer resistant to cisplatin treatment), MOLT-4 (acute lymphoblastic leukaemia), HL-60 (myeloid- 
granulocyte precursor in bone marrow- leukaemia), CACO-2 (epithelial colorectal adenocarcinoma cells), UtSMC (normal uterus smooth muscle cells), TCS (uterus cervix cancer). 
 PS-1 PS-2 PS-3 PS-4 
Native strain 84-HS-1-11; A1170 90-F-45-14; A1547 89-T-26-17; A1462 89-T-34-22; A1470 
Cry designation Cry31Aa1 Cry46Aa1 Cry41Aa1 Cry45Aa1 
Serovar kurstaki dakota Untypable shandongiensis 
Susceptible cancer  
cell lines 
(EC50 μg/ml): 
HeLa (0.12), HL-60 (0.32), 
MOLT-4 (2.2), HepG2 (3) 
Jurkat (0.015), HepG2 
(0.023), Sawano (0.041), 
MOLT-4 (0.044),  
HL-60 (0.066) 
HL-60 (1.25),  
HepG2 (1.86) 
 
CACO-2 (0.12), Sawano 
(0.24), MOLT-4 (0.47), TCS 
(0.71), HL-60 (0.72), 
HepG2 (1.9) 
Lethal dose used (µg/ml) 10 0.1 10 2-4 
Activity towards normal 
cells (EC50 µg/ml) 
Initial studies reported 
low to moderate activity 
against lung cells; UtSMC 
cells (>10) 
T cells (0.148), 
hepatocytes (>10) 
T cells (>10),  
hepatocytes (>10) 
Significant activity against 
T cells of native and 
recombinant PS-4; 
recombinant PS-4 also 
cytotoxic to UtSMC 
Activation enzyme Proteinase K, trypsin Proteinase K Proteinase K Proteinase K, pepsin 
Protoxin (kDa) 81 37 88 31 
Active fragment (kDa) 15 and 56 – heterodimer 30 64 27 
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Cleavage at a terminus N N and C N and C N and C 
Conserved Cry toxin 
blocks 
Blocks detected in 56 kDa 
fragment but low 
homology especially in 
block 3 
Not present 
Blocks 1-5 in the active 
fragment 
Not present 
Structural homology 
Crystal structure resolved: 
similar to a three domain 
Cry toxin fold 
Crystal structure resolved: 
similar to aerolysin type β-
PFTs 
Possibly similar to a three 
domain Cry toxin fold 
Possibly similar to 
aerolysin type β-PFTs 
Sequence homology 
Low sequence homology 
to Bt proteins (<25%)  
Low sequence homology 
to Bt proteins (<25%) and 
β-PFTs from other species. 
41% sequence identity to 
hydralysin from Ch. 
viridissima 
Low sequence homology 
to Bt proteins (<30%). 34% 
sequence identity with 
coleopteran active Cry3Ba. 
Presence of a ricin type 
domain 
Low sequence homology 
to Bt proteins (<30%) and 
β-PFTs from other species 
Apoptosis 
Presence of apoptotic 
markers in HeLa cells 
treated with PS-1 (10 
µg/ml); caspase inhibitor 
decreased cytotoxicity 
Presence of apoptotic 
markers in HepG2 cells 
treated with low PS-2 
dose, but caspase 
inhibitor did not prevent 
Not assessed 
Little caspase 3/7 activity, 
induced as a secondary 
effect by a high PS-4 dose 
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cytotoxicity 
Morphology of susceptible 
cells 
Granulation of the 
cytoplasm, swelling 
(MOLT-4 and HeLa), 
swelling (HepG2), 
fragmentation (HL-60) 
Blebbing, disintegration of 
cytoskeleton and 
organelles (HepG2), 
swelling, vacuolation 
(MOLT-4) 
Swelling within 1 hour and 
membrane rapture within 
24 hours (HepG2) 
Swelling and blebbing 
within 10 minutes, nuclear 
disintegration within 1 
hour, membrane rupture 
within 24 hours (MOLT-4) 
Membrane permeability 
No membrane damage 
 (PI, LDH) or 
depolarisation (DiSC3) 
Rapid membrane damage 
(PI, LDH) and 
depolarisation (DiBAC4) 
Rapid membrane damage 
(LDH, Trypan Blue) 
Rapid membrane damage 
(LDH, flow cytometry) 
Pore size 
No small pores within 30 
minutes (PI), no big pores 
within 4 hours (LDH) 
Big (up to 3 nm) pores 
(PEGs) 
Not assessed 
Big pores  
(70 kDa dextrans enter 
MOLT-4 cells) 
Oligomerization and 
cholesterol dependence 
Not assessed 
Formation of 200 kDa SDS 
resistant oligomers in 
HepG2 cells corresponded 
with cytolysis and 
decreased after depletion 
of cholesterol or GPI-
anchored proteins  
Not assessed 
Formation of 90-200 kDa 
SDS resistant oligomers in 
CACO-2 and MOLT-4 but 
not in resistant HeLa cells. 
PS-4 activity is cholesterol 
independent 
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Receptor Beclin-1 
Possibly a GPI-anchored 
protein 
Not identified Not identified 
References: 
(Katayama et al., 2007, 
Katayama et al., 2005a, 
Mizuki et al., 1999a, 
Mizuki et al., 2000, Akiba 
et al., 2005, Katayama et 
al., 2011, Akiba and 
Okumura, 2016) 
(Abe et al., 2008, Ito et al., 
2004, Kim et al., 2000, 
Kitada et al., 2009, Kitada 
et al., 2006, Okumura et 
al., 2008, Akiba et al., 
2009a) 
(Mizuki et al., 1999a, 
Yamashita et al., 2000, 
Yamashita et al., 2005) 
(Okumura et al., 2011, 
Okumura et al., 2005, 
Okumura et al., 2006, Lee 
et al., 2001, Okumura et 
al., 2008) 
1.4 Different models of Cry toxin modes of action 
The exact mechanism of insect killing by the Cry toxins has been the subject of 
discussion for a long time. Results gathered in this area are intriguing and often 
inconsistent. Conflicting theories result from the presence of many different insect 
targets, toxins and receptors that are currently under investigation and are further 
complicated by experimental artefacts.  
Given that pore-facilitated cytolysis is a common strategy adopted by 
pathogenic bacteria, it is not a surprise that the most widely accepted model of Cry 
toxin mode of action is based on the colloid-osmotic lysis model, proposed first by 
Knowles and Ellar in 1987 (Knowles and Ellar, 1987). It is based on the action of the 
three domain δ-endotoxins on lepidopteran larvae. In order to exert toxicity, the Bt 
crystals have to be ingested by the larvae. They are solubilized inside their guts, usually 
in high pH (above 9.5). After that, the protoxin is cleaved by midgut proteases to the 
toxic core. Activated in this way toxin binds to a specific receptor in the gut brush 
border membrane. Following toxin-receptor interaction, toxin oligomerization occurs. 
In vitro studies support the hypothesis that oligomerization of monomeric Cry toxins 
does not occur spontaneously in a solution, suggesting that it requires interaction with 
the membrane (Güereca and Bravo, 1999). Following toxin insertion into the 
membrane, non-specific pores are formed. Generation of pores results in rapid 
changes in membrane potential, ion imbalance, influx of water, cell swelling, colloid-
osmotic lysis of gut cells, and larval death (Knowles and Dow, 1993). Since the colloid-
osmotic lysis model was proposed, many further studies provided additional 
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information in the aim to unravel the mechanism of toxicity, including e.g. the 
identification of receptors and crystal structures of different Cry toxins, including 
structures of toxin-receptor complexes. The main current models are presented below.  
The Bravo Model 
The Bravo model is based on Knowles and Ellar osmotic-lysis theory and involves 
experiments with insecticidal Cry1Ab and its interactions with Manduca sexta brush 
border membrane vesicles (BBMV). It suggests that Cry1A toxins require not one but 
two receptors for toxin action: cadherin-like protein (e.g. BT-R1) and aminopeptidase 
N (APN) (Bravo et al., 2004). The model proposes sequential binding of the activated 
monomers to these receptors. This hypothesis is based on co-immunoprecipitation 
experiments, which provide evidence that primary binding of Cry1Ab to BT-R1 is 
followed by binding to APN (Bravo et al., 2004). Binding to BT-R1 facilitates cleavage of 
α-helix 1 of the domain I by membrane-associated proteases, which is thought to 
expose a hydrophobic surface allowing toxin oligomerization into pre-pore structures 
(Gómez et al., 2002). Supportive data comes from Soberón et al., who demonstrated 
that genetically modified Cry1Ab and Cry1Ac lacking helix α-1 region (named 
Cry1AbMod and Cry1AcMod) are able to form oligomeric structures in vitro in the 
absence of cadherin receptor and exert toxicity in vivo in resistant insects with a 
mutated cadherin gene (Soberón et al., 2007). Finally, oligomerization greatly 
increases binding affinity to the second receptor APN, which directs oligomers into the 
lipid rafts facilitating insertion and tetrameric pore formation (Bravo et al., 2004). 
However, there is evidence that toxin monomers can also insert into the membrane. 
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Changes in the number of fluorophore labelled Cry1Aa monomers were monitored in 
the lipid bilayer system. The toxin entered the membrane as monomers before 
forming tetrameric pores, indicating that oligomerization could be occurring after toxin 
insertion by lateral diffusion of the monomers (Groulx et al., 2011). A simplified 
mechanism of the Bravo pore formation model is depicted in Figure 10 (top diagrams). 
 
Figure 10 Two different models representing the mode of action of Bt Cry toxins. 
Cry toxins are solubilised and cleaved by proteases followed by toxin monomer binding to a cadherin-like receptor 
(1, 2, and 3; steps shared in both models). Top diagrams (4-6) represent the Bravo model in which, after cadherin 
binding, a small portion of the toxin is cleaved, monomers are able to oligomerize, oligomers bind to the second 
GPI-anchored receptor, which facilitates membrane insertion and pore formation. Bottom diagrams (4a-5a) 
represent the signalling model according to Zhang et al., which proposes the involvement of adenylyl 
cyclase/protein kinase A signalling pathway. Figure was taken from Bravo et al. (Bravo and Soberón, 2008). 
 
More recently, a ‘ping pong’ binding mechanism was suggested by Pacheco et al., 
where the Cry1Ab monomer first binds with low affinity to highly abundant APN 
through domain II loop 3. This is followed by binding with higher affinity to the second 
low-abundance receptor cadherin via loops in domain II (including loop 3). Cleavage of 
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α–helix 1 and oligomerization increase binding affinity to APN via domain III. Finally 
APN facilitates oligomer insertion in the membrane. Pacheco et al. showed that 
mutations in domain II loop 3 of Cry1Ab differentially affected binding to the two 
receptors depending on the oligomeric state of the toxin. Because binding of the 
monomeric - but not oligomeric - Cry1Ab mutants to APN was greatly reduced, this led 
to the conclusion that oligomerization involves conformational change which in turn 
affects receptor interaction. This ‘ping pong’ interaction with receptors (graphically 
shown in Figure 11) together with toxin oligomerization were proposed to be 
prerequisite for Cry1Ab toxicity towards M. sexta (Pacheco et al., 2009).   
 
Figure 11 ‘Ping pong’ mechanism suggested for Cry1A toxins in lepidopteran insects. 
A ‘ping pong’ model suggests initial Cry1A toxin binding with a low affinity to ALP or APN receptors (APN in 
Manduca sexta or ALP in Heliothis virescens), followed by a high affinity interaction with cadherins that promotes 
cleavage of the N-terminal end of the toxin. After cleavage toxin monomers oligomerize into pre-pore structures 
that bind APN or ALP with high affinity resulting in pore formation. The figure was taken from Pardo-Lopez et al. 
(Pardo-Lopez et al., 2013b). 
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The Zhang model 
Another mechanism proposed by Zhang et al., attributes toxic events solely to a 
signalling pathway, and not to pore formation. This group suggested that only the 
monomeric form of Cry1Ab can specifically bind to BT-R1 receptor and induce toxicity, 
and that toxin oligomers do not form lytic pores (Zhang et al., 2005). Further, the 
model states that the mode of action involves an adenylyl cyclase (AC), protein kinase 
A (PKA) signalling pathway (Zhang et al., 2006) as illustrated in Figure 10 (bottom 
diagrams) and Figure 12. 
The model is based on experiments conducted using Cry1Ab toxin and 
transformed ovarian cells of the cabbage looper Trichoplusia Ni. The cell line, called S5, 
has been engineered to stably express BT-R1 receptor on the cell surface. Western blot 
experiments using anti-Cry1Ab antibody showed that only monomeric form of the 
toxin incorporated into the membranes of cells expressing BT-R1, whilst oligomeric 
forms were detected in membrane fractions of both susceptible and non-susceptible 
cells. Moreover blocking the receptor binding site prevented monomer but not 
oligomer incorporation in the membrane while inhibiting the toxicity. Monomer 
incorporation in S5 cells was rapid (5 minutes after treatment) and stable, whereas 
oligomer incorporation started appearing after 15 minutes and was dose dependent in 
both S5 and non-susceptible cells. Moreover, oligomers stayed incorporated in the 
membrane for a few generations without any toxic effects. All these results led to the 
conclusion that only toxin monomers can bind specifically and exert toxicity in 
susceptible cells (Zhang et al., 2005).  
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In the proposed model Zhang et al. further suggested that binding of the 
monomer to BT-R1, stimulates a G protein-coupled receptor (GPCR), which activates 
AC/PKA pathway. After activation of GPCR with extracellular ligand, a conformational 
change occurs in the attached heterotrimeric G protein complex on the intracellular 
side of the membrane. The Gαs subunit exchanges GDP for GTP, dissociates from the 
complex and binds to AC. Activated AC promotes the increase of a second messenger 
cAMP in cytoplasm, which in turns activates PKA. PKA regulates a wide range of 
cellular processes such as gene expression, protein phosphorylation, and conductance 
of ion channels (Lodish, 2008). The Zhang et al. model is based on the experiments, 
which show that cAMP and PKA levels increased in toxin treated S5 cells, cell 
permeable inhibitors of Gαs and AC considerably decreased cytotoxicity of Cry1Ab, 
whereas two PKA inhibitors completely prevented morphological changes (blebbing 
and swelling) and cellular death (Zhang et al., 2006). Zhang et al. additionally showed 
that Cry1Ab toxicity can be abolished by 5 mM EDTA cell pre-treatment in vitro. This 
effect was interpreted as Mg2+ depletion as supplementation with magnesium salt 
restored toxicity. Interestingly, EDTA prevented toxicity, but not the binding, as 
evidenced by the monomer and oligomer bands detected in western blot analysis of 
EDTA treated cells. The authors suggested the importance of Mg2+ ions in post-binding 
toxicity of Cry1Ab and imply that interaction with the receptor is not sufficient for full 
toxin action (Zhang et al., 2005). The authors support the AC/PKA signalling pathway 
model with the fact that Mg2+ is required in the mechanism of cAMP synthesis by AC as 
well as for stimulation of G protein (Sprang, 1997, Tesmer et al., 1999, Zimmermann et 
al., 1998).  
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Figure 12 The Zhang model implicating AC/PKA signalling pathway in toxicity of Cry proteins.  
The Zhang model postulates that it is the binding of the monomeric Cry1Ab toxin to cadherin receptor that leads to 
toxicity. Receptor binding results in G protein stimulation, which activates adenylyl cyclase and subsequent increase 
of cAMP in cytoplasm. Increased levels of cAMP activate protein kinase A, which phosphorylates target proteins 
leading to disruption of ion channels and cell death. Figure was taken from Zhang et al. (Zhang et al., 2006). 
 
The Zhang model remains controversial and has been challenged (Kirouac et al., 2006, 
Vachon et al., 2012). Conclusions drawn by Zhang et al. are based on experiments that 
involved an engineered insect cell line, transformed to express BT-R1, which does not 
represent midgut environment of the susceptible insect larvae. Vachon et al. points to 
the fact that the amount of EDTA used by Zhang et al. was insufficient to effectively 
chelate all MgCl2 present in the insect medium and that low pH of the medium 
affected the efficiency of ion chelating by EDTA and EGTA, leading to wrong 
conclusions about Mg2+ dependence. The authors note that factors like pH, ionic 
composition, temperature, presence of proteases influence experimental data and 
should be taken into account when drawing conclusions (Vachon et al., 2012). More 
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importantly the model contradicts the ability of Cry toxins to form pores, proven 
before by different research groups, both in insect epithelial membranes and artificial 
bilayers.  
The Jurat-Fuentes interpretation 
The interpretation of Cry toxin mode of action by Jurat-Fuentes et al. combines the 
Bravo and the Zhang models together. The authors suggest that both pore formation 
and signalling pathway leading to apoptosis may in cooperation play a role in toxicity 
and that the presence of one does not exclude the other. The model tries to explain 
the mode of action of Cry1Ac in Heliothis virescens larvae (Jurat-Fuentes and Adang, 
2006a). The model of multiple binding sites for Cry1Ac was proposed in H. virescens 
(Van Rie et al., 1989). HevCaLP, a cadherin-like protein was proposed to be one of 
them as HevCaLP gene knockout was connected with Cry1Ac resistance in some 
resilient strains (Gahan et al., 2001). The second receptor was identified as a GPI-
anchored alkaline phosphatase called HvALP. Decreased activity of alkaline 
phosphatase in brush border membrane proteins from resistant strains of H. virescens 
correlated with reduced levels of HvALP in these larvae (Jurat-Fuentes and Adang, 
2004). In addition, actin was identified as a novel receptor in BBMV proteome of M. 
sexta and H. virescens (Krishnamoorthy et al., 2007, McNall and Adang, 2003), as well 
as intracellular phosphatases (Jurat-Fuentes and Adang, 2006a). The Jurat-Fuentes 
model proposes two mechanisms that are not mutually exclusive. Both of them may 
considerably contribute to cell death. In the first one, Cry1Ac associates with HevCaLP 
cadherin and after oligomerization binds the second receptor HvALP, which leads to 
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pore formation in lipid rafts. Pore formation causes cell death due to osmotic shock 
but may additionally activate some signalling pathways. The second mechanism 
proposes that binding to HevCaLP induces a signalling pathway regulated by 
intracellular phosphatases, which may activate intracellular apoptotic pathway. There 
also may be a direct interaction between Cry1Ac and actin. The interaction between 
actin and a cytosolic domain of cadherin via tyrosine phosphatases (catenin and 
actinin) was already demonstrated (Lilien and Balsamo, 2005). The authors suggested 
that actin, although it is a cytoskeleton protein, may interact with the cytosolic domain 
of cadherin or with the toxin itself after its conformational change (Jurat-Fuentes and 
Adang, 2006a, Pigott and Ellar, 2007). The model is graphically presented in Figure 13. 
 
Figure 13 Proposed mechanisms of action of Cry1Ac toxin in H. virescens. 
Following toxin processing in the insect midgut activated Cry1Ac binds to HevCaLP. Monomers oligomerize and bind 
to GPI-anchored HvALP receptor leading to membrane insertion and pore formation. Binding to cadherin may also 
exert toxicity via a signalling pathway after the interaction between cadherin intracellular domain and actin, which 
is regulated by phosphatases (P). Figure was taken from Jurat-Fuentes and Adang et al. (Jurat-Fuentes and Adang, 
2006a). 
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1.5 Cellular responses to pore forming toxins 
Cells have evolved different ways to cope with bacterial toxins. Attack on cell 
membranes by PFTs is a conserved mechanism and due to the widespread nature of 
PFTs, many of the host cellular responses overlap. Yet, some remain cell and toxin 
specific, additionally dependent on toxin concentration and time of exposure. When 
toxin concentration is high, cells die quickly as a result of rapid and irreversible 
membrane damage. However when the dose is sub-lytic, cells often produce signals 
promoting survival and repair.  
Research has shown that one of the conserved responses to various PFTs is the 
phosphorylation of p38 mitogen-activated protein kinase (MAPK) (Ratner et al., 2006). 
The MAPK protein family comprises highly conserved serine/threonine kinases that are 
activated in response to extracellular signals and stresses, like osmotic shock, UV 
radiation, heat shock, ischemia, or DNA damage. MAP kinases can be classified into 
four subgroups: ERK (extracellular signal regulated kinase), JNK/SAPK (c-Jun N-terminal 
kinases or stress activated protein kinases), BMK1 (ERK/big MAP kinase 1) and p38. 
MAP kinases are activated by MAP kinase kinases (MKKs), with MKK3 and MKK6 being 
known p38 activators (Zarubin and Han, 2005). p38 is present in four isoforms: α, β, ٧, 
and δ, but only α and β are ubiquitously expressed. Following stress, cytosolic p38 
upon activation is translocated into the nucleus to access its nuclear substrates (Gong 
et al., 2010). When activated, p38 phosphorylates a broad range of proteins. The 
downstream targets may be as many as 200-300 and include: cytokines (TNF-α, 
interleukins), nuclear transcription factors and extracellular receptors (Zarubin and 
Han, 2005).  
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Phosphorylation of p38 was previously reported for: Streptococcus aureus 
streptolysin O, Gardnerella vaginalis vanginolysin, B. anthracis anthrolysin O, S. 
pneumonia pneumolysin, Staphylococcus aureus α-hemolysin, Aeromonas hydrophyla 
proaerolysin, Listeriolysin O, Vibrio cholera cytolysin, Escherichia coli hemolysin A (Fickl 
et al., 2005, Gelber et al., 2008, Huffman et al., 2004, Kloft et al., 2009, Ratner et al., 
2006, Gonzalez et al., 2011b). p38 pathway was activated in experiments involving C. 
elegans treated with low doses of Cry5B toxin (Huffman et al., 2004). Activation of p38 
MAPK was also shown in lepidopteran M. sexta and dipteran A. aegypti exposed to 
Cry1Ab and Cry11Aa respectively (Cancino-Rodezno et al., 2010).  
In the studies with C. elegans, M. sexta and A. aegypti silencing of p38 MAPK 
pathway resulted in hypersensitivity to Cry toxins (Cancino-Rodezno et al., 2010, 
Huffman et al., 2004), suggesting a role in cellular defence. However, published data 
are contrasting. In a study by Husmann et al., it has been shown using the same target 
cell line that inhibition of p38 MAPK pathway impeded cellular recovery in cells 
exposed to S. aureus α toxin but not in cells exposed to streptolysin O (Husmann et al., 
2006). Also, a specific p38 inhibitor prevented cell death in neural cells exposed to 
pneumolysin, implicating a role of p38 in facilitating apoptosis (Stringaris et al., 2002). 
Therefore, the p38 MAPK pathway - depending on a cell and toxin type - may exert 
different biological effects. Interestingly, a recent study by Guo et al. showed that 
MAPK genes can trans-regulate expression levels of ALP and ABCC genes (encoding Cry 
toxin receptors) in Bt resistant P. xylostella larvae. The authors suggested that MAPK 
signalling pathway could play an important role in insect resistance by altering 
expression levels of Cry toxin receptors (Guo et al., 2015).   
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The unfolded protein response (UPR) of the endoplasmic reticulum (ER) was 
identified as one of the downstream targets of p38 MAPK pathway in C. elegans 
(Bischof et al., 2008, Huffman et al., 2004). Under stressful conditions, like nutrient 
deprivation, disruption of Ca2+ or redox homeostasis, protein folding in the ER may be 
impaired, leading to accumulation of misfolded or unfolded proteins. Cells have 
evolved to deal with this threat by activating pathways that on the transcriptional and 
translational levels lead to a decrease in protein translation, degradation of misfolded 
proteins, and promotion of correct folding (Zhang and Kaufman, 2004). Loss of this 
pathway was demonstrated to cause hypersensitivity of C. elegans and mammalian 
cells to the attack of Cry5B and aerolysin, respectively and was functionally linked to 
upstream components of p38 pathway (Bischof et al., 2008).  
It was shown that in addition to the p38 pathway some PFTs like proaerolysin 
and listeriolysin O speciﬁcally triggered activation of the ERK pathway. It was suggested 
that these two pathways helped to recover ion homeostasis as inhibition of either p38 
or ERK by specific inhibitors signiﬁcantly diminished the recovery of intracellular K+ 
(Gonzalez et al., 2011b). Furthermore JNK MAPK was activated in experiments 
involving C. elegans and Cry5B toxin (Huffman et al., 2004). JNK MAPK was later shown 
to protect nematode cells from both small pore (Cry5B) and large pore (streptolysin O) 
inducing PFTs. Based on a genome-wide RNAi screen results, JNK and p38 MAPKs were 
suggested to play a paramount role in cellular protection of C. elegans against Cry5B 
(Kao et al., 2011). 
Efflux of intracellular potassium, arising as a consequence of transmembrane 
pores, was shown to mediate various cellular responses. It was demonstrated that 
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potassium efflux promoted p38 activation after exposure to S. aureus α-toxin, V. 
cholerae cytolysin, streptolysin O, and E. coli hemolysin A (Kloft et al., 2009). Potassium 
efflux induced activation of the inflammasome and caspase-1 in aerolysin treated 
Chinese hamster ovary cells. Because caspase-1 positively regulates the Sterol 
Regulatory Element Binding Proteins (SREBPs) involved in membrane biogenesis, it is 
thought that this pathway promotes cell survival by assisting in membrane repair 
(Gurcel et al., 2006). Another consequence of potassium efflux is autophagy, which 
was observed in aerolysin treated HT29 cells. Although it did not restore ion 
homeostasis or help in membrane repair, its function was predicted to benefit cells in 
a quiescent state, where recycling cellular molecules and organelles via autophagy 
would help surviving low energy consumption state following a PFT attack (Gonzalez et 
al., 2011b). Autophagy was also observed in cells exposed to S. aureus α-toxin, V. 
cholerae cytolysin, E. coli haemolysin and streptolysin O. A similar conclusion was 
drawn, that autophagy promotes energy maintenance during recovery in cells affected 
by pore formation (Kloft et al., 2010). A significant increase in lipid droplet formation 
was observed in HeLa cells following cell treatment with: proaerolysin, listeriolysin O, 
streptolysin O, S. aureus α-haemolysin. Lipid droplets were beneficial to cells and their 
formation was abolished by ERK inhibitor in aerolysin treated cells. The authors 
suggested that - along with an arrest in protein synthesis - storing energy in lipid 
droplets represents a mechanism that puts the cells into a low energy consumption 
mode (Gonzalez et al., 2011b).  
Hypoxia (low oxygen levels) and hypoxia response was identified as another 
protective mechanism in C. elegans against Cry21A, Cry5B and V. cholerae cytolysin. 
Loss of function of the main hypoxia response effector HIF-1 (hypoxia inducible factor 
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1) led to hypersensitivity of previously resistant nematodes. Moreover, the hypoxia 
pathway was shown to work upstream of UPR. The role of low amount of oxygen in 
pathogenicity and the role of UPR being the downstream effector of hypoxia response 
was suggested (Bellier et al., 2009).  
Additionally, activation of the nuclear factor kappa B (NF-κB) pathway and 
production of inflammatory molecules was observed in immune cells exposed to the 
following PFTs: S. aureus α-toxin, aerolysin, pneumolysin, listeriolysin O, streptolysin O 
(Aroian and van der Goot, 2007). Antimicrobial peptides were released in Spodoptera 
larvae in response to Cry1Ca and Vip3 (Herrero et al., 2016). In other studies extensive 
cell vacuolization was noted after treatment with aerolysin or S. marcescens hemolysin 
(Abrami et al., 1998, Hertle et al., 1999). Listeriolysin O, perfringolysin O and 
pneumolysin caused Ubc9 degradation, decreasing the levels of protein SUMOylation 
and increasing at the same time infection efficiency. De-SUMOylation was shown to be 
independent of the calcium influx or MAPKs (Ribet et al., 2010).  
Another pathway activated by PFTs is apoptosis, often mediated by 
uncontrolled influx of Ca2+ ions – a known apoptosis inducer. An apoptotic pathway 
was triggered by: S. aureus α-toxin in epithelial cells (Imre et al., 2012) and 
lymphocytes (Jonas et al., 1994), by listeriolysin in dendric cells (Guzmán et al., 1996), 
aerolysin in lymphocytes (Nelson et al., 1999), PS-2 like protein in HepG2 (Brasseur et 
al., 2015b), and PS-1 in HeLa cells (Katayama et al., 2007), however the pore forming 
nature of PS-1 (from strain A1190) has not been demonstrated. 
Other mechanisms attributed to PFT-induced Ca2+ influx is a repair process 
based on exo- and endocytosis. The studies suggest that after plasma membrane injury 
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and calcium entry, lysosomal enzyme acid sphingomyelinase is released during 
exocytosis of lysosomes, where it converts sphingomyelin into ceramide. Ceramides 
form microdomains which in turn facilitate endosome formation. Endosomes 
internalise transmembrane pores by disruption of actin cytoskeleton and target them 
for degradation contributing to membrane repair. The model is based on experiments 
with cells permeabilized with streptolysin O, but similar processes were observed in 
mechanically injured cells (Idone et al., 2008, Tam et al., 2010). Vesicle trafficking 
pathways were also noted for S. aureus α-toxin, Cry5B and V. cholerae cytolysin; 
reviewed by Los et al. (Los et al., 2013).  
Cellular processes triggered by PFTs are graphically presented in Figure 14. 
 
Figure 14 Cellular responses to PFTs. 
Schematic diagram represents signalling pathways and cellular mechanisms triggered by pore formation.  
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In summary, despite the deceptively simple mechanism of action of PFTs, cellular 
responses upon pore formation remain complex and not fully characterised. Disrupting 
protective barrier of plasma membrane initiates numerous pathways arising mostly as 
a result of uncontrolled flow of ions. 
1.6 Cry toxin receptors 
Receptors have been shown to be critical determinants of specificity of Cry toxins. 
Receptor recognition has been done mostly by identification and characterization of 
toxin binding partners. However, correlation between binding and toxicity was not 
always consistent. For example, a positive correlation was demonstrated for Cry1Ab 
and Cry1Ba toxins (Hofmann et al., 1988), but not for Cry1Ac, where BBMV from 
naturally resistant Spodoptera frugiperda insect larvae showed high-affinity, saturable 
binding sites (Garczynski et al., 1991). Later on, Liang et al. separately analyzed the 
kinetics of reversible and irreversible binding of Cry1Aa, Cry1Ab and Cry1Ac and 
demonstrated that in these experiments only irreversible binding directly correlated 
with toxicity (Liang et al., 1995). Problems with binding studies additionally involve a 
high risk of false-positive results, which may arise as a result of: non-specific binding, 
conditions used (denatured versus non-denatured epitopes), similarity in protein size, 
posttranslational modification (which is the case for APNs) and erroneous exogenous 
expression. To separate putative from functional receptors, Table 2 presents reported 
Cry toxin binding partners, whereas Table 3 shows receptors confirmed to be 
responsible for susceptibility to the toxin. The best characterized classes of insecticidal 
Cry toxin receptors include: aminopeptidase N (APN), cadherin-like receptor and 
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alkaline phosphatase (ALP), reviewed extensively by Pigott and Ellar (Pigott and Ellar, 
2007). 
APN is a zinc binding metalloprotease that cleaves neutral amino acids from the 
protein N-terminus digesting dietary proteins (Wang et al., 2005b). The mature protein 
(90 - 170 kDa) is attached to the membrane by a glycosylphosphatidylinositol (GPI) 
anchor and is modified post-translationally by glycosylation. The presence of this 
carbohydrate has been demonstrated to be crucial for interaction with some Cry 
toxins, e.g. GalNAc – containing APN in Cry1Ac binding (Knight et al., 1994). Binding to 
APNs has been demonstrated for Cry1Aa, Cry1Ab, Cry1Ac, Cry11Ba, Cry1Ba, Cry1Ca 
and Cry1Fa. Functionality of APN as a receptor was confirmed for Cry1Aa, Cry1Ab, 
Cry1Ac, Cry1Ca and Cry11Ba (references in Table 2 and Table 3). 
Cadherins are calcium-dependent, transmembrane proteins, playing a variety 
of roles including: cell adhesion, migration, and morphogenesis (Leckband and 
Prakasam, 2006). Their expression in insects is regulated temporarily and spatially, 
increasing during larval development. The exact role of insect cadherins remains 
unclear, however they are believed to help with the organization of midgut epithelial 
cells (Midboe et al., 2003). Toxin binding regions in cadherin occur near the membrane 
proximal extracellular domain and adjacent cadherin repeats (Pigott and Ellar, 2007). 
Cadherins have been shown to be important receptors for Cry1A toxins, especially in 
lepidopteran species, but not all of them. Binding was demonstrated for Cry1Aa, 
Cry1Ab, Cry1Ac, Cry11Aa and Cry4Ba; receptor functionality for Cry1Aa, Cry1Ab, 
Cry1Ac and Cry3Ba (references in Table 2 and Table 3). 
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Alkaline phosphatases (ALPs) represent another group of Bt Cry toxin 
receptors. Similarly to APNs, ALPs are zinc binding, GPI anchored proteins and undergo 
glycosylation. GalNAc-dependent binding was detected for Cry1Ac and H. virescens ALP 
(Jurat-Fuentes and Adang, 2004), but there is no indication of a general role for 
carbohydrates in the interaction with toxin. Binding to ALP was demonstrated for 
Cry1Ac, Cry11Aa, Cry4B, and Cry11Ba; APN conferring susceptibility - only for Cry11Ba 
(references in Table 2 and Table 3). 
Some of other molecules that have been reported to interact with Cry toxins 
are ADAM 10 metalloprotease in L. decemlineata and sodium solute symporter in T. 
castaneum (Table 2). Interestingly binding partners have been identified for two 
parasporins. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) – an enzyme 
performing diverse functions in cell metabolism, transcription and apoptosis - was 
revealed as a binding partner for parasporin-like protein Bt18 in leukemic T-cells 
(Krishnan et al., 2010). Also, beclin-1 - a tumor suppressor with a role in the regulation 
of autophagy and cell death (Qu et al., 2003) - was identified as a PS-1 receptor in HeLa 
cells, based on experiments with anti-beclin-1 antibody that suppressed toxin binding 
and toxicity (Katayama et al., 2011). 
The identification of genes involved in insect resistance to Cry toxins led to 
discovery of new putative receptors. ABCC2 transporter, was linked to resistance to 
Cry1A toxins in H. virescens, B. mori, P. xylostella and T. ni (Atsumi et al., 2012b, Baxter 
et al., 2011, Gahan et al., 2010). Functional studies confirmed the involvement of the 
transporter in Cry1A toxicity in B. mori and S. exigua (Table 3). Direct binding however 
was never demonstrated and therefore it is believed that the interaction between Cry 
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toxins and ABCC2 transporter may be of transient nature, e.g. toxin insertion into the 
membrane may be driven by the transport cycle of the ABC protein (Heckel, 2012). 
Research on resistance mechanisms in C. elegans and forward genetic 
experiments, revealed four genes: bre2, bre3, bre4 and bre5, which when mutated 
brought resistance towards nematocidal Cry5Ba. The bre genes encode 
glycosyltransferases, which are involved in the biosynthesis of glycosphinglipids. Most 
importantly, these glycolipids were found to be necessary for the toxin interaction with 
intestinal cells (Griffitts et al., 2005, Griffitts et al., 2003, Griffitts et al., 2001). 
Comparison of transcripts from larval midgut cells from resistant and 
susceptible populations of P. xylostella was performed after exposure to DiPel (Bt 
pesticide containing: Cry1Aa, Cry1Ab, Cry1Ac, Cry2Aa). Among others, the following 
genes were identified: homologues of methylthiotransferase (CDKAL1), co-chaperone 
(SDF2L1), and metalloproteinase (PxHEL-1). RNAi-based silencing of these genes 
signiﬁcantly increased the mortality of resistant but also susceptible insects (Ayra-
Pardo et al., 2015). In another studies, among other proteins, actin was identified as 
intracellular binding targets in proteome analyses in M. sexta and H. virescens BBMVs 
(McNall and Adang, 2003, Krishnamoorthy et al., 2007). The exact role of these 
proteins remains unclear, but the data points to the significance of molecules other 
than classical receptors, and involved in cellular processes, in the toxin mode of action 
and resistance mechanisms.  
To sum up, lepidopteran APNs and cadherins remain the best characterised Cry 
toxins receptors. Nevertheless, there is more and more data evidencing novel 
receptors as well as molecules influencing toxin binding and host susceptibility. 
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Table 2 Reported binding between Cry toxins and putative receptors. 
Table presents putative Cry toxin receptors based on the results of binding assays. Species full names: Anopheles 
(A.): quadrimaculatus, gambiae; Tribolium (T.) castaneum; Spodoptera (S.): frugiperda, exigua, litura; Drosophila 
(D.) melanogaster; Heliothis (H.) virescens; Aedes (A.) egypti; Ostrinia (O.) nubilalis; Caenorhabditis (C.) elegans; 
Helicoverpa (H.) armigera; Trichoplusia (T.) ni; Bombyx (B.) mori, Manduca (M.) sexta, Lymantria (L.) dispar, 
Epiphyas (E.) postvittana, Leptinotarsa (L.) decemlineata. 
Receptor Origin Toxin Method Reference 
APN M. sexta Cry1Ac Ligand blot 
(Knight et al., 
1994); 
(Sangadala et 
al., 1994); 
APN M. sexta 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
SPR 
(Masson et al., 
1995) 
APN H. virescens 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
SPR (Luo et al., 1997) 
APN H. virescens 
Cry1Ac, 
Cry1Fa 
Ligand blot 
(Banks et al., 
2001) 
APN B. mori Cry1Aa Ligand blot 
(Yaoi et al., 
1999) 
APN 
H. armigera 
(expressed in T. 
ni cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Ligand blot 
(Rajagopal et al., 
2003) 
APN M. sexta Cry1Ab Ligand blot 
(Denolf et al., 
1997) 
APN L. dispar Cry1Ac Ligand blot, SPR 
(Valaitis et al., 
1997) 
APN H. virescens Cry1Ac Ligand blot (Gill et al., 1995) 
APN 
H. armigera 
(expressed in T. 
ni cells) 
Cry1Ac Ligand blot 
(Rajagopal et al., 
2003) 
APN 
E. postvittana 
(expressed in S. 
frugiperda 9 
cells) 
Cry1Ac, 
Cry1Ba 
Ligand blot 
(Simpson and 
Newcomb, 
2000) 
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APN 
S. litura 
(expressed in S. 
frugiperda 21 
cells) 
Cry1Ca 
Ligand blot, 
immunofluorescence 
(Agrawal et al., 
2002) 
APN 
A. 
quadrimaculatus 
Cry11Ba SPR 
(Abdullah et al., 
2006) 
APN AgAPN2 
A. gambiae 
(expressed in E. 
coli) 
Cry11Ba 
Competition assay, 
ligand dot blot, ELISA  
(Zhang et al., 
2008) 
Cadherin 
BT-R1 
M. sexta Cry1Ab Ligand blot 
(Vadlamudi et 
al., 1993) 
Cadherin 
BT-R1 
M. sexta 
(expressed in 
COS-7 and HEK-
293 cells) 
Cry1Ab Ligand blot 
(Vadlamudi et 
al., 1995) 
Cadherin 
BT-R1 
M. sexta 
expressed in (S. 
frugiperda 21 
cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Ligand blot 
(Keeton and 
Bulla, 1997) 
Cadherin 
BT-R(1a) 
M. sexta 
(expressed in D. 
melanogaster S2 
cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Ligand blot 
(Hua et al., 
2004) 
Cadherin 
BT-R1 
M. sexta 
(expressed in H5 
T. ni cells) 
Cry1Ab Ligand blot 
(Zhang et al., 
2005) 
Cadherin 
BTR175 
B. mori Cry1Aa Immunoprecipitation 
(Nagamatsu et 
al., 1998) 
Cadherin 
BTR175b 
B. mori 
(expressed in 
HEK-293 cells) 
Cry1Aa Immunofluorescence 
(Ikawa et al., 
2000) 
Cadherin 
HevCaLP 
H. virescens Cry1Aa Ligand blot 
(Jurat-Fuentes 
et al., 2004) 
Cadherin 
HevCaLP 
H. virescens 
(expressed in E. 
coli) 
Cry1Ab, 
Cry1Ac 
SPR (Xie et al., 2005) 
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Cadherin 
OnBT-R1 
O. nubilalis Cry1Ab Ligand blot 
(Flannagan et 
al., 2005) 
Cadherin 
BTR harm 
H. armigera 
(expressed in E. 
coli) 
Cry1Ac Binding assay 
(Wang et al., 
2005a) 
Cadherin 
AaeCad 
A. aegypti  
(expressed in E. 
coli)  
Cry11Aa Ligand blot 
(Chen et al., 
2009) 
Cadherin 
SeCad1b 
S. exigua Cry1Ac Ligand blot 
(Chen et al., 
2014) 
Cadherin 
AgCad1 
A. gambiae 
(expressed in D. 
melanogaster S2 
cells) 
Cry4Ba Ligand blot 
(Hua et al., 
2008) 
ALP 
HvALP 
H. virescens Cry1Ac Ligand blot 
(Jurat-Fuentes 
and Adang, 
2004) 
ALP M. sexta Cry1Ac Ligand blot 
(McNall and 
Adang, 2003) 
ALP A. aegypti Cry11Aa 
Immunofluorescence, 
Ligand blot 
(Fernandez et 
al., 2006) 
ALP A. aegypti Cry4B Ligand blot 
(Buzdin et al., 
2002) 
ALP AgALP1 
A. gambiae 
(expressed in E. 
coli) 
Cry11Ba Ligand blot, ELISA 
(Hua et al., 
2009) 
ALP H. armigera Cry1Ac Ligand blot 
(Sarkar et al., 
2009) 
APN (TcAPN-I), 
E-cadherin 
(TcCad1), 
sodium solute 
symporter 
(TcSSS) 
T. castaneum Cry3Ba Ligand blot 
(Contreras et al., 
2013) 
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Glycolipids C. elegans Cry5B 
TLC overlay, 
supported lipid 
bilayers 
(Griffitts et al., 
2005) 
Metalloprotease 
ADAM 10 
L. decemlineata Cry3Aa Ligand blot 
(Ochoa-
Campuzano et 
al., 2007) 
GAPDH 
Leukemic T-cells 
(CEM-SS) 
Cytotoxic 
Cry toxin 
Bt18 
Ligand blot, 
immunofluorescence 
(Krishnan et al., 
2010) 
Beclin-1 HeLa cells PS-1 
Photo-reactive 
chemical crosslinking, 
competition assay 
(Katayama et al., 
2011) 
Actin M. sexta Cry1Ac 
2 dimensional 
electrophoresis, mass 
spectrometry 
(McNall and 
Adang, 2003) 
Actin H. virescens Cry1Ac 
2 dimensional 
electrophoresis, mass 
spectrometry 
(Krishnamoorthy 
et al., 2007) 
 
 
 
Table 3 Reported functional Cry toxin receptors. 
The table presents a list of studies that have reported a positive correlation between presence of the receptor and 
toxicity/pore formation. Species full names: Anopheles (A.): quadrimaculatus, gambiae; Tribolium (T.) castaneum; 
Spodoptera (S.): frugiperda, exigua, litura; Drosophila (D.) melanogaster; Heliothis (H.) virescens; Aedes (A.) egypti; 
Ostrinia (O.) nubilalis; Caenorhabditis (C.) elegans; Helicoverpa (H.) armigera; Trichoplusia (T.) ni; Bombyx (B.) mori, 
Manduca (M.) sexta, Lymantria (L.) dispar. 
 
Receptor Origin Toxin Method Reference 
APN M. sexta Cry1Ac 
Permeability: Rb+ 
efflux assay 
(Sangadala 
et al., 1994); 
APN H. virescens 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Permeability: Rb+ 
efflux assay 
(Luo et al., 
1997) 
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APN 
M. sexta 
reconstituted in 
PLBs 
Cry1Aa, 
Cry1Ac, 
Cry1Ca 
PLB experiments 
(Schwartz et 
al., 1997) 
APN 
M. sexta 
(expressed in D. 
melanogaster) 
Cry1Ac Feeding bioassay 
(Gill and 
Ellar, 2002) 
APN S. litura Cry1Ca 
RNAi, feeding 
bioassay 
(Rajagopal 
et al., 2002) 
APN  
AgAPN2 
A. gambiae 
(expressed in E. 
coli) 
Cry11Ba 
Competition assay, 
feeding bioassay  
(Zhang et 
al., 2008) 
Cadherin 
BT-R1 
M. sexta 
(expressed in 
COS-7 and HEK-
293 cells) 
Cry1Ab 
Morphological 
changes tracked by 
immunofluorescence 
(Dorsch et 
al., 2002) 
Cadherin 
BT-R(1a) 
M. sexta 
(expressed in D. 
melanogaster S2 
cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Flow cytometry, 
propidium iodide 
(Hua et al., 
2004) 
Cadherin 
BT-R1 
M. sexta 
(expressed in H5 
T. ni cells) 
Cry1Ab 
Permeability: Trypan 
Blue 
(Zhang et 
al., 2005) 
Cadherin 
BT-R1 
M. sexta 
(expressed in S. 
frugiperda 9 cells) 
Cry1Aa 
Whole cell patch 
clamping 
(Nagamatsu 
et al., 1999) 
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Cadherin 
BTR175b 
B. mori 
(expressed in 
HEK-293 cells) 
Cry1Aa 
Permeability: LDH 
assay 
(Tsuda et 
al., 2003) 
Cadherin 
HevCaLP 
H. virescens 
(expressed in D. 
melanogaster S2 
cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Flow cytometry, 
propidium iodide 
(Jurat-
Fuentes and 
Adang, 
2006b) 
Cadherin 
OnBT-R1 
O. nubilalis 
(expressed in S. 
frugiperda 9 cells) 
Cry1Ab 
Microscopic 
observation 
(Flannagan 
et al., 2005) 
Cadherin  
SeCad1b 
S. exigua Cry1Ac 
RNAi, feeding 
bioassay 
(Chen et al., 
2014) 
E-cadherin 
(TcCad1), sodium 
solute symporter 
(TcSSS) 
T. castaneum Cry3Ba 
RNAi, feeding 
bioassay 
(Contreras 
et al., 2013) 
ALP  
AgALP1 
A. gambiae 
(expressed in E. 
coli) 
Cry11Ba 
Competition assay, 
feeding bioassay 
(Hua et al., 
2009) 
Glycolipids 
synthesised with 
the help of 
glycosyltransfe-
rases encoded by: 
bre2, bre3, bre4, 
bre5 genes. 
C. elegans Cry5B 
Immunofluorescence, 
chase assay, feeding 
bioassay 
(Griffitts et 
al., 2003) 
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ABCC transporter 
ABCC2 
S. exigua 
Cry1Ca, 
Cry1Ac 
RNAi, feeding 
bioassay 
(Park et al., 
2014) 
ABCC transporter 
ABCC2 
B. mori Cry1Ab 
Germline 
transformation 
(Atsumi et 
al., 2012a) 
ABCC transporter 
BmABCC2 
B. mori 
(expressed in S. 
frugiperda 9 cells) 
Cry1Ab, 
Cry1Ac 
Permeability: LDH 
assay, cell swelling 
assay 
(Tanaka et 
al., 2013) 
ABCC transporter 
HevABCC2 
H. virescens 
(expressed in S. 
frugiperda 9 cells) 
Cry1Aa, 
Cry1Ab, 
Cry1Ac 
Viability assay 
(Bretschneid
er et al., 
2016) 
Homologues of 
methylthiotrans-
ferase (CDKAL1), 
co-chaperone 
(SDF2L1), 
metalloproteinase 
(PxHEL-1) 
P. xylostella 
DiPel: 
Cry1Aa, 
Cry1Ab, 
Cry1Ac, 
Cry2Aa 
RNAi, feeding 
bioassay 
(Ayra-Pardo 
et al., 2015) 
Beclin-1 HeLa cells PS-1 
Beclin-1 polypeptide 
competition assay 
(Katayama 
et al., 2011) 
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2. Objectives 
Overall, this project aims to uncover the mechanism of action of a human cancer cell 
active toxin – parasporin-3, also known as Cry41Aa. Different features of PS-3 toxic 
action were investigated on susceptible HepG2 cells, like the presence of apoptotic and 
necrotic markers, changes in cell morphology, effect on metabolic activity and 
membrane permeability. The toxin’s ability to form pores in planar lipid bilayers was 
also assessed. Activation of certain signalling pathways was evaluated to gain basic 
understanding of cellular responses to the toxin. Aiming to increase knowledge about 
toxin specificity, PS-3 was tested on cell lines not examined before. Finally, this work 
attempted to identify a PS-3 receptor predicted to be present on susceptible cells, 
which is thought to play a pivotal role in cytotoxicity.  
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3. Materials and methods 
3.1 Materials 
Bacterial strains and plasmids 
E. coli DH5α - a high efficiency transformation strain, used for routine cloning. 
E. coli GM2163 – a dam-/dcm-, chloramphenicol resistant strain used to obtain non-
methylated DNA for transformation of Bt 4D7.  
Bt 4D7 - a crystal minus strain, derivative of Bt subspecies kurstaki, obtained from the 
Bacillus Genetic Stock Centre. 
Bt pSVP2741Aa – a recombinant 4D7 strain expressing cry41Aa PS-3 gene (Krishnan, 
2013) using E.coli - Bt expression shuttle vector pSVP27A, ampicillin and 
chloramphenicol resistant, under the control of the cyt1A promoter (Crickmore et al., 
1994, Crickmore and Ellar, 1992).  
Bt pSVP2741Aa-∆R-HA - a recombinant 4D7 strain expressing cry41Aa with ricin 
sequence deleted and HA tag sequence introduced (Etherington et al., unpublished). 
Buffers 
5 x TBE buffer: 108 g of tris, 55 g of boric acid, 40 ml of 0.5 M EDTA, 2 l of dH2O, pH 8.0. 
RGB:  18.18 g tris, 0.4 g SDS, 100 ml of dH2O, pH 8.8. 
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SGB: 6.06 g tris, 0.4 g SDS, 100 ml of dH2O, pH 6.8. 
5 × SDS running buffer: 7.6g tris-HCl, 36g glycine, 2.5g SDS, 250 ml of dH2O. 
2 × protein gel sample loading buffer: 2 g SDS, 6 mg EDTA, 20 mg Bromophenol Blue, 5 
ml of RGB, 50 ml glycerol, 100 ml of dH2O.  
Coomassie Blue stain: methanol, dH2O, acetic acid (10:9:1 v/v/v), Brilliant Blue R-250 
(0.25%, w/v). 
De-staining buffer: methanol, dH2O, acetic acid (10:9:1, v/v/v).  
10 × PBS: 80 g of 1.37 M NaCl, 2 g of 27 mM KCl, 14.4 g of 100 mM Na2HPO4, 2.4 g of 
18 mM KH2PO4, 1 l of dH2O, pH 7.4. 
NP-40: 150 mM NaCl, 1.0% NP-40 or Triton X-100, 50 mM tris, pH 8.0. 
RIPA: 150 mM NaCl, 1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 
50 mM tris, pH 8.0. 
Dry blot buffer: 39 M glycine, 48 mM tris, 0.0375% SDS, 20% methanol. 
Chemiluminescent detection solution: 10 ml of 100 mM tris pH 8.5, 3 µl of H2O2, 25 µl 
of 14.7 mg/ml p-coumaric acid, 50 µl of 88.6 mg/ml luminol.  
Coupling buffer:  50 mM tris, 5 mM EDTA-Na, pH 8.5. 
Patch clamp NaCl buffer: 140 mM NaCl, 5 mM KCl, 1.1 mM MgCl2, 1.1 mM CaCl2, 10 
mM HEPES (pH 7.4). 
Patch clamp KCl buffer: 140 mM KCl, 1.1 mM MgCl2, 0.1 mM EGTA, 10 mM HEPES (pH 
7.4).  
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PLB KCl buffer: 150 mM KCl, 1 mM CaCl2, 10 mM HEPES, (pH 7.5). 
Reagents and enzymes 
Reagents obtained from Sigma - Aldrich: SDS, tris base, tris-HCl, CAPS, sodium 
pyruvate, 1-thioglycerol, sodium carbonate, Brilliant Blue R-250, hydrogen peroxide, 
BSA fraction V, PEGs: 1000, 2000, 4000, DMSO, sodium deoxycholate, ammonium 
persulfate, Bromophenol Blue, β-mercaptoethanol, TEMED, acrylamide/bis-acrylamide 
30%, chloramphenicol, etoposide, EGTA, p-coumaric acid, luminol, sodium 
orthovanadate, sodium arsenite, PI-PLC, MβCD, trypsin, α-chymotrypsin, pepsin, 
proteinase K, lysozyme, menadione. The following were purchased from AnalaR BDH: 
glucose, NaCl, NaOH, Ponceau S, NP-40, TX-100, EDTA, CaCl2, ethanol, sodium acetate, 
sodium hydrogen carbonate. Chemicals obtained from Thermo Fisher Scientific: FITC, 
glycine, methanol, 1-butanol, KCl, glycerol, mono-potassium phosphate, di-potassium 
phosphate, acetic acid, MgCl2. Microcystin and SB202190 were purchased from 
Calbiochem; mono-sodium phosphate from Laboratory FSA Supplies. Pre-stained 
Protein Ladder (7-175, 11-245 and 10-230 kDa), 1 Kb DNA ladder, DpnI, T4 DNA ligase 
were from New England Biolabs. HaeIII was obtained from Promega. BSA, PKi (14-22 
amide, myristoylated), 8-bromo-cAMP were obtained from Torcis. 
Chloramphenicol was prepared as 5 mg/ml stock solution in ethanol, diluted 
further in LB agar to 5 µg/mL. Etoposide was prepared as 50 mM stock solution in 
DMSO and diluted to 0.1 mg/ml in tissue culture medium. EGTA and EDTA were 
prepared as a 55 mM stock solution in dH2O (pH adjusted to 8), diluted in culture 
medium accordingly. CaCl2 and MgCl2 were dissolved in dH2O to make 280 mM stock 
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solutions and later diluted to 5 mM. PI-PLC aqueous solution from Bacillus cereus was 
diluted directly in culture medium to obtain the desired concentration. MβCD was 
prepared as a 37.55 mM stock solution in dH2O, diluted in culture medium to 1 - 5 mM. 
p-coumaric acid was diluted in DMSO to 14.7 mg/ml stock, then diluted in 100 mM tris 
to 36.7 μg/ml. Luminol was diluted in DMSO to 88.6 mg/ml stock, then diluted in 100 
mM tris to 443 μg/ml. Stock of 8-bromo-cAMP was made up and used on the same day 
by dissolving the powder in dH2O to 10 mg/ml. 5 mM H-89 stock was a gift from Prof 
George Kemenes. PKi was diluted to 1 mg/ml in dH2O and this stock was frozen in 
small aliquots. PEGs were made in 25 mM tris, 150 mM NaCl, pH 8.0 as 330 mM stock 
solution, later accordingly diluted in DMEM. Menadione was dissolved in DMSO to 100 
mM, diluted later in dH2O. 5 mg/ml stock of HA peptide was prepared in dH2O, later 
diluted in PBS. FITC was dissolved in DMF to 10 mg/ml, and then further diluted to 
desired concentration in DMF. Complete Mini EDTA-free Protease Inhibitor Coctail 
Tablet (Roche) was prepared and diluted according to the manufacturer’s instruction. 
ECL Protein Biotinylation Module (Amersham) and SulfoLink Coupling Resin (Thermo 
Scientific) – were used according to manufacturer’s instruction. 
Antibodies 
Rabbit monoclonal antibody against phospho-p38 (Thr180+Tyr182) and rabbit 
polyclonal antibodies against phospho-ERK, total p38 and total ERK were from Cell 
Signaling Technology (9215S, 9101S, 9212 and 9102 respectively). Second vial of rabbit 
monoclonal antibody against phospho-p38 (Thr180+Tyr182) was from Thermo Fisher 
Scientific (MA5 15182). The following primary antibodies were purchased from Abcam: 
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rabbit monoclonal against CD59 (ab126777), chicken polyclonal anti – HA tag HRP 
(ab1190), rabbit monoclonal anti-CREB phospho S133 (ab32096), rabbit polyclonal 
anti-N-cadherin (ab95440), anti-Fluorescein HRP (ab19492). Secondary HRP 
conjugated goat anti-rabbit antibody was purchased from Abcam (ab97051). 
Cell lines 
HepG2, human hepatocyte carcinoma cell line was purchased from ECACC, Salisbury, 
UK. HeLa, lymphoblastoid (GM12878, IB4) and Burkitt's lymphoma (MUTU1, BL31) cells 
were gifts from Dr Michelle West (University of Sussex, UK). HL-60 cell line was a gift 
from Dr Helen Stewart (University of Sussex, UK). Another batch of HL-60 cells was 
purchased from ECACC, Salisbury, UK. Cell lines used in electrophysiology experiments 
were provided by Prof Jean-Louis Schwartz (University of Montreal, Canada). 
Culture media, reagents and plasticware 
DMEM (high glucose), Advanced DMEM (high glucose), DMEM (high glucose, no 
phenol red), DMEM (low glucose), RPMI 1640, MEM, PSG, DPBS, DPBS with Ca2+ and 
Mg2+, trypsin/EDTA (0.05% trypsin and 0.53 mM EDTA), Trypan Blue (0.4%) were 
obtained from Gibco (Life Technologies); FCS, 40 μm Nylon Mesh Cell Strainer, Nalgene 
2.0 mL cryogenic vials, Trypan Blue HyClone (0.2 μm filtered) were from Fisher 
Scientific. 25, 75 and 175 cm2 flasks; 60 mm dishes; 6, 12, 24 and 96-well clear and 
black-walled clear flat bottom plates were obtained from Nunc (Nunclon surface 
treated). Poly-D-Lysine treated 96-well white and black wall clear bottom plates (3843) 
and cell scrapers (1.8 cm) were from Corning. 
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Cell assay kits 
The following cell assay kits manufactured by Promega were used: 
- CellTiter-Blue Cell Viability Assay, 
- CellTiter-Glo Luminescent Cell Viability Assay, 
- RealTime-Glo Cell Viability Assay, 
- ApoTox-Glo Triplex Assay, 
- Caspase-Glo 3/7 Assay, 
- CellTox Green Cytotoxicity Assay, 
- CytoTox-Glo Cytotoxicity Assay, 
- ROS-Glo H2O2 Assay. 
3.2 Methods 
Storage of cells and proteins 
For long-term storage cancer cells were kept in liquid nitrogen at - 197°C and for short-
time storage at - 80°C in complete medium with 10% glycerol. For bacterial strains 
long-term storage was in LB with 15% glycerol at - 80°C and short-term on appropriate 
agar plates at 4°C. Toxins were stored at - 20°C.  
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Bacterial growth conditions 
Bt transformants were grown on high nutrient LB (Gerhardt, 1994) agar plates 
supplemented with chloramphenicol (5 μg/ml) for 3 - 4 days at 30°C. E.coli DH5α 
transformants were grown on LB agar plates containing ampicillin (100 µg/ml) and 
GM2163 transformants on chloramphenicol plates (5 μg/ml). E.coli and Bt cells prior to 
transformation were grown on LB plates without antibiotic overnight at 37°C. Before 
transformation bacterial strains were grown in LB broth shaking at 37°C.  
Agarose gel electrophoresis 
1% agarose gel was prepared in TBE buffer and heated until dissolved. After brief 
cooling 0.5 µl of Gel Red dye (Biotium) was added, and gel was left to solidify. A 
mixture of the DNA and a loading buffer (5:1 v/v) was loaded per lane, alongside a 1 kB 
DNA ladder. Gel was run at 120 V in TBE buffer for 30 min. The bands were visualised 
using Image Lab 4.0.1 software (Bio-Rad). 
PCR 
Bt pSVP2741Aa-∆R-HA plasmid was used as a template in the mutagenesis experiment. 
The PCR programme named PFU Ultra 10 Kb involved the following steps: initial 
denaturation at 98°C for 2 min, 30 cycles of denaturation at 92°C for 40 seconds, 30 
cycles of annealing at 63°C for 8 min, 30 cycles of elongation at 68°C for 5.5 min and 
final extension at 68°C for 5 min. The primers used to create the mutation were 
obtained from Eurofins Genomics at a concentration of 10 pmol/μl each: 
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Forward primer: 5’- GCAATTGAATTCATTCCGCTAAGTCC – 3’ 
Reverse primer: 5’ - GTCAATCCAAATAGGCCCG – 3’ 
PCR mixture (50 µl total volume) contained: 1 µl of forward and reverse primers each, 
1 µl of template DNA, 25 µl of the PfuUltra II Hotstart PCR Master Mix (Agilent) and 22 
µl of dH2O. PCR product was purified using QIAquick kit and visualised on a gel. 
Purification of DNA from a bacterial culture 
Purification of DNA from a bacterial culture was done using QIAprep kit (QIAgen). 
Briefly, the area of 1 cm2 of freshly grown Bt cells was scraped and re-suspended in P1 
buffer containing dissolved lysozyme (10 mg/ml). This mixture was incubated at 37°C 
for 30 min. For E.coli cells the lysozyme incubation step was omitted. Next, 250 µl of 
buffer P2 was added to the tubes and they were inverted until solution became clear. 
Then, 350 µl of buffer N3 was added and tubes were mixed by inverting until solution 
went cloudy. Tubes were spun at 17,000 x g for 10 min. Supernatant was applied to 
spin column. Tubes were spun briefly at 17,000 x g and flow-through was discarded. 
500 µl of PB buffer was added, followed by a brief spin at 17,000 x g. Supernatant was 
discarded. Next, samples were washed with 750 µl of PE buffer, followed by a brief 
centrifugation. Flow-through was discarded and samples centrifuged again at 17,000 x 
g to remove residual buffer. Spin columns were placed in clean 1.5 ml tubes. Finally, 
after 1 min incubation, DNA was eluted in 30 µl of EB buffer (10mM tris-Cl, pH 8.5) by 
brief centrifugation at 17,000 x g. 
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Purification of PCR products 
Amplified PCR products were purified using QIAquick kit (QIAgen) according to 
manufacturer’s instruction. 
DNA Digestion 
DpnI enzyme was used to digest the methylated DNA prior to transformation into 
E.coli DH5α to remove template DNA. 1 µl of DpnI was added to 45 µl of PCR product. 
This mixture was incubated for 1 hour at 37C. HaeIII enzyme was used to digest 
plasmids to confirm that the purified DNAs were the right constructs. Digestion tube 
contained: 1 µl of DNA, 7.5 µl of dH2O, 1 µl of Buffer C, 0.5 µl of HaeIII enzyme. Tube 
was incubated for 30 min at 37°C. Experimental restriction banding patterns were 
compared with the pattern predicted by the NEBcutter (Vincze et al., 2003). 
DNA ligation 
After digestion with DpnI and purification using QIAquick kit, PCR product was self-
ligated. Ligation mixture included: 8.5 µl of purified DNA, 1 µl of ligase buffer, 0.5 µl of 
T4 ligase enzyme. The tube was left at RT overnight.  
Bacterial Transformation 
Bacterial strain was inoculated in 100 ml LB broth and incubated with shaking at 37°C 
until OD600 0.4-0.8 (about 2 – 3 hours). Cell suspension was then centrifuged at 15,000 
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x g for 10 min at 4°C. The broth was discarded and the pellet was washed with 100 ml 
of cold water and centrifuged again. The supernatant was discarded and pellet was re-
suspended in 1 ml of cold water. Cells were transferred to a microcentrifuge tube and 
spun briefly at 16,873 x g. Supernatant was poured off and the cells were re-
suspended in 200 µl of cold water. 1 µl of the DNA was mixed with 50 µl of cell 
suspension and this mixture was placed into a pre-chilled 2 mm electroporation 
cuvette. Cuvette was slotted into a Gene Pulser II (Bio-Rad) set to 1.8 kV, 200 Ohms, 25 
µF and electro-transformation was induced. Cells were washed with 0.5 ml of LB broth, 
transferred into a clean bottle and incubated for 1 hour at RT. No DNA transformation 
was performed as a negative control. After incubation the mixture was then plated out 
on appropriate antibiotic supplemented plates and incubated overnight at 37°C. The 
next day plates were analysed for colonies followed by DNA purification. 
Verification of mutation 
Purified DNA from colonies after transformation into E. coli DH5α and Bt 4D7 was 
sequenced to confirm presence of the correct mutation by Eurofins Genomics. This 
was done using the primer: 5’- CATCATATGGATA - 3’. 
Protein harvesting 
Sporulation and crystal production was assessed under a light microscope (Leica 
DMLS). Sporulated cells were aseptically scrapped off the plate and suspended in 30 ml 
of cold dH2O. The cells were lysed by repeated sonication at 150 Watt (four cycles of 1 
min) on ice. The pellet was collected by centrifugation at 12,000 x g for 10 min at 4°C 
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and re-suspended in 1 ml of dH2O. Crystal/spore mixture was analysed under the light 
microscope.  
Protein solubilisation and activation 
Pellet containing parasporal inclusions was solubilized in 50 mM sodium carbonate (pH 
10.5) in the presence of 5 mM dithiothreitol (DTT) at 37°C for 1 hour (1:1 v/v ratio of 
pellet to buffer). Sample was then spun down at 16,873 x g for 5 - 10 min and 
supernatant containing solubilized protein was treated with a protease. 10 mg/ml of 
trypsin solution in dH2O was used for activation at the ratio of 1:10 (v/v) enzyme to 
supernatant at 37°C for 1 hour. Sometimes proteinase K solution (0.1 mg/ml) was used 
instead. After digestion, Complete mini EDTA-free protease inhibitor was added to 
stop further proteolysis.  
Protein dialysis and concentration 
The proteins were dialysed overnight before being used in cell assays to remove traces 
of DTT and other low molecular weight contaminants. The dialysed samples were 
analysed using SDS-PAGE. For small volumes this was done using a 10 kDa MW cut - off 
Micro DispoDialyzer (Harvard Apparatus). For bigger volumes (>100 μl) 12 kDa MW cut 
- off Dialysis Tubing Cellulose Membrane (D9777-100FT Sigma) was used. Samples 
were dialysed usually against 1 litre of either 50 mM Na2CO2 (pH 7.4), PBS (pH 7.4), 25 
mM tris-HCl 150 mM NaCl (pH 7.4), or 10 mM CAPS (pH 10.4) at 4°C using a magnetic 
stirrer. For dialysis, buffer exchange and sample concentration Vivaspin500 and 
Vivaspin6 columns (GE Healthcare) were used.  
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Protein purification 
Sephacryl S-200 High Resolution (Amersham) resin was used for gel filtration. A glass 
column was filled with 15 ml of resin and equilibrated with appropriate buffer (5 times 
the column volume). Most common buffers used for sample elution were: 50 mM 
Na2CO3 (pH 7.4), 25 mM tris-HCl 150 mM NaCl (pH 7.4), or PBS (pH 7.4). Generally 0.5 
ml of the solubilized or protease treated protein was applied to the equilibrated 
column and sample was eluted with around 10 ml of the buffer. Collected fractions 
(0.5 - 1 ml) were analysed for protein content using Bio-Rad protein assay and SDS-
PAGE. 
Proteins were also purified and separated by the means of Resource Q 1 ml (GE 
Healthcare Life Sciences), a strong anion exchange column connected to ÄKTA Purifier 
FPLC System. Toxins were first dialysed overnight against 10 mM CAPS (pH 10.4) using 
12 kDa MWCO Dialysis Tubing Cellulose Membrane, spun and 0.22 µM filtered before 
injection. Sample was injected in 10 mM CAPS (pH 10.4) and elution was achieved with 
a gradient of NaCl (0 to 1 M) over 20 minutes at a flow rate of 1 ml/minute. 0.5-1 ml 
fractions were collected and analysed using Bio-Rad protein assay and SDS-PAGE.  
Protein concentration 
Protein concentration was determined by the Bradford method (Bradford, 1976) using 
a Bio-Rad Protein Assay Kit (Bio-Rad) with BSA as the standard. All presented 
concentrations represent final concentrations used (unless stated otherwise). The 
assay involves the addition of Coomassie Brilliant Blue G-250 to a protein solution, 
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which in acidic conditions binds to basic amino acids and can be measured at 595 nm 
with a spectrophotometer. The mixture was incubated for 5 - 10 min at RT before 
measurement. Concentration of the unknown sample was determined by comparing 
its absorbance value against a plotted BSA standard curve. The standard curve showed 
near linear response (R2=0.9975) over 0 - 1 mg/ml BSA concentration range.  
Protein analysis by SDS-PAGE 
Proteins were resolved in 7.5 - 12% separating gels depending on the fragment size by 
SDS-PAGE based on method described by Laemmli (Laemmli, 1970) using Mini-
PROTEAN® II Electrophoresis Cell (Bio-Rad). Samples were mixed with 2 or 4 x sample 
loading buffer additionally supplemented with reducing agent β- mercaptoetanol (5%), 
boiled for 3-5 min, and spun. Supernatant samples were loaded on the gel and run at 
200 V for approximately 35 min using a tris - glycine buffer. Gels were stained with 
Coomassie blue staining and de-stained. Molecular masses of proteins were estimated 
by comparison with molecular standards (New England BioLabs). 
Microscopy 
Nikon Eclipse TS100 inverted microscope was used for routine cell viability observation 
and post-treatment monitoring of swelling. For DIC morphological observation cells 
were seeded in the Chambered 1.0 Borosilicate Coverglass slide (Lab-Tech) at the 
density of 2.97 x 104 cells per chamber well and cultured overnight. For detailed DIC 
cell examination using purified toxins, cells were seeded in 1 μ-Slide 8 well coated 
(Collagen IV) Microscopy Chamber (ibidi) at the density of 1.54 x 104 cells per well and 
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cultured overnight. The next day cells were observed using Zeiss Axiovert 200M 
motorized inverted microscope with 63x air objective. 
Cell culture conditions 
The cells were maintained under the conditions recommended by the supplier. For 
adherent cells, culture medium DMEM with high glucose (4.5 g/l) was supplemented 
with 10% FCS, and with 1% PSG (100 U/ml penicillin, 100 µg/ml streptomycin, 292 
µg/ml L-glutamine). Suspension cells were cultured in RPMI 1640 supplemented with 
10% FCS and 1% PSG. For the culture of BL31 cells, RPMI 1640 was additionally 
supplemented with sodium pyruvate (100 nM) and 1-thioglycerol (100 nM). 
The cells were routinely cultured in sterile polystyrene 75 cm2 flasks (Nunc) in 
standard cell culture conditions (37°C and 5% CO2 humidified air). Medium was 
changed twice a week. When adherent cells reached confluency (between 70-80%) 
they were washed with DPBS and detached by trypsinization (trypsin/EDTA containing 
0.05% trypsin and 0.53 mM EDTA) at 37°C for 5 - 10 minutes. This was followed by 
spinning (100 - 200 x g for 5 min). Adherent cells were dispersed by banging and re-
suspension in fresh medium. Cells were counted and split depending on the desired 
seeding ratio.  
For electrophysiology experiments HepG2 cells were cultured in DMEM and 
low glucose (1 g/l). HeLa cells were cultured in MEM. Both media were supplemented 
with 10% FCS and 1% PS (10 U/ml penicillin, 10 µg/ml streptomycin). Media were 
buffered with 25 mM HEPES and cultured in the absence of CO2 in non-coated 60 mm 
plastic dishes. 
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Cell assays 
Fluorescent and luminescent cell assays were performed in 96-well plates. Each well 
received 90 μl of cell suspension at a density of 5,000 or 22,500 cells per well 
(equivalent to 5.5 x 104 or 25 x 104 cells/ml) in complete DMEM (DMEM supplemented 
with FCS and PSG) and cultured overnight under standard cell culture conditions 
(unless specified otherwise). After incubation, each well received 10 µl of treatment. In 
most cases mock control wells contained 90 μl of cell suspension and 10 μl of the 
appropriate buffer. The following control buffers were used: for non-purified, dialysed 
toxins - Na2CO3 (7.4 pH), for gel filtered toxin - 25 mM tris-HCl, 150 mM NaCl (pH 7.4), 
for ÄKTA purified toxin - PBS (7.4 pH). For background fluorescent/luminescent control 
100 µl of appropriate cell culture medium was aliquoted. Additionally, whenever 
possible, to test for possible interference between analyte and culture medium, a 
control containing 90 µl of medium only and 10 µl of treatment was set up. Generally, 
each treatment was tested in triplicate (three technical replicates).  
The viability of the cells was measured using CellTiter-Blue, generally after 24 
hours of treatment. For CellTiter-Blue assays cell density and incubation time with the 
reagent were optimised for each cell line. 20 µl of the reagent was added at the end of 
toxin exposure period and the reading was taken after additional 2 hours (end-point 
method). Fluorescence was measured with a green filter with excitation wavelength at 
525 nm and emission wavelength range of 580-640 nm. For RealTime-Glo cell viability 
assay ‘Continuous – Read Method: Reagent Addition at Cell Plating’ was selected. 
CellTox-Green and CytoTox-Glo assays were used for evaluation of cytotoxicity 
by measuring changes in membrane permeability. CytoTox-Glo assays were done 
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according to the manufacturer’s protocol. For CellTox-Green assays ‘Express, No-Step 
Addition at Seeding Method’ was selected. In brief: to 5 ml of cell suspension 10 µl of 
CellTox Green dye was added and then 90 µl of the mixture was dispensed into each 
well and allowed to adhere overnight. The next day each well received 10 µl of 
treatment followed by the desired incubation length. Fluorescence was measured 
before the treatment and at different time-points post-treatment using a blue filter 
with excitation wavelength at 490 nm and emission wavelength range of 510-570 nm.  
Caspase 3/7 levels were assessed in compromised cells over 8 hour period 
using ApoTox-Glo Triplex Assay and over 24 hour period using Caspase-Glo 3/7 Assay. 
The former was performed according to the manufacturer’s protocol. The latter was 
multiplexed with CellTiter-Blue for simultaneous assessment of cell viability. At the end 
of each treatment 20 µl of CellTiter-Blue reagent (for this assay diluted 1:4 v/v in DPBS) 
was added to each well and the reading was taken after 1.5 hours. After that 100 µl of 
Caspase-Glo 3/7 reagent was added to each well and the luminescence readings were 
taken after brief orbital mixing and 30 min incubation at RT. 
The fluorescent and luminescent readings were performed using GloMax - 
Multi Detection System (Promega) according to each assay instructions. After the 
readings were acquired, the CellTox-Green values before toxin treatment were 
subtracted from the readings after treatment in that same well. In the case of other 
cell assays fluorescent or luminescent signal in the background control wells was 
subtracted from each experimental value.  
Trypan Blue exclusion method was used for additional assessment of cell 
viability (Mehdizadeh, 1991). HL-60 (25 x 104 cells/ml) or HepG2 (20 x 104 cells/ml) 
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cells were grown in a 96-well plate and incubated with either PS-3 (12 µg/ml) or buffer 
only for 3 or 24 hours. The medium was removed from HepG2 and cells were 
trypsinized (100 µl of trypsin/EDTA) for 10 min at 37°C, followed by the addition of 100 
µl of 0.4% Trypan Blue dye aqueous solution. In case of HL-60 cells, 100 µl of Trypan 
Blue was added straight in the wells containing 100 µl of cell suspension. Viable cells 
were counted after 10 min incubation with Trypan Blue.  
In experiments with metal chelators 90 µl of cell suspension (containing 25 x 
104 cells/ml) were pre-treated with a chelator for 30 min (unless specified differently) 
followed by toxin treatment for 3 hours. After that CellTiter-Blue reagent was added 
and the reading was taken after additional 2 hours. If metal salts were used they were 
added 10 min before toxin addition. 
Statistical analysis and data presentation 
Cell assay results were expressed as means ± SEM for each experimental triplicate 
(unless stated otherwise). To establish PS-3 EC50, Probit Regression analysis was 
performed in SPSS software version 22.0 (IBM, 2013). For statistical comparison of 
treatments in salt supplementation experiments, Post-Hoc analysis applying a 
Bonferroni adjustment was carried out in SPSS. Dose-response curves in chapter 5 
were performed using nonlinear regression analysis and the equation ‘Dose-response 
– Stimulation, log (agonist) vs. response - Variable slope’ in GraphPad Prism version 
7.00 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com. 
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Planar lipid bilayer 
Preparation of planar lipid bilayers involved creating a lipid mixture containing: 
phosphatidylethanolamine (PE), phosphatidylcholine (PC) and cholesterol (Avanti Polar 
Lipids) in a ratio of 7:2:1 (w/w/w). Lipids were first dried with N2 to evaporate 
chloroform and then dissolved in n-decane, at a final concentration of 20 µg/ml. 1 ml 
of KCl buffer (150 mM KCl, 1 mM CaCl2, 10 mM HEPES, pH 7.5) was added to each of 
the custom made disposable chambers. A 250 µm diameter hole present at the 
junction of both chambers was painted with the lipid mixture using a blunt end glass 
pipette. However, only the central area of around 100 µm in diameter created a 
functional bilayer. Chambers were connected to the electrodes through conducting 
agar bridges and placed inside a Faraday cage to decrease electrical interference. 
Voltage was applied to the cis chamber (trans chamber was grounded). Membrane 
activity was recorded for 30 minutes before toxin was added to ensure that there was 
no contamination. Capacitance of the membrane was between 180 - 200 pF and the 
painted membranes remained stable for a few hours. PS-3 was dosed at a starting 
concentration of 4 µg/ml, later increased to 8 µg/ml, and current was recorded at 
different applied voltages. At the end of each of the three experiments, concentration 
of KCl in the cis chamber was increased to 450 mM to test if the pore was more cation 
or anion selective. All experiments were performed at RT. Voltage was applied using 
Axopatch – 1D (Molecular Devices). Detected current was recorded and amplified by 
the same instrument and converted into a digital signal with Axon Digidata 1440A 
(Molecular Devices). Currents were filtered at 5 kHz and digitized at 50 kHz. Recordings 
were analysed using pCLAMP 10.5 (Molecular Devices). To measure the conductance, 
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20 to 25 current jumps were recorded for each voltage and averaged. Currents were 
plotted versus applied voltages (I/V curves) and the data points were fitted by linear 
regression. Mean conductance (G) was read from the slope of each I/V curve 
regression line. Probability of channel opening was evaluated from recordings by 
digital analysis of the distribution of all current values and plotted for each voltage as a 
histogram using pCLAMP 10.5 software. 
Patch clamping 
Cells were seeded at a low density on 24 mm circular glass coverslips inside 35 mm 
dishes, usually 24 - 48 hours before the experiments. Just before patching, cells were 
washed three times with appropriate buffer and mounted inside a coverslip holder 
that was fitted to the stage of an inverted microscope (IMT-2, Olympus). 1 ml of either 
NaCl (140 mM NaCl, 5 mM KCl, 1.1 mM MgCl2, 1.1 mM CaCl2, 10 mM HEPES, pH 7.4) or 
KCl buffer (140 mM KCl, 1.1 mM MgCl2, 0.1 mM EGTA, 10 mM HEPES, pH 7.4) was 
added. Pipettes were prepared using a Narishige glass capillary puller in a two-step 
heating process. Two types of pipettes were used: borosilicate LG16 (Warner 
Instruments) for some of single channel recording and soda lime 200 (Kimble Chase) 
for single channel and whole cell recordings. The heater was set to 84/77 for 
borosilicate and 84/74 for soda lime pipettes. The following configurations were used 
in patch clamp experiments: cell attached, whole cell, inside out (explained in section 
4.7). Pipettes were mounted inside a holder attached to an automatic 
micromanipulator. Electrical connection between the pipette and the amplifier was via 
Ag/AgCl pellets. Bath solution was grounded. In some experiments, the pipette was 
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first filled with appropriate buffer, followed by toxin addition on top to allow slow 
diffusion towards the tip of the pipette. In other experiments, the toxin was added 
straight to the bath. The filled pipettes had the resistance of around 4 MΩ and the 
resistance of the seal was in the range of 2 - 10 GΩ. In the whole cell mode a voltage of 
- 20 mV was applied to ease the transition from the cell attached into the whole cell 
mode. Currents were induced by a set of seventeen 1 second depolarizing potential 
steps from −20 to 140 mV (10 mV increments). Current values between 0.95 – 1 s were 
analysed at each voltage, counting from the beginning of each recording. Values were 
corrected for the averaged baseline current measured just prior to the applied 
potential. Current – voltage curves in the whole cell experiments were generated from 
each data set for each time point and conductance was calculated from the slope of 
regression line of each I/V curve. In the single channel experiments, with excised 
patches conductance was calculated using G = I/V equation. Similar conductance 
values were grouped and mean conductance calculated. In the cell attached mode the 
data points were plotted and reversal potential (Vr) calculated from the intersection of 
the voltage axis with the linear regression at zero current. Conductance was calculated 
using: G=I/(V-Vr) equation to correct for the intracellular voltage. Similar conductance 
values were grouped and mean conductance calculated. All experiments were 
performed at RT. Voltage was applied using Axopatch – 1D (Molecular Devices). 
Detected current was amplified and converted into a digital signal with Axon Digidata 
1550 (Molecular Devices). Currents were filtered at 10 kHz and digitized at 50 kHz. 
Recordings were analysed using pCLAMP 10.6 (Molecular Devices).  
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Cell lysis prior to western blot 
For western blot experiments, cells were plated inside 6, 12, 24-well plates or 60 mm 
dishes. In general, cells were lysed with either RIPA, NP-40 (1 ml of lysis buffer per 2.8 
x 107 cells) or 1.5% NOG (1 ml of lysis buffer per 2 x 107 cells). Each lysis buffer 
contained protease inhibitors: Complete protease inhibitor mixture, 1 mM EGTA, 1 
mM EDTA and phosphatase inhibitors: 2 mM sodium orthovanadate and 1 μM 
microcystin. 
Cell lysis for ligand blots with biotinylated PS-3, HA-tagged PS-3 and N-cadherin, pCREB 
western blots: 
HepG2 and HeLa cells were seeded at the density of 3.5 x 106 cells/ml in 60 mm dishes 
(14 x 106 cells/dish) unless specified differently. The next day medium was removed; 
cells were washed twice with cold DPBS and lysed with RIPA, NP-40 or NOG as 
described above. Lysed cells were incubated on ice with swirling for 30 min. RIPA cell 
extracts were transferred into tubes and sonicated on ice 3 x 10 sec. at 21% output 
(Sonics, The Vibra-Cell). Lysates were spun at 16,873 x g for 15 - 60 min at 4°C. 
Supernatant was collected and frozen down for further analysis. 
Cell lysis for p38, ERK western blots: 
HepG2 or HeLa cells were seeded at the density of 25 x 104 cells/ml in 6 well-plates (75 
x 104 cells/dish). When cells reached >70% confluency (often the next day) they were 
exposed to sodium arsenite, buffer, or toxins for 15 - 30 min before being washed 
twice with DPBS. Intact cells were gently scraped, spun at low speed (200 x g) and 
supernatant was discarded. Pellet containing intact cells was re-suspended in 100 µl of 
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NP-40 with protease and phosphatase inhibitors (1 ml of lysis buffer per 7.5 x 106 
cells). Samples were vortexed for 10 seconds, left on ice shaking for 20 minutes and 
spun at 16,873 x g for 15-30 min at 4°C. Supernatant was collected, diluted 3 - 5 times 
and protein concentration measured using the Bradford method. In case of HL-60, the 
cells were harvested on the same day. 1 x 106 cells were placed in each test tube 
containing 1 ml. Cells were treated and the tubes were placed in the incubator slightly 
open. After 30 min incubation supernatant was removed by gentle spin and the cells 
were gently washed with 1 ml of DPBS. After a gentle centrifugation DPBS was 
removed and the pellet was lysed with 100 µl of NP-40 buffer as described above. 
Cell lysis for western blots with HA-tagged PS-3 - modified protocol: 
HepG2 cells were seeded at the density of 40 x 104 cells/ml in 6 well-plates (1.2 x 106 
cells/dish). Cells were exposed to concentrated HA-PS-3 (60 μg/ml) for 20 min and 
washed three times with DPBS. Fresh DMEM was added and cells were incubated for 
additional 40 min at 37°C. After that the medium was gently removed and cells were 
lysed in 250 µl of either RIPA or NP-40 with inhibitors (1 ml of lysis buffer per 4.8 x 106 
cells). Cells were scraped, transferred into tubes, shaken on ice for 30 min and spun at 
16,873 x g for 15 min at 4°C. 
Western blot 
Western blot protocol was optimised for each experiment.  
p-p38, t-p38, p-ERK, t-ERK, CD59, p-CREB, N-cadherin western blots: 
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Between 5-30 µg of protein were loaded per well. The proteins were resolved on SDS-
PAGE gels (7.5 - 12%). The gel was soaked in dry blot buffer gently rotating for 10 min. 
Proteins were transferred to a nitrocellulose membrane (HyBond ECL or Bio-Rad, pore 
size 0.45 µm) using a Bio-Rad Trans-Blot Semi-Dry Transfer Cell system (100 mA for 60 
min). Membrane was washed for 5 min with PBS and then blocked with PBS containing 
0.02% Tween-20 (PBS-T) and 3% BSA for 1-3 hours at RT. Membranes were washed 3 x 
10 min with PBS-T. Probing was done overnight at 4°C by incubating the membranes 
with rocking in a fresh blocking solution containing 3% BSA and primary antibody 
diluted in PBS-T (1:1000 v/v dilution for antibodies against total and phosphorylated 
ERK and p38; 1:50000 v/v dilution for anti-CD59 antibody). In p CREB and N-cadherin 
western blots both blocking and incubation with primary antibody (1 µg/ml final) was 
done using 5% non-fat dry milk instead of BSA. The next day the membranes were 
washed 3 x 10 min with PBS-T, followed by 1 hour incubation with an appropriate 
horseradish peroxidase-conjugated secondary antibody diluted 1:2000 v/v in PBS-T 
containing 5% non-fat dried skimmed milk. Finally, the membranes were washed again 
(3 x 10 min, PBS-T) and soaked in the chemiluminescent detection solution and 
exposed to X-ray film (FUJI medical X-ray film).  
Biotin labelled PS-3 western and ligand blots: 
In western blots with biotin labelled toxin, blocking was done for 1 hour using supplied 
blocking reagent diluted to 5% in PBS with Tween-20 (0.1%). Membrane was rinsed 
with PBS-T twice followed by 1 hour incubation with biotinylated toxin diluted in PBS-T 
gently shaking at RT. Next, membrane was washed three times with PBS-T, first for 15 
then twice for 5 min and incubated with Streptavidin – HRP (1 in 1500 v/v) in PBS-T for 
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another hour at RT. After 3 x 15 min washes signal was detected using supplied 
enhanced luminol-based chemiluminescent detection (ECL).    
HA-PS-3, HA-PS-3 (K668A), FITC-PS-3 western and ligand blots: 
Protocol was modified in a way that blocking was done for 1-2 hours at RT with PBS-T 
containing 5% non-fat dry milk (in experiments with FITC-PS-3 blocking was done using 
3% BSA). In toxin ligand blot experiments the membranes were then washed and 
incubated with different amounts of tagged PS-3 diluted in PBS-T or PBS usually for 1 
hour at RT. Incubation with FITC-PS-3 was done in the dark. After washes, the 
membrane was incubated with appropriate antibody (either anti HA-tag HRP 
conjugated; 0.5 µg/ml or anti FITC-HRP conjugated; 7.5 µg/ml) for 1 hour at RT in PBS-T 
5% Milk, followed by washes and ECL detection.  
Native western blots: 
PAGE gels were cast as in SDS-PAGE, except SDS was omitted in gels and running 
buffers. Non-reducing (without β-mercaptoethanol) and non-denaturing (without SDS) 
5 x sample loading buffer was used and samples were not boiled before loading. Gels 
were run at 100 - 150 V for about 1 - 2 hours.  
Pull down 
Pull down with anti-HA agarose slurry: 
Pull down was carried out as recommended by the manufacturer (Pierce). Briefly 100 
µl of anti HA agarose slurry was placed in a tube and washed with TBS. Roughly 50 - 
150 µg of HA tagged protein was added to pelleted resin and samples were incubated 
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for varying amounts of time on a rocking platform either at RT or 4°C. Next, cell extract 
(containing between 150 - 350 µg of protein) was added and the tube was incubated 
with rotation for the designated period of time. After incubation resin was washed 
three times with TBS with 0.05% Tween-20. Finally HA-tagged protein was eluted with 
50 µl of either 0.1 M glycine (pH 2.4) or 3 M NaSCN. When using glycine, supernatant 
containing eluted protein was neutralized with 1:10 volume with 0.1 M tris pH 9.5. 
Elution step was repeated twice.  
Coupling of cysteine residues and pull down with SulfoLink resin:  
Toxin coupling was carried out as recommended by the manufacturer (Thermo Fisher 
Scientific). Briefly 100 µl of agarose slurry was placed in a tube and washed four times 
with the coupling buffer. Roughly 50 - 150 µg of ÄKTA purified toxin concentrated and 
dialysed against coupling buffer was added to pelleted resin and samples were 
incubated with rocking at RT for 15 min. Next, non-specific binding sites on the resin 
were blocked to avoid cell extract proteins with reactive –SH groups binding to the 
beads. 50 µl of 50 mM L-cysteine-HCl solution in coupling buffer was added to the 
resin and incubated for 15 min at RT rotating, followed by a 30 min additional 
incubation without mixing. Next, resin was washed and incubated with cell extract 
(containing between 150 - 350 µg of protein) rotating for 1 hour at RT. After incubation 
resin was washed three times with coupling buffer and samples (supernatant and 
pellet) were analysed using SDS-PAGE. 
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Biotinylation 
ECL Protein Biotinylation kit (Amersham) was used according to manufacturer’s 
instruction. Briefly 40 µl of biotinylation reagent was incubated per 1 mg of activated 
toxin in 40 mM bicarbonate buffer for 1 hour at RT shaking. Next, sample was applied 
to a pre-equilibrated column and eluted with PBS.   
FITC labelling 
PS-3 was trypsin activated, gel filtered and eluted in 50 mM sodium carbonate buffer 
(pH 8.5). Molar concentration of PS-3 was calculated based on Beer-Lambert law which 
relates concentration of a solute to its absorbance (Wood, 1983): A = ε c l, were A = 
absorbance, ε = molar extinction coefficient, c = concentration and l = light path-
length. Given this equation, concentration can be calculated:  c = A/ε l. ε is related to 
protein’s tryptophan (W), tyrosin (Y)  and cysteine (C) amino acid composition. At 280 
nm, ε can be calculated as follows:  ε = (nW × 5500) + (nY × 1490) + (nC × 125), where n 
stands for the number of each residue. In the PS-3 sequence after trypsin cleavage the 
following are most likely present: W=24, Y=45 and C=6. ε was calculated as 199,800, 
and protein absorbance at 280 nM was 7.664. Molar concentration of activated PS-3 
came up as 38.358 µM. 50 µl of activated PS-3 was mixed gently with 25 µl of 1534 µM 
solution of FITC (to achieve 20 fold excess of the dye). Mixture was incubated in the 
dark for 1 hour, then excess dye and DMF was removed and buffer exchanged into 50 
mM sodium carbonate (pH 8.0) via at least five washes with a Vivaspin500 column.  
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4. Protein characterization and cytotoxic effects 
4.1 Introduction 
Conditions for toxin solubilisation and digestion used by the research group that first 
characterised PS-3 involved a 1 hour incubation at 37°C in 50 mM sodium carbonate 1 
mM EDTA (10.5 pH), followed by a 90 minute treatment with proteinase K (10 µg/ml) 
in the presence of 10 mM DTT reducing agent at 37°C (Yamashita et al., 2005). Here a 
characterization of recombinant PS-3 was carried out in order to find the optimum 
conditions for protein solubilisation, digestion and purification. 
Many attempts were made to purify PS-3. Mono S HR 5/5 (strong cation 
exchange) and Phenyl Sepharose 6 Fast Flow column (hydrophobic interaction 
chromatography) proved unfruitful (data not shown). Successful purification (but not 
separation of toxic fragments) was achieved with the gel filtration resin Sephacryl S-
200. In gel filtration molecules in solution are separated according to their sizes and 
shapes as they pass through a column packed with a chromatographic medium. 
Sephacryl is a hydrophilic composite gel made by covalently cross-linking allyl dextran 
with N,N'-methylene bisacrylamide, that allows for protein purification in the range 
from 5,000 to 250,000 Daltons for globular proteins (Biotech, 2010). Successful 
purification and separation of toxic fragments was achieved with a 1 ml Resource Q 
column (strong anion exchange, GE Healthcare Life Sciences) connected to an ÄKTA 
Purifier – FPLC System. In anion exchange chromatography, negatively charged 
molecules are attracted to a positively charged solid phase. Ionic interaction between 
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the oppositely charged sample molecule and the column resin retains the sample, 
which is later eluted by increasing salt concentration. The predicted pI of PS-3 protoxin 
calculated by Compute pI/Mw Expasy tool (Elisabeth Gasteiger, 2005) is 6.18 and only 
slightly changes when proteolytically cleaved toxin sequence is input. Close to neutral 
pI should make PS-3 suitable for both cation and anion exchange methods. However 
because PS-3 fragments were previously successfully separated using anion exchange 
(Yamashita et al., 2005) and because previous attempts to use cation exchange 
purification failed, anion exchange method was optimised to separate PS-3 fragments. 
Cell based assays were used to measure viability of PS-3 treated cells in vitro. 
Metabolic activity and ATP levels were used as viability indicators. Trypsin activated 
Cry1Ca was tested as a negative control in these and other cell assays for two reasons. 
It shares a similar three domain Cry toxin fold with PS-3 while having activity against 
lepidopteran insects and no known human cytocidal activity. Secondly, Cry1Ca was 
expressed in the same acrystalliferous Bt strain as recombinant PS-3. Most of the cell 
assays were performed with susceptible HepG2 cells. Additionally, the effect of PS-3 
was assessed on cellular viability of other cell lines not examined before, like Burkitt's 
lymphoma and lymphoblastoid cells.  
Measurement of cell membrane integrity in compromised cells was achieved 
using two cytotoxicity cell assays. CellTox-Green assay, using a non-toxic small cyanine 
dye (~661 Da), allows for continuous assessment of membrane permeability for up to 
72 hours in the same set of cells. The dye is excluded from viable cells, whereas in cells 
with compromised membranes it binds to the minor grove of the DNA producing a 
fluorescent signal proportional to the amount of cells with disrupted membranes. 
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Another membrane permeability assay, CytoTox-Glo measures a distinct protease 
activity associated with a cytotoxic marker, which is released from cells that have lost 
membrane integrity. The substrate cannot cross the intact membrane of live cells but 
in the presence of the released protease generates a stable luminescent signal. 
Scientists speculate that the cellular protease responsible for this reaction is consistent 
with tripeptidyl peptidase II (Niles et al., 2007), which is a relatively big 138 kDa 
protein. Osmotic swelling resulting from toxin induced membrane damage was 
recorded using a differential interference contrast (DIC) microscope. 
Additionally, changes in membrane permeability were monitored in 
electrophysiology experiments using both artificial bilayers and biological membranes. 
Electrophysiology allows the measurement of electrical properties of a membrane. In a 
simplified model, the membrane represents a charge storing capacitor separating two 
current conducting solutions. In the presence of a pore, ions driven by the 
electrochemical gradient pass through the pore and current can be detected. The 
current is directly proportional to the voltage potential as described by Ohm’s law: 
I=V/R, where V is potential, I current and R resistance (Millikan et al., 1917). The planar 
lipid bilayer (PLB) technique has been widely used to study the properties of pores 
induced by Cry toxins (Lorence, 1995, Peyronnet et al., 2001, Rausell et al., 2004, 
Schwartz et al., 1993, Schwartz et al., 1997, Slatin et al., 1990a, Walters et al., 1993). 
The advantage of the PLB method is having a simplified system with total control over 
experimental conditions like lipid composition, pH and ionic concentration. For this 
study, the most significant is the fact that being receptor-free, the PLB method 
enabled evaluation of the innate pore forming ability of PS-3. Patch clamp recordings 
from cells exposed to Cry toxins have been previously documented (Schwartz et al., 
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1991, Stumpff et al., 2007). However in contrast to PLBs, biological complexity of the 
cell membrane and the presence of endogenous channels are the main reasons why 
this technique has not been fully exploited in the studies of PFTs. Here, the whole cell 
and single channel patch clamp experiments were attempted and conductance levels 
compared with each other and with values obtained in PLB experiments. 
PEGs are linear, generally non-toxic to cells polyethers, but they act like 
spherical molecules in aqueous solutions (Scherrer and Gerhardt, 1971). Pore diameter 
can be estimated from the smallest PEG that is excluded from the cells and prevents 
osmotic swelling (Sabirov et al., 1993). Using this approach pore size was estimated for 
various proteins, including Bt toxins: Cry1C (Peyronnet et al., 2002), PS-2 (Kitada et al., 
2006). This method was also applied to estimate the size of PS-3 induced primary 
lesions.  
4.2 Optimizing conditions for solubilisation and digestion 
The coding region of the cry41Aa gene was cloned from Bt A1462 strain and expressed 
in the acrystalliferous 4D7 Bt strain (Krishnan, 2013). Crystals of the recombinant PS-3 
were observed during sporulation (Figure 15).  
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Figure 15 Scanning electron micrograph of PS-3 crystal and spores expressed in Bt 4D7 strain. 
Sonicated suspension containing spores and PS-3 crystals was spread over a metal stub, dried overnight and coated 
with gold. The next day sample was visualised using transmission electron microscopy. 
 
Crystals had a bi-pyramidal shape similar to Cry1 toxins. Figure 16 shows PS-3 samples 
before and after solubilisation and post-activation resolved on an SDS-PAGE gel.  
 
Figure 16 SDS-PAGE analysis of alkali solubilisation and activation of PS-3. 
PS-3 samples were run on a 7.5% SDS-PAGE gel: protein marker (M), crude solution before solubilisation, PS-3 
solubilized in the presence or absence of DTT (5 mM), solubilised protoxin activated with 1 mg/ml trypsin or 0.01 
mg/ml proteinase K (PK). 
104 
 
An 80 kDa protein representing PS-3 was clearly visible in the crude sample after three 
days of growth. The 120 kDa band (Figure 16, lane 2) represents the protein coded by 
ORF3, normally degraded during solubilisation. Proteinase K and trypsin activated toxin 
forms are presented for comparison. They showed different digestion patterns. The 
relatively big difference in size between the lower and higher MW fragments after 
toxin activation can be attributed to the C-terminal cleavage since the extent of N-
terminal removal was previously demonstrated to be small (Yamashita et al., 2005).  
Independent solubilisation and proteolysis 
Before this optimization, PS-3 had been solubilized and trypsin digested in a single 
tube for 1 hour at 37°C. This process resulted in a single band of around 80 kDa on a 
gel. However, when solubilisation and trypsin activation were performed separately (1 
hour at 37°C each) two main bands appeared: around 80 and 65 kDa (Figure 17).  
 
Figure 17 The effect of sequential activation on toxin processing. 
PS-3 was incubated in 50 mM sodium carbonate (10.5 pH) with 5 mM DTT and trypsin (1 mg/ml) or proteinase K 
(0.01 mg/ml) for 1.5 hour at 37°C (Try and PK) or incubated first in 50 mM sodium carbonate/5 mM DTT for 1 hour 
at 37°C and then with the protease for another hour at 37°C. Samples were run on a 7.5% SDS-PAGE gel. Try (SN) 
and Try (Pellet) represent supernatant and total of solubilised toxins respectively after trypsin activation.  
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The effect of sequential activation was tested on protein cytotoxicity (Figure 18).  
 
Figure 18 The effect of sequential activation on PS-3 cytotoxicity.  
PS-3 was solubilized and trypsin treated either separately (sequential activation) or at the same time (single step 
activation). HepG2 cells were seeded at density 5.5 x 10
4
 cells/ml. The next day cells were treated with non-purified 
PS-3 either sequentially activated (96 μg/ml) or activated in a single step (98 μg/ml). Viability was measured 24 
hours later using CellTiter-Blue. 
 
Consecutive solubilisation and digestion altered toxin processing and significantly 
increased toxicity in case of trypsin activated PS-3. Separate solubilisation and 
proteolysis did not improve cytotoxicity or processing of proteinase K digested 
proteins (data not shown). PS-3 fragments after proteinase K digestion showed similar 
75 and 60 kDa fragments regardless of the activation method (Figure 17).  
Endogenous proteolysis of protoxin 
High molecular weight proteins including ORF3 degraded upon alkali solubilisation of 
PS-3 (Figure 16). Also, PS-3 protoxin showed some degree of cytotoxic activity in 
presented later viability (Figure 39) and membrane permeability (Figure 45 and Figure 
46) assays implying some processing of the protoxin. To test that, PS-3 was solubilised 
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in the presence or absence of protease inhibitors. Purified samples were run on an 
SDS-PAGE gel (Figure 19) and tested on HepG2 cells (Figure 20).   
 
Figure 19 The effect of protease inhibitors on protoxin solubilisation. 
Toxin crude suspension was solubilised in 50 mM sodium carbonate (pH 10.5) with 5 mM DTT for 1 hour at 37°C 
either in the presence or absence of protease inhibitors. After 1 hour protease inhibitors were added to stop 
proteolysis in a sample containing protoxin without previously added inhibitors and both proteins were purified. 
Fractions collected were run on a 10 % SDS-PAGE gel.   
 
 
Figure 20 The effect of protease inhibitors on protoxin cytotoxicity 
HepG2 cells were seeded at the density of 20 x 10
4
 cells/ml together with CellTox-Green dye in a black 96-well plate. 
The next day cells were treated with purified protoxin incubated previously with (56 µg/ml) or without (58 µg/ml) 
protease inhibitors. After cytotoxicity was measured (data presented in Figure 46) CellTiter-Blue reagent was added 
and viability was measured 28 hours after toxin exposure. 
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Experiments with protease inhibitors showed that protoxin processing occurs due to 
proteolysis by the endogenous proteases present in the crude sample and that this 
processing is responsible for protoxin induced drop in cell viability (Figure 20) and 
membrane damage (Figure 46). They also suggest that protoxin is not processed in 
culture medium in the presence of cells. 
The effect of DTT 
Concentration-dependent effects of DTT were assessed on solubilisation and activation 
of PS-3 (Figure 21) as well as toxicity (Figure 22). 
 
Figure 21 The effect of DTT on PS-3 solubilisation and trypsinization. 
Sonicated crude suspension of PS-3 was solubilized in the presence of different DTT concentrations (0, 2.5, 5, or 10 
mM) followed by trypsin digest (1 mg/ml). Samples at different stages of activation were run on a 7.5% SDS-PAGE 
gel. 
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Figure 22 The effect of DTT assisted activation on PS-3 cytotoxicity. 
HepG2 cells were seeded at density 25 x 10
4
 cells/ml. The next day cells were treated with samples presented in 
Figure 21: PS-3 solubilized in the presence of different DTT concentrations (0, 2.5, 5, or 10 mM) followed by trypsin 
digest (1 mg/ml). The effect on cell viability was measured 6 hours later using CellTiter-Blue. Data come from only 
one technical replicate. 
 
The presence of DTT greatly increased solubilisation yield and was prerequisite for 
effective trypsin cleavage. The presence of as little as 2.5 mM DTT significantly 
increased PS-3 cytotoxicity. Similar toxin processing was obtained whether DTT was 
added at solubilisation or at proteolysis step (data not shown). Efficient solubilisation 
in the presence of DTT was confirmed by obtaining no protein bands on an SDS-PAGE 
gel after pellet re-solubilisation (data not shown). Addition of 1 mM EDTA to 50 mM 
sodium carbonate buffer during solubilisation did not influence toxin processing (data 
not shown), but its effect on toxicity was not assessed.  
The effect of pH 
Solubilisation and activation of PS-3 was tested at pH 8 (Figure 23) in the hope that the 
number of sample dialysis steps during purification could be reduced and to provide an 
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optimum pH for proteolytic digestion which for trypsin is 7-9 (Sipos and Merkel, 1970) 
and 7.5-12 for proteinase K (Ebeling et al., 1974). 
 
Figure 23 The effect of pH on solubilisation and activation of PS-3. 
PS-3 was solubilised for 1 hour at 37°C in 50 mM sodium carbonate/5 mM DTT at pH 8 or 10.5. This was followed by 
1 hour proteinase K digest (0.01 mg/ml) at 37°C (in duplicates). Supernatant samples were run on a 7.5% SDS-PAGE 
gel.  
 
pH 10.5 was slightly more efficient for toxin solubilisation and proteinase K digestion 
than pH 8, also when trypsin was used for processing (data not shown). Experiments 
where activation was done at pH 6 showed similar to pH 8 results, whereas 
solubilisation in 20 mM sodium acetate 1 M NaCl, pH 5 was ineffective (data not 
shown). Interestingly, solubilisation at lower pH (6-8) seemed to inhibit the 
degradation of protein coded by ORF3. Also, solubilisation and trypsin activation of PS-
3 was relatively well attained in 10 mM CAPS (pH 10.4), but was not practiced due to 
lower protein stability during storage (data not shown).  
Generally Bt inclusion bodies are solubilized in alkaline conditions, mimicking 
the high pH of the digestive juice of most insects. However, a few studies 
demonstrated efficient solubilisation and activation of Bt Cry inclusions using acidic 
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buffers while retaining similar cytotoxic activities to the alkali-treated toxins (Koller et 
al., 1992, Okumura et al., 2006). Solubilising PS-4 in 10 mM HCl and digesting it with 
pepsin (200 µg/ml, activity 1:10,000) resulted in about 25 fold higher protein yield in 
comparison to alkaline solubilisation and proteinase K treatment (Okumura et al., 
2006). To test whether PS-3 can be activated in acidic conditions, PS-3 crude sample 
was solubilised in HCl, followed by pepsin treatment (Figure 24). 
 
Figure 24 Solubilisation and pepsin treatment of PS-3 at low pH. 
PS-3 toxin was solubilised for 1 hour at 37°C in either 50 mM sodium carbonate (pH 10.5) or 10, 50 or 100 mM of 
HCl (pH around 2). After that, samples were spun and supernatant was digested for 1 hour at 37°C with either 
trypsin (1 mg/ml) or pepsin (33 µg/ml, activity 1:60,000). Supernatant samples were run on a 12% SDS-PAGE gel. 
 
Acidic solubilisation followed by pepsin digest did not result in higher MW bands that 
could represent the toxin (the 35 kDa band represents pepsin, degraded at higher HCl 
concentrations); samples were not tested for toxicity against HepG2.  
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Protein stability 
Changes in protein stability were assessed because protease inhibitors had not been 
routinely added to the toxin samples before. Protease treated PS-3 (trypsin or 
proteinase K) was incubated for 24 hours either at room temperature or 37°C with or 
without protease inhibitors (Figure 25).  
 
Figure 25 Assessment of PS-3 stability in the presence or absence of protease inhibitors. 
Trypsin or proteinase K activated PS-3 was incubated for 1 or 24 hours at RT or 37°C in the presence or absence of 
protease inhibitors (PI). Samples were run on a 7.5% SDS-PAGE gel. 
 
Protease inhibitors considerately slowed down the rate of toxin degradation, which 
was greater at 37°C than at RT. However, inhibitors did not preserve the lower band of 
proteinase K activated PS-3 suggesting its instability. 
For the purpose of cation exchange purification activated toxin was dialysed 
overnight against low pH (3) or high salt concentration (3M NaCl) buffer. SDS-PAGE 
analysis confirmed that PS-3 was structurally stable in these conditions (data not 
shown).  
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Proteolytic processing 
Solubilized toxin was treated with various concentrations of proteases to identify the 
dose that would result in optimum toxin processing; also to examine possible toxin 
degradation at a high dose of the protease used. PS-3 protoxin was activated with 
different concentrations of trypsin or proteinase K (Figure 26 and Figure 27 
respectively) and activated toxins were tested on HepG2 cells (Figure 28 and Figure 
29).  
 
Figure 26 Dose dependent effect of trypsin activation on toxin processing. 
Solubilised protoxin was digested for 1 hour at 37°C with trypsin to achieve the following final concentrations: 
0.005, 0.01, 0.5, 0.2, 0.3, 0.6, 1 mg/ml. Protease inhibitors were added and samples were run on a 7.5% SDS-PAGE 
gel.   
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Figure 27 Dose dependent effect of proteinase K activation on toxin processing. 
Purified solubilised protoxin was digested for 1 hour at 37°C with proteinase K to achieve the following final 
concentrations: 0.01, 0.1, 1, 10 mg/ml. After proteolytic digestion samples were run on a 12% SDS-PAGE gel.  
  
 
Figure 28 Dose dependent effect of toxin activation by trypsin on HepG2 cell viability.  
Purified protoxin (100 µg/ml) was processed for 1 hour at 37°C with trypsin at the following final concentrations: 
0.005, 0.01, 0.05, 0.2, 0.3, 0.6, 1 mg/ml. After that protease inhibitors were added to each sample. HepG2 cells 
were seeded at density 25 x 10
4
 cells/ml. The next day cells were treated with trypsin activated samples. Control 
cells were treated with respective concentrations of trypsin dissolved in buffer. After 24 hour incubation cell 
viability was measured using CellTiter-Blue assay. 
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Figure 29 Dose dependent effect of toxin activation by proteinase K on HepG2 cell viability.  
Purified protoxin (100 µg/ml) was processed for 1 hour at 37°C with proteinase K at the following final 
concentrations: 0.01, 0.1, 1, 10 mg/ml. After that protease inhibitors were added to each sample. HepG2 cells were 
seeded at density 25 x 10
4
 cells/ml. The next day cells were treated with proteinase K activated samples. Control 
cells were treated with respective concentrations of proteinase K dissolved in buffer. After 24 hour incubation cell 
viability was measured using CellTiter-Blue assay. 
 
The SDS-PAGE results showed that PS-3 was very resistant to degradation when 
treated with trypsin up to 1 mg/ml, whereas it degraded when proteinase K was used 
at concentration ≥1 mg/ml, breaking down to low MW bands. PS-3 was stable even in 
the presence of 10 mg/ml of trypsin or chymotrypsin (data not shown). 
Although proteinase K activated toxin showed more toxicity compared with 
trypsin processing (also shown in Figure 39), this activity greatly decreased when 
higher proteinase K concentrations were used (≥1 mg/ml). Trypsin activated PS-3, on 
the contrary, resulted in a cytotoxic effect when processed with higher enzyme doses. 
For these reasons, trypsin was used as a preferred choice for proteolytic treatment.  
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4.3 Protein purification 
Toxin was purified using size exclusion resin as detailed in the method section. Sample 
before purification and purified fractions were run on an SDS-PAGE gel (Figure 30). 
Toxicity of PS-3 before and after purification was assessed (Figure 31). 
 
Figure 30 Purification of PS-3 by Sepharose gel filtration.  
PS-3 was purified from DTT and other small MW contaminants using gel filtration as described in the method 
section. Trypsin activated toxin before and fractions collected after purification were run on a 7.5% SDS-PAGE gel: 
A) toxin before purification; B), C) and D) collected fractions of purified toxin. 
 
 
Figure 31 Comparison of PS-3 toxicity before and after gel filtration.   
HepG2 cells were seeded at density 5.5 x 10
4
 cells/ml. The next day cells were treated with trypsin activated PS-3 
before (96 μg/ml) or after gel filtration (6 μg/ml). Cell viability was measured 24 hours later using CellTiter-Blue. 
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Gel filtration did not allow for separation of the lower 65 kDa band (Figure 30, C). In 
general, gel purified toxins – despite dilution - had similar cytotoxicity to non-purified 
PS-3. Gel filtration was used to purify most toxins used in the cell assays. 8 ml stocks of 
gel filtered PS-3 and Cry1Ca (120 µg/ml each) were mass prepared and band intensities 
were compared on an SDS-PAGE gel as shown in Figure 32. Gel filtration was also used 
for purifying PS-3 protoxin, ricin deleted PS-3, HA-tagged PS-3, biotin labelled and FITC 
labelled PS-3. 
 
Figure 32 Gel purified stocks of PS-3 and Cry1Ca.  
Trypsin activated PS-3 and Cry1Ca toxins were purified by gel filtration. Fractions containing purified toxins were 
combined together to create 8 ml stocks at 120 µg/ml concentration. A sample from each stock was run on a 10% 
SDS-PAGE gel for comparison. 
 
Anion exchange chromatography was applied in an attempt to separate PS-3 
fragments. Toxin was dialysed overnight against 10 mM CAPS (pH 10.4) as described in 
the methods section. Elution was achieved with an increasing gradient of NaCl (0 to 1 
M). Upper band of protease treated PS-3 was eluted earlier than the bottom one, 
indicating a stronger ionic interaction between the more processed toxin and the 
column. Figure 33 shows separated toxin fragments on SDS-PAGE gels.   
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Figure 33 Separation of PS-3 bands using anion exchange chromatography. 
Fragments of proteinase K (PK-PS-3) and trypsin activated PS-3 (Try-PS-3) were ÄKTA separated and purified using 
10 mM CAPS (pH 10.4) buffer and an increasing gradient of NaCl (0 to 1 M). 0.8 ml fractions were collected and run 
on 10% SDS-PAGE gels. 
  
Figure 34 and Figure 35 show sample elution profiles of proteinase K and trypsin 
activated toxins respectively.  
 
Figure 34 Elution profile of proteinase K activated PS-3.  
Proteinase K activated PS-3 was ÄKTA purified. Toxin was eluted in 10 mM CAPS (pH 10.4) buffer as a double peak at 
~750 mM NaCl. 
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Figure 35 Elution profile of trypsin activated PS-3.  
Trypsin activated PS-3 was ÄKTA purified. Toxin was eluted in 10 mM CAPS (pH 10.4) buffer mainly as a single peak 
at ~750 mM NaCl. 
 
Selected fractions were desalted, concentrated and had buffer exchanged. Protein 
concentration was equalized and fragments were run on a gel (Figure 36). Toxicity of 
purified fragments was assessed on HepG2 cells (Figure 37 and Figure 38). 
 
Figure 36 SDS-PAGE analysis of ÄKTA separated PS-3 fragments.  
Proteinase K and trypsin activated PS-3 fragments were separated using ÄKTA. Samples were desalted, 
concentrated, and the buffer was changed to 25 mM tris-HCL 150 mM NaCl pH 7.4 (proteinase K activated toxin) or 
PBS pH 7.4 (trypsin activated toxin). Protein concentration was equalized to 100 µg/ml and samples were run on 
7.5% SDS-PAGE gels: A) upper 75 kDa and B) lower 60 kDa bands of proteinase K activated toxin; C) lower 65 kDa 
fragment and D) upper 80 kDa fragment of trypsin activated toxin.    
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Figure 37 Toxicity of PS-3 separated bands after proteinase K digestion.  
HepG2 cells were seeded at density 5.5 x 10
4
 cells/ml. The next day cells were treated with proteinase K activated 
ÄKTA separated toxins: 60 kDa and 75 kDa (10 µg/ml). The effect on cell viability was measured 24 hours later using 
CellTiter-Blue. 
 
 
Figure 38 Toxicity of PS-3 separated bands after trypsin digestion.  
HepG2 cells were seeded at density 25 x 10
4
 cells/ml. The next day cells were treated with trypsin activated ÄKTA 
separated toxins: 65 kDa and 80 kDa (10 µg/ml). The effect on cell viability was measured 24 hours later using 
CellTiter-Blue. 
 
Both lower and higher MW proteins after proteolytic activation with either trypsin or 
proteinase K were cytotoxic. 
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4.4 Assessment of cell viability  
Estimation of metabolic activity 
The majority of cell viability assays presented in this thesis was carried out using 
CellTiter-Blue. It is a ﬂuorometric method estimating the number of viable cells by 
measuring metabolic activity. It uses the non-toxic and cell permeable resazurin dye, 
which is reduced by cellular enzymes in viable cells into highly fluorescent resoruﬁn 
(O'Brien et al., 2000). Non-viable cells do not reduce the indicator dye. When reagent 
was added at the same time as toxin or incubated with cells for much longer than 2 
hours, artefacts were often noted where high ﬂuorescent signal did not correlate with 
immense cell death (data not shown). For this reason CellTiter-Blue was incubated 
with cells for no more than 2 hours and was always used as an endpoint reagent. 
 Initially experiments aimed to confirm the cytotoxic property of PS-3 on HepG2 
cells after 24 hours as shown in Figure 39.  
 
Figure 39 HepG2 cell viability after 24 hour exposure to toxins.  
HepG2 cells were seeded at density 25 x 10
4
 cells/ml. The next day cells were treated with non-purified, dialysed 
toxins: protoxin (100 μg/ml), trypsin treated PS-3 (100 μg/ml) and proteinase K treated PS-3 (50 μg/ml). Viability 
was measured 24 hours later using CellTiter-Blue.  
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A 24 hour incubation with proteinase K or trypsin digested toxin resulted in a 
significant decrease in cell viability. Reduction was greater in cells treated with 
proteinase K PS-3 even though smaller concentration was used. Protoxin showed 
moderate effect on cell viability as observed before.  
Next, a 28 hour time course viability experiment was designed to establish how 
long it takes for the toxic effects to occur (Figure 40). 
 
Figure 40 Time course experiment of HepG2 cells exposed to different forms of PS-3 over 28 hours.  
HepG2 cells were seeded at density 25 x 10
4
 cells/ml. The next day cells were treated at different time-points with 
non-purified, dialysed toxins: protoxin (100 μg/ml), trypsin treated PS-3 (100 μg/ml), proteinase K treated PS-3 (50 
μg/ml), etoposide (100 μg/ml), Triton X-100 (0.01%) or buffer (mock). 20 minutes after the last toxin dose (2 hour 
time point), CellTiter-Blue was added to all cells and the fluorescence was measured for all time points after 
another 2 hours. 
 
Proteinase K and trypsin activated PS-3 performed consistently, with viability readings 
increasing for Try-PS-3 towards the end of the time-course. PS-3 significantly affected 
cell viability within the first two hours, which was confirmed later using a real-time 
viability cell assay (Figure 182 and Figure 183). The viability of cells treated with 
protoxin was low initially. With time metabolic activity measurements of protoxin 
0
5000
10000
15000
20000
25000
282624222018161412108642
Fl
u
o
re
sc
en
ce
 (
R
FU
) 
Time (hours) 
Mock
Protoxin
Try-PS-3
PK-PS-3
TX-100
Etoposide
122 
 
treated cells increased, reaching after 24 hours the control levels. However, this rapid 
cell recovery seems unlikely and other factors like technical variables may have 
contributed to this effect. Etoposide and Triton X-100 showed the expected patterns of 
reduced viability associated with the different cytopathic effects they cause (rapid and 
severe viability decrease in case of Triton X-100, a detergent used for cell 
permeabilization and lysis, and gradual decrease in case of apoptosis inducer 
etoposide).  
Estimation of ATP levels 
Total ATP levels were measured in compromised cells as a second marker of cell 
viability (Figure 41). 
 
Figure 41 Assessment of ATP levels in HepG2 cells after exposure to PS-3. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml, in a white wall 96-well plate. The next day cells were 
dosed with PS-3 (12 µg/ml) or buffer. Luminescence was measured at different time points using CellTiter-Glo assay. 
 
ATP levels were significantly reduced after the first 2.5 hours of toxin exposure. 
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Assessment of viability after a brief toxin exposure 
Viability was assessed in HepG2 cells transiently exposed to PS-3 to determine how 
toxicity depends on the time, during which cells stay in contact with toxin molecules 
(Figure 42). Also toxin efficiency was tested by exposing different sets of cells to the 
same single toxin dose to check if there was a limitation in the amount of toxin that 
would reflect in viability levels (Figure 43).  
 
Figure 42 HepG2 cell viability in response to a brief or continuous toxin exposure. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were exposed to PS-3 (12 µg/ml) 
transiently for 0.5, 2, 5, 10 or 20 minutes or continuously for 24 hours. After transient treatment cells were washed 
once with DPBS and incubated in toxin free medium. Viability was measured using CellTiter-Blue 24 hours after 
toxin treatment. Data come from one technical replicate. 
 
Within the first 5 minutes PS-3 toxicity seemed to be dependent on the time of 
exposure, but not after that. This effect may result from diffusion time it takes for the 
toxin to reach the cell membrane. Experiment was repeated with similar outcome 
(data not shown). 
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Figure 43 HepG2 cell viability after exposure to a single toxin dose transferred from one well to another. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a 96-well plate. The next day the 1st well was dosed 
with PS-3 (12 µg/ml) for 20 minutes. After 20 minutes, medium from the 1st well was removed and transferred to 
the 2nd one (previously emptied) for another 20 minutes. Fresh medium was placed in the 1st well. The transfer 
was repeated eight times. The last two times toxin medium containing the toxin was kept with the cells for longer: 1 
and 24 hours for well 8th and 9th respectively. Viability was measured using CellTiter-Blue 24 hours after first toxin 
exposure. Data come from one technical replicate.  
 
Results of the second experiment revealed high toxin potency to affect the cells. If PS-3 
acts by binding and inserting into the membrane, it may indicate that the amount of 
toxin required to trigger toxicity is not limiting in this assay. Experiment was repeated 
with similar outcome (data not shown). 
4.5 Estimation of EC50 
Figure 44 presents a dose response curve for HepG2 cells treated with different 
concentrations of PS-3 for 24 hours.  
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Figure 44 Dose response curve for HepG2 cells treated with PS-3. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were incubated with different doses 
of PS-3 (trypsin digested, purified, 0.1 - 6 μg/ml). Fluorescence was measured after 24 hours using CellTiter-Blue. 
EC50 = 2.17 µg/ml. 
 
Half maximal effective concentration (EC50) value was determined as 2.17 μg/ml by 
Probit analysis using SPSS software. 
4.6 Assessment of membrane damage using cytotoxic 
markers 
Membrane permeability to a small marker 
The effect of PS-3 on HepG2 membrane permeability to a small DNA binding dye was 
assessed over a 34 hour period using the CellTox-Green cytotoxic assay (Figure 45).  
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Figure 45 Analysis of membrane permeability to a small marker in HepG2 cells exposed to PS-3 over 34 hours.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in the presence of CellTox-Green dye in a black 96-well 
plate. The next day cells were treated with Triton X-100 (0.01%), buffer, or non-purified, dialysed toxins: trypsin or 
proteinase K activated PS-3 or protoxin (1, 10, or 50 µg/ml). Fluorescence was measured at different time points 
after toxin addition. 
 
The fluorescent signal indicating membrane damage increased in a dose dependent 
manner. In cells treated with high toxin doses significant increase in permeability was 
noted after initial 10 minutes, with values gradually increasing with the toxin 
incubation time. PS-3 digested with proteinase K had greater impact on membrane 
permeability than trypsin digested toxin, consistent with CellTiter-Blue viability data 
(Figure 39). Unexpectedly high signal levels were obtained for protoxin treated cells, 
indicating significant membrane damage, even though microscopic observation did not 
show cell swelling. The experiment was repeated when stocks of purified PS-3, Cry1Ca 
and protoxin had been prepared. Also, to define the source of protoxin toxicity, its 
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effect on membrane permeability was additionally assessed after pre-treatment with 
protease inhibitors (Figure 46).  
 
Figure 46 Analysis of membrane permeability to a small marker in HepG2 cells exposed to PS-3 over 6 hours. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in the presence of CellTox-Green dye, in a black 96-well 
plate. The next day cells were treated with digitonin (13 µg/ml), buffer, purified toxins: trypsin activated PS-3 (1, 6 
or 12 µg/ml), Cry1Ca (12 µg/ml), or protoxin incubated previously with (56 µg/ml) or without protease inhibitors (58 
µg/ml). Fluorescence was measured at different time points after toxin addition. 
 
Purified PS-3 activated with trypsin increased membrane permeability in a time and 
dose dependent manner. Inhibiting native proteases during solubilisation step also 
inhibited protoxin associated membrane damage. 
Membrane permeability to a large marker 
The effect of purified PS-3 was assessed on HepG2 membrane permeability to a big 
protease marker over a 6 hour period using CytoTox-Glo cytotoxic assay (Figure 47). 
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Figure 47 Analysis of membrane permeability to a big marker in HepG2 cells exposed to PS-3 over 6 hours. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate. The next day cells were treated 
with TX-100 (0.01%), buffer, purified toxins: trypsin activated PS-3 (5 μg/ml), Cry1Ca (5 or 80 µg/ml), or protoxin (5 
or 58 µg/ml). Luminescence was measured at different time points after toxin addition. After the measurement, 
digitonin solution was added to all cells (43.7 μg/ml) and 15 minutes later another reading was taken to determine 
the total cytotoxicity from remaining live cells using CytoTox-Glo. All data were background-subtracted and plotted 
as a percentage of the digitonin treated cells. 
 
Compromised cells showed time-dependent membrane damage, similar to that 
created by membrane permeabilizing agent TX-100. Interestingly, damage caused by 
protoxin (at 58 µg/ml) relative to trypsin activated PS-3 was smaller in CytoTox-Glo 
assay compared with CellTox-Green assay (Figure 46), pointing to a possibility that 
pores created by protoxin may be of smaller size or less stable compared with the 
activated form of toxin. 
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4.7 Assessment of membrane damage using 
electrophysiology 
Since the discovery of the patch clamp technique by Neher and Sakmann (Neher and 
Sakmann, 1976) it has been possible to study the behaviour of ion channels. The 
technique allows high resolution recordings of current in excised patches as well as in 
intact membranes. In principle, a membrane patch is isolated electrically from the 
external buffer by pressing a glass pipette containing electrolyte solution onto the cell 
membrane. Currents flowing through the channels in this patch can be recorded by an 
electrode mounted inside the pipette and connected to the amplifier. Experiments in 
this cell attached mode have the advantage of recording channel activity with 
functioning cellular metabolism; however the resting potential of the cell (Vr) remains 
unknown. One possibility to work with excised membrane patches is in the inside out 
configuration. After establishing the cell attached mode, the glass pipette is pulled off 
the cell to create a patch with intracellular side exposed to the bath solution. Because 
of the strong seal formed prior to pulling, the current passing through the patch will 
flow into the pipette and can be recorded. The advantage of this method is the control 
over ionic composition of the buffer on both sides of the patch. Both configurations 
can be used to measure single channel activity. Whole cell mode is achieved from the 
cell attached configuration by applying a strong suction to rapture the membrane 
patch, but without affecting the seal between the outside membrane and the pipette 
rim. The solution in the pipette equilibrates over time with the cytoplasm. Whole cell 
currents are much bigger as they result from opening of numerous channels 
simultaneously. However this technique, opposite to single channel recording, lacks 
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the sensitivity to characterise the properties of a single channel. Instead it is used to 
observe macroscopic currents in the membrane of the entire cell. Figure 48 
summarises the patch clamp modes used in this study.  
 
Figure 48 Schematic drawing of patch clamp configurations used in this study. 
The four methods used to study PS-3 in patch clamp system. In a cell attached configuration a pipette is attached to 
the cell membrane by applying a mild suction to obtain a tight seal. After the seal is established, the inside out 
mode can be achieved by firmly pulling the pipette off isolating a membrane patch. In this configuration, 
cytoplasmic side of the membrane is exposed to the buffer in the bath while external one to the medium in the 
pipette. Depending to which side the toxin is added, both sides of the membrane can be tested. Whole-cell 
configuration is obtained from the cell attached mode by applying a brief and strong suction. The membrane is 
raptured and the buffer in the pipette comes into contact with the cytoplasm. The whole cell patch clamping 
records currents flowing through multiple channels across the entire membrane of the cell, while the other modes 
allow recordings from a single channel. 
 
The experiments were performed under voltage clamp conditions. Two basic 
physiological buffers were used: 140 mM NaCl, 5 mM KCl, 1.1 mM MgCl2, 1.1 mM 
CaCl2, 10 mM HEPES, pH 7.4 (named NaCl buffer) and 140 mM KCl, 1.1 mM MgCl2, 0.1 
mM EGTA, 10 mM HEPES, pH 7.4 (named KCl buffer). The solution inside and outside 
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of the pipette was determined by the desired method of patch clamping, e.g. working 
in the whole cell mode required the pipette solution to have ionic composition close to 
that of the cytoplasm (like KCl buffer). In single channel experiments, with the 
exception of the cell attached mode where the pipette solution differed from the 
content on the other side of the membrane, working under symmetrical conditions 
(the same buffer in the bath and in the pipette) was the preferred choice. In the 
majority of patch clamp experiments a high resistance seal (2 - 10 GΩ), which reduces 
the current noise, was achieved. A higher chloride conductance was observed in 
dividing hepatocytes suggesting swelling activated conductance in proliferating liver 
cells (Wondergem et al., 2001). For this reason, non-dividing cells with well-developed 
pseudopods were targeted for patching. 
Whole cell patch clamping 
Whole cell patch clamping was used to observe macroscopic current activity in HepG2 
and control cells during exposure to PS-3. The recordings were obtained before toxin 
addition and every 5 minutes for at least 20 minutes after toxin treatment. Resting 
membrane potential of hepatocytes is in the range of − 30 to − 40 mV due to the high 
basal chloride conductance (Moule and McGivan, 1990). Therefore, before the whole 
cell configuration was achieved, a holding potential of - 20 mV was applied to the 
pipette (close to the resting membrane potential of HeLa and HepG2 cells). KCl buffer 
was used in the pipette, and NaCl buffer in the bath. NaCl buffer was used as 
extracellular solution to avoid cell depolarization and because KCl solution, with 0.1 
mM EGTA and no calcium, most likely would not permit toxicity, according to data 
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presented in Figure 100. Currents were induced by a set of seventeen 1 second 
depolarizing step potentials from −20 to 140 mV from a holding potential of − 20 mV. 
Figure 49 shows an example of the whole cell raw data of the current traces prior to 
analysis. 
 
Figure 49 An example of the whole cell current traces from HepG2 cells exposed to Cry1Ca or PS-3.  
The raw data traces of the whole cell current prior to baseline correction and I/V curve generation. The top and 
lower traces were obtained with the HepG2 cells in the NaCl buffer exposed for 20 minutes to Cry1Ca (12 µg/ml) or 
PS-3 (12 µg/ml) respectively in the whole cell mode using soda lime glass pipettes. Currents were induced by a set 
of seventeen 1 second depolarizing potentials from −20 to 140 mV from a holding potential of -20 mV. Traces were 
not baseline corrected. 
 
Figure 50 shows a set of current – voltage relationships (I/V curve) of HepG2 cells 
exposed to PS-3 in time-course experiments. Digitonin treated HepG2 cells served as a 
positive control (Figure 51). HepG2 cells exposed to Cry1Ca and HeLa or CHOK1 cells 
exposed to PS-3 were tested as negative controls (Figure 52). Signal was baseline 
corrected and - with the exception of digitonin treated cells – lines represent the 
average of 3 experiments (three different cells patched). 
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Figure 50 Whole cell patch clamp recordings from a time course experiment of HepG2 cells exposed to PS-3. 
HepG2 cells were seeded at the density of 5 x 10
4
 cells/ml on the glass coverslip inside the 35 mm petri dish. The 
next day whole cell patch clamp recordings from a single cell were reported at 0, 5, 10, 15, 20 minutes after PS-3 (12 
µg/ml) addition to the bath containing NaCl solution. Currents were induced by a 1 second set of depolarizing 
potentials from −20 to 140 mV from a holding potential of −20 mV. Error bars indicate the standard error of the 
mean. The lines show the mean currents from three representative experiments from three different cells patched. 
 
 
Figure 51 Whole cell patch clamp recordings from a time course experiment of HepG2 cells exposed to digitonin. 
HepG2 cells were seeded at the density of 5 x 10
4
 cells/ml on the glass coverslip inside the 35 mm petri dish. The 
next day whole cell patch clamp recordings from a single cell were reported at 0, 5, 10, 15, 20 minutes after 
digitonin (13 µg/ml) addition to the bath containing NaCl solution. Currents were induced by a 1 second set of 
depolarizing potentials from −20 to 140 mV from a holding potential of −20 mV. Data come from a single patch 
clamp experiment. 
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Figure 52 Whole cell patch clamp recordings from various cell types in response to treatment with PS-3 or Cry1Ca. 
HepG2, HeLa, CHOK1 cells were seeded at the density of 5 x 10
4
 cells/ml on the glass coverslip inside the 35 mm 
petri dish. The next day whole cell patch clamp recordings from a single cell were reported 20 minutes after the 
addition of PS-3 (12 µg/ml) or Cry1Ca (12 µg/ml) to the bath containing NaCl solution. Currents were induced by a 1 
second set of depolarizing potentials from −20 to 140 mV from a holding potential of −20 mV. Error bars indicate 
the standard error of the mean. The lines show the mean currents from three representative experiments from 
three different cells patched. 
 
PS-3 induced large currents in HepG2, unlike Cry1Ca. In PS-3 and digitonin treated 
HepG2 cells at 20 minute time point currents increased proportionally with increased 
voltage applied, in accordance with the Ohm’s law.  PS-3 did not induce large currents 
in HeLa or CHOK1 despite a high toxin dose used in these experiments (12 µg/ml) at 20 
minutes, but also at 5, 10, 15 and 30 minutes after treatment (data not shown). 
Conductance values were low also in HepG2 cells treated with PS-3 in the presence of 
2 mM EGTA (Figure 91). In general, whole cell patch clamp results align with those 
obtained in membrane permeability cell assays (Figure 46 and Figure 47). To sum up, 
conductance levels were calculated from the slope of linear regression line of each I/V 
curve in the whole cell experiments at 10 and 20 minute time points and presented 
together in Table 4. 
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Table 4 Conductance levels calculated for the whole cell patch clamp experiments. 
Conductance (nS) was calculated from the slope of linear regression line of individual whole cell I–V relationship for 
10 and 20 minute time point (number of patches: n = 3, except for HepG2 cells treated with digitonin, mean +/- 
SEM). Conductance for HepG2 cells exposed to PS-3 in the presence of EGTA was calculated from data presented in 
Figure 91. 
 
Time 
(min) 
Patch No. 
Mean SEM 
1 2 3 
CHOK1 + PS-3 
10 9.4 7.6 3.4 6.8 1.8 
20 9.8 5.7 5.9 7.1 1.3 
HeLa + PS-3 
10 10.3 19.6 14.3 14.7 2.7 
20 21.8 17.3 15.7 18.3 1.8 
HepG2 + Cry1Ca 
10 7.9 6.2 6.8 7.0 0.5 
20 10.5 11.4 5.8 9.2 1.7 
HepG2 + Digitonin 
10 55.5 - - - - 
20 199.6 - - - - 
HepG2 + EGTA + 
PS-3 
10 19.1 5.5 11.8 12.1 3.9 
20 16.2 6.1 15.3 12.5 3.2 
HepG2 + PS-3 
10 28.3 29.3 37.6 31.7 2.9 
20 247.1 361.5 192.2 266.9 49.9 
 
 
A significant increase in the whole cell conductance, to a few hundred nS, was 
observed only in HepG2 cells exposed to PS-3 or digitonin. 
Single channel activity in biological membranes 
Single channel activity was recorded from HepG2 and HeLa membranes exposed to PS-
3. However, results may not be representative because of too few experiments 
performed and conditions not fully optimised. For these reasons, except for 
conductance, other channel characteristics were not analysed. Figures displaying 
recorded traces show channel activity uncorrected for leakage of the seal. In the cell 
attached mode the toxin was applied inside the pipette in NaCl buffer. In the inside out 
mode the toxin was applied either inside the pipette or in the bath, exposing external 
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or cytoplasmic side of the membrane to the toxin respectively. In the inside out 
configuration both NaCl and KCl buffers were used under symmetrical conditions.  
Activation of endogenous channels in HepG2 cells was first monitored in the 
absence of PS-3 in the inside out mode for 10 minutes (Figure 53). 
 
Figure 53 Single channel patch clamp recordings from HepG2 cells in the inside out mode in NaCl buffer. 
Single channel activity was recorded at 9 minutes after establishing the seal at + 60 mV (upper trace) and at - 60 mV 
(lower trace) from HepG2 in the inside out configuration using soda-lime glass pipettes and NaCl buffer. Records 
were filtered at 120 Hz. 
 
Membrane showed no channel activity at voltages applied in the range of - 60 to + 60 
mV for 10 minutes until the seal was lost.    
Figure 54 and Figure 55 show single channel recordings from HepG2 cells in the 
inside out mode after PS-3 was applied to the cytoplasmic and external side of the 
membrane respectively in the presence of KCl buffer. Figure 56 shows recordings after 
exposing external side of HepG2 cell membrane to PS-3 in NaCl buffer.  
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Figure 54 Single channel patch clamp recordings from HepG2 cells in the inside out mode after PS-3 was applied 
to the cytoplasmic side of the membrane in KCl buffer. 
Single channel activity was recorded at +20 mV (upper trace) and -30 mV (lower trace) from HepG2 in the inside out 
configuration (two independent experiments) using LG16 borosilicate glass pipettes and KCl buffer. Channel activity 
started around 2 hours after toxin addition (either 30 or 20 µg/ml) to the bath. Records were filtered at 100 Hz. 
 
Figure 55 Single channel patch clamp recordings from HepG2 cells in the inside out mode after PS-3 was applied 
to the external side of the membrane in KCl buffer. 
Single channel activity was recorded at +60 mV (upper trace) and -80 mV (lower trace) from HepG2 in the inside out 
configuration from two independent experiments using soda-lime glass pipettes and KCl buffer. Channel activity 
started around 20 minutes after addition of PS-3 (12 µg/ml) to the pipette. Records were filtered at 100 Hz. 
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Figure 56 Single channel patch clamp recordings from HepG2 cells in the inside out mode after PS-3 was applied 
to the external side of the membrane in NaCl buffer. 
Single channel activity was recorded at - 10 mV (upper trace) and -40 mV (lower trace) from HepG2 in the inside out 
configuration from two independent experiments using soda-lime glass pipettes and NaCl buffer. Channel activity 
started around 10 minutes after addition of PS-3 (50 or 10 µg/ml) to the pipette. Records were filtered at 100 Hz. 
 
Exposing both cytosolic and external side of the HepG2 membrane to PS-3 resulted in 
channel activity, regardless of the buffer used. The aim of including 0.1 mM EGTA in 
KCl buffer was to chelate potential metal cations, specifically Ca2+, resulting from 
buffer contamination to prevent activation of Ca2+ activated ion channels. However, 
because it was noted that the cell swelling was delayed in KCl buffer compared with 
NaCl buffer, a single channel experiment was attempted in KCl buffer without EGTA 
(Figure 57), on the assumption that EGTA may have decreased toxin activity, as 
evidenced in chapter 5.  
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Figure 57 Single channel patch clamp recordings from HepG2 cells in the inside out mode after PS-3 was applied 
to the cytoplasmic side of the membrane in KCl buffer without EGTA. 
Single channel activity was recorded at -10 mV (upper and lower trace) from HepG2 in the inside out configuration 
using soda-lime glass pipette and KCl buffer without EGTA from a single experiment. Channel activity started around 
1.5 hours after addition of PS-3 (12 µg/ml) to the bath. Records were filtered at 80 Hz. 
 
The absence of EGTA seemed to have increased the HepG2 membrane conductance 
compared to results in KCl buffer with EGTA (Figure 54 and Table 5); however these 
experiments may not be representative and results should not be generalized. 
Moreover lack of 0.1 mM EGTA in the buffer did not increase the cell swelling rate 
(data not shown). 
Next, channel activity was monitored in HepG2 cells in the cell attached mode 
in the absence of PS-3 for 27 minutes to test the activation of endogenous channels in 
the absence of toxin (Figure 58). 
140 
 
 
Figure 58 Single channel patch clamp recordings from HepG2 cells in the cell attached mode in NaCl buffer. 
Single channel activity was recorded at 26 minutes after establishing the seal at + 60 mV (upper trace) and at - 60 
mV (lower trace) from HepG2 in the cell attached configuration using soda-lime glass pipettes and NaCl buffer. 
Records were filtered at 100 Hz. 
 
Membrane showed no channel activity at voltages applied in the range of - 60 to + 60 
mV for 27 minutes until the seal was lost.    
Channel activity was then recorded in HepG2 cells in the cell attached mode in 
the presence of PS-3 (Figure 59).  
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Figure 59 Single channel patch clamp recordings from HepG2 cells in the cell attached mode after PS-3 was 
applied in the pipette to the external side of the membrane in NaCl buffer. 
Single channel activity was recorded at -50 mV (upper and lower trace) from HepG2 cells in the cell attached 
configuration from two independent experiments using soda-lime glass pipettes and NaCl buffer. Channel activity 
started around 15 minutes after addition of PS-3 (10 or 12 µg/ml) to the pipette. Records were filtered at 100 Hz. 
 
Similar to the inside out mode, there was a single channel activity in PS-3 treated 
HepG2 cells in the cell attached configuration.  
 Next, negative controls were examined that included recordings in the cell 
attached mode from: HeLa cells exposed to PS-3 (Figure 60), HepG2 cells exposed to 
PS-3 but pre-treated with 2 mM EGTA (Figure 61), and HepG2 cells exposed to Cry1Ca 
(Figure 62).  
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Figure 60 Single channel patch clamp recordings from HeLa cells in the cell attached mode after PS-3 was applied 
in the pipette to the external side of the membrane in NaCl buffer. 
Single channel activity was recorded at + 60 mV (upper trace) and – 10 mV (lower trace) from HeLa in the cell 
attached configuration from two independent experiments using soda-lime glass pipettes and NaCl buffer. Channel 
activity started around 15 and 30 minutes after addition of 14 and 10 µg/ml of PS-3 respectively to the pipette. 
Record representing upper trace was filtered at 40 Hz and lower trace was filtered at 100 Hz. 
 
Figure 61 Single channel patch clamp recordings from HepG2 cells pre-treated with 2 mM EGTA in the cell 
attached mode after PS-3 was applied in the pipette to the external side of the membrane in NaCl buffer. 
HepG2 cells were pre-treated with 2mM EGTA in NaCl buffer for 10 minutes before establishing a cell-attached 
mode. Single channel activity was recorded at + 70 mV (upper trace) and at - 40 mV (lower trace) from two 
independent experiments using soda-lime glass pipettes. Channel activity started around 10 minutes after addition 
of PS-3 (12 µg/ml) to the pipette. Records were filtered at 80 Hz. 
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Figure 62 Single channel patch clamp recordings from HepG2 cells in the cell attached mode after Cry1Ca was 
applied in the pipette to the external side of the membrane in NaCl buffer. 
Single channel activity was recorded at 0 mV (upper trace) and at - 30 mV (lower trace) from HepG2 in the cell 
attached configuration using soda-lime glass pipettes and NaCl buffer from a single experiment. Channel activity 
started around 5 minutes after addition of Cry1Ca (12 µg/ml) to the pipette. Records were filtered at 80 Hz. 
 
Unexpectedly, some channel activity was present in HepG2 cells exposed to Cry1Ca, 
PS-3 treated HeLa cells, as well as HepG2 cells treated with PS-3 in the presence of 2 
mM EGTA. Channel opening was also evident in resistant HepG2 cells (with developed 
resistance to ≤ 50 µg/ml of PS-3) when exposed to PS-3 at 14 µg/ml, in both inside out 
and cell attached modes (data not shown).  
The main characteristic of ion channels is conductance. It provides information 
on the ease at which current flows through a pore and can predict the efficiency of 
pore formation. Average conductance levels in single channel recordings were 
estimated by looking at the open channel amplitudes in the inside out (Table 5) and 
cell attached (Table 6) configurations. Current amplitudes were measured for clear and 
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instantaneous channel openings (an example in Figure 63). Jumps smaller than 5 pA 
were not analysed. Conductance was calculated as described in the methods section.  
 
Figure 63 An example of current jump analysis performed in single channel recordings. 
An example of a signal channel current analysis from HepG2 cell in the inside out mode with PS-3 (10 µg/ml) applied 
to the external side in NaCl buffer. Single channel openings are marked by downward current deflections at – 40 
mV. The size of manually selected current jump was generated by pCLAMP 10.6. 
 
Table 5 Average single channel conductance levels in the inside out configuration. 
Average single channel conductance levels (pS) were calculated using the G=I/V equation, by analysing the current 
amplitudes for the period for which the channel was open at a given voltage in the inside out mode. Similar 
conductance values were averaged. Traces were filtered at 80 - 100 Hz before analyses. Number of cells 
patched/experiments is in brackets; NOB refers to the number of observations of certain current amplitude. 
HepG2 cytoplasmic side + PS-3 
(20-30 µg/ml) in KCl (four exp.)  
HepG2 external side + PS-3 
(12 µg/ml) in KCl (one exp.) 
Mean SEM NOB 
 
Mean SEM NOB 
99.8 5.7 10 
 
125.9 6.4 8 
154.8 5.5 8 
 
248.8 6.9 8 
220.8 18.6 4 
 
346.9 15.1 7 
396.3 17.6 4 
 
440.8 14.8 4 
533.0 13.0 2 
 
558.0 12.7 5 
673.0 38.9 3 
 
665.3 46.8 3 
       
HepG2 cytoplasmic side + PS-3 
(12 µg/ml) in KCl w/o EGTA                  
(one exp.) 
 
HepG2 external side + PS-3 
(50 µg/ml) in NaCl (one exp.) 
Mean SEM NOB 
 
Mean SEM NOB 
431.8 18.1 5 
 
256.6 8.6 10 
589.4 15.8 8 
 
343.3 12.6 8 
820.7 13.6 7 
 
444.2 9.8 10 
955.5 8.9 11 
 
536.3 11.7 8 
145 
 
1349.5 55.7 32 
 
631.9 10.9 7 
2535.8 67.9 13 
 
738.9 7.6 15 
3539.0 75.5 10 
 
845.3 9.6 10 
5020.0 820.0 2 
 
951.3 9.8 6 
    1354.9 64.2 17 
HepG2 external side + PS-3 (10 
µg/ml) in NaCl (one exp.) 
 
2576.7 77.4 9 
 
3415.0 111.1 10 
 
4467.9 67.5 16 
 
5180.0 64.4 4 
Mean SEM NOB 
 
 
384.0 28.3 5 
    
654.2 16.8 10 
    
763.4 13.6 5 
    
922.3 37.7 3 
 
 
  
 
 
Table 6 Average single channel conductance levels in the cell attached configuration. 
Average single channel conductance levels (pS) were calculated using the G=I/(V-Vr) equation as described in the 
methods section, by analysing the current amplitudes for the period for which the channel was open at a given 
voltage in the cell attached mode. Similar conductance values were averaged. Traces were filtered at 80 - 100 Hz 
before analyses. Number of cells patched/experiments is provided in brackets; NOB refers to the number of 
observations of certain current amplitude. 
HepG2 external side + PS-3 
(10-14 µg/ml) in NaCl (three 
exp.) 
 
HeLa external side + PS-3 (10-
14 µg/ml) in NaCl (two exp.) 
Mean SEM NOB 
 
Mean SEM NOB 
78.3 5.0 44 
 
91.6 3.2 7 
138.6 4.8 86 
 
143.8 7.3 17 
225.7 6.0 38 
 
227.6 3.2 3 
350.4 8.2 13 
 
447.1 0.0 2 
439.6 9.9 5 
 
549.0 12.0 7 
563.9 52.2 2 
 
649.5 11.4 4 
    
824.8 42.3 3 
    942.6 18.5 3 
       
HepG2 external side + Cry1Ca 
(12 µg/ml) in NaCl (one exp.) 
 
HepG2 external side + PS-3 
(12 µg/ml) in NaCl + 2 mM 
EGTA (two exp.) 
Mean SEM NOB 
 
Mean SEM NOB 
91.6 3.2 7 
 
86.8 3.3 8 
143.8 7.3 17 
 
161.3 13.4 18 
227.6 3.2 3 
 
246.1 9.7 18 
447.1 0.0 2 
 
336.2 16.0 11 
549.0 12.0 7 
 
435.6 7.7 9 
649.5 11.4 4  501.2 12.5 3 
kkk 
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824.8 42.3 3 
    942.6 18.5 3 
    173.3 3.8 3 
    242.2 10.1 9 
    361.8 10.2 8 
    458.1 11.8 9 
    556.7 8.7 12 
    650.0 6.1 18     
728.1 10.3 8     
843.8 7.4 15     
939.9 7.9 12     
939.9 7.9 12     
2557.5 61.8 26     
3275.0 140.0 5     
4512.5 196.3 4     
 
Many conductance levels were present indicating more than one channel opening 
simultaneously, involving more than one type of channel or different substates of a 
single channel population. It was observed that generally channel activity was stronger 
at negative than at positive voltages (data not shown). This difference may have 
resulted from potential dependent changes in the number of channels or opening 
probability. Typically, channel activity increased with the time of the experiment often 
to a point where distinct levels of channel opening could not be easily established (e.g. 
Figure 62 upper trace). In most cases the recordings were stopped due to a lost seal, 
usually after large channel activity indicating membrane instability. This was possibly 
due to high toxin concentration and an increased tendency of its aggregation in the 
membrane environment. The cells in the cell attached mode did not show swelling or 
lysis at the end of experiments most likely because of local toxin application. Swelling 
of the cells in the whole cell mode was delayed, probably due to a basic biological 
buffer used and relatively low temperature (RT), which may have underestimated the 
real conductance. 
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Increased conductance could be attributed to the Cry toxin action, but also to 
the endogenous channels present in the cell membrane and activated either by the 
toxin or patching procedure. Most likely ion channel candidates include:  
- Stretch-activated channels (Bear, 1990), as slight horizontal movements of the 
micromanipulator holding the glass pipette was noticed, which could have 
affected measurements in the cell attached and the whole cell modes; 
- Ca2+-activated channels (Chen et al., 1997), e.g. in the inside out experiments 
NaCl buffer rich in Ca2+ could have activated calcium channels;   
- Voltage-gated ion channels (Chen et al., 1997), as some channels may have 
been activated by the applied voltage; 
- Other endogenous channels, which activity was not blocked by inhibitors, e.g. 
K+ channels blocked by ATP (Liu et al., 2003).  
However, micromanipulator movements did not correlate with increased channel 
activity, most experiments were performed with 0.1 mM EGTA present to chelate free 
Ca2+ and in the first few minutes of the recordings, channel activity was tested by 
applying relatively high positive and negative voltages (usually in the range of +50 to -
50 mV). Quality of the seal was monitored often during the recordings and in the case 
of its deterioration it would result in increased leakage currents or membrane 
breakage rather than channel openings. Also channel activity in all experiments started 
after time needed for the toxin to diffuse in the buffer and reach the membrane and 
was not seen in the absence of toxin. Therefore the more probable cause of increased 
conductance in membranes exposed to PS-3 was either pore formation per se, or toxin 
directly influencing opening of endogenous channels or both. 
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Some of the ion channels have been characterised in HepG2 cells and in 
mammal hepatocytes. Characterization of ion channels in HepG2 was performed by 
Chen et al. (Chen et al., 1997). In the inside out mode, the conductance values were 
18.9 in KCl and 19.8 pS in NaCl solution, not far from the ones measured in the cell 
attached mode: 22.2 in KCl and 19.7 pS in NaCl solution. Inside out experiments 
demonstrated that these channels were calcium and voltage dependent as well as 
cationic with low selectivity for a particular cation (Chen et al., 1997). Malhi et al. 
found that the whole cell currents from HepG2 in the absence of ATP (K+ channel 
inhibitor) were low and ATP-sensitive K+ channels in these cells required drug 
stimulation by potassium channel openers for full channel activation indicating 
decreased basal activity of these channels in HepG2 (Malhi et al., 2000). In rat 
hepatocytes a stretch activated channel of 16 pS conductance was identified, activated 
by suction as well as cell swelling induced by osmotic shock (Bear, 1990). Also in rat 
hepatocytes, single channel patch clamp studies identified calcium independent K+ and 
Cl- channels with an inward conductance of 55 and 30 pS and an outward conductance 
of 25 and 10 pS respectively (Breit et al., 1997). In guinea-pig hepatocytes a Cl- channel 
with a conductance of 7.4 pS was present (Koumi S, 1994) as well as calcium activated 
K+ channels with 20 pS single channel conductance (Capiod and Ogden, 1989). 
Conductance levels reported for hepatocytes and hepatoma cells are relatively low. 
Therefore, the most plausible explanation for large conductance values observed in 
single channel patch clamp experiments with PS-3 is channel formation de novo. 
Contrary to PLB experiments, data on single channel activity induced by Cry 
toxins using the patch clamp technique is scarce. In one study, the effect of Cry1C was 
investigated on the single channel activity in SF-9 cultured lepidopteran cells using cell 
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attached (toxin added to the bath) and inside out patch clamp configurations. A 
voltage dependent anionic channel was observed 10 minutes after toxin treatment 
(EC50 dose) with a similar conductance of 26 pS in both cell attached and inside out 
configuration (with cytoplasmic side of the membrane exposed to the toxin). 
Interestingly, the initial response to Cry1C involved calcium influx via voltage 
dependent calcium channels, which demonstrated for the first time a role of ion 
channels in the cellular response to Cry toxins (Schwartz et al., 1991). A different Cry 
toxin Cry1Ac induced a large conductance (a few nS) in cell attached and inside out 
configurations in intact midgut cells of M. sexta larvae, activity that was not seen 
before exposure to toxin (Peyronnet et al., 2004). In another study, the activity of 
Cry1Ab (100 ng/ml) was assessed in ruminal sheep epithelium cells using whole cell 
and single channel conﬁgurations of the patch clamp technique. Although sheep 
ruminal cells, like other mammalian cells, are thought to be naturally resistant to Cry 
toxins, and viability of these cells were not affected by the toxin dose used in 
electrophysiology experiments, the conductance increased significantly in almost half 
of the cells tested in whole cell experiments and Cry1Ab induced single channel activity 
of conductance over 500 pS in outside out patch clamp configuration. The authors 
interpreted these results as toxin induced pore formation, pointing to similar Cry toxin 
behaviour in PLB experiments in the absence of receptors (Stumpff et al., 2007).  
Generally, when PS-3 was added to the bath, a much higher dose was used (20-
30 µg/ml) and more time (1 - 2 hours) was required to start channel activity, compared 
to the dose (10 - 14 µg/ml) and time (5-15 minutes) when toxin was added inside the 
pipette. This was probably caused by the differences in the rate of toxin diffusion, 
faster in experiments where toxin was put in the pipette due to a lesser distance to the 
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membrane patch and a smaller buffer volume. Also, due to almost vertical position of 
the pipette and gravitation force, applied toxin was able to reach the membrane patch 
quicker than in the bath. In both cases the membrane patch had roughly the same 
surface area of around 0.25 µm2, with differing buffer volumes: 1000 µl in the bath, 50 
µl in soda lime and 70 µl in borosilicate glass pipette.  
In the inside out mode, channel conductance was similar when PS-3 was 
applied to the external or cytoplasmic side of the membrane. It may mean that the 
presence of the receptor did not affect the conductance, but the assumption that the 
external side of the patch contained the receptor may be wrong. If a physiological 
density of the receptor in the HepG2 membrane is small, it may have happened that it 
was not present in the patch. In case of more than one molecule critical for activity, 
the probability of having them both inside the patch would be even smaller. Another 
explanation of the data could come from the high toxin dose used, in which case the 
benefits of having the receptor would be unnoticed due to spontaneous toxin insertion 
regardless of the exposed membrane side.    
In the inside out mode with PS-3 applied to the external side, there was a 
difference in conductance depending on the buffer composition. The values were 
higher in the NaCl, compared to KCl buffer. Interestingly, large difference in 
conductance was also noted between KCl buffer with and without 0.1 mM EGTA. The 
solutions differed not only in NaCl, KCl and EGTA but also in CaCl2 concentration. It is 
possible that these differences could be influenced by selective ionic conduction or by 
the effect these ions may have on the membrane. 
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Selectivity of channels recorded in single channel patch clamp experiments in 
the presence of PS-3 remains unknown due to lack of substitution experiments. 
Endogenous conductance in hepatocytes is considerably driven by chloride ions. A 
study by Graf et al. showed that chloride accounts for 25%–80% of hepatocyte 
membrane conductance (Graf et al., 1987), which increases by 30 – 100 fold as a result 
of cell swelling (Meng and Weinman, 1996). Moreover, channels formed by Cry1C in 
SF-9 cells were anionic with high selectivity to Cl- ions (at slightly acidic pH), but this 
effect was pH dependent (Schwartz et al., 1991). On the other hand a role of cations in 
passing current cannot be excluded, especially that PS-3-induced channels in PLBs 
were cationic (shown later in section 4.7), with K+ being the candidate as in the 
hydrated form it is smaller than hydrated Na+. To add to complexity, in the cell 
attached experiments NaCl buffer generates a potential due to asymmetric ion 
concentration inside and outside the membrane. After a pore is open ion movement 
that takes place will depend not only on the applied voltage and pore selectivity (like in 
symmetrical experiments with excised patches), but also on the voltage across the 
membrane and ionic gradient (Na+, K+ and Cl- being the main players). Moreover, some 
ions due to the gradient will run in the opposite directions (Na+, K+), in which case the 
overall current and conductance may be underestimated.  
In the cell attached mode, conductance in HepG2 cells exposed to PS-3 was not 
lowered compared to the values in the excised-patch mode, despite physically intact 
membrane and active cell metabolism during the experiments. Assuming that 
membrane activity in single channel patch clamp experiments was caused directly by 
the toxin, and not by endogenous channels, it is difficult to explain increased 
conductance in experiments involving negative controls. Conductance values in the cell 
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attached configuration were high regardless of the Cry toxin (PS-3 or Cry1Ca) or cell 
line (HepG2 or HeLa) used. Also, previously established resistance (explained in 
chapter 5) was insignificant as relatively high conductance values were recorded in 
EGTA pre-treated HepG2 cells exposed to PS-3 as well as in toxin-resistant HepG2 cells 
treated with PS-3 in two independent experiments (data not shown). These 
conductance levels do not match huge differences in conductance in the whole cell 
recordings, where for example Cry1Ca didn't induce large currents in HepG2 (similar to 
PS-3 in the presence of 2 mM EGTA or PS-3 in HeLa cells). Comparison of currents 
between the whole cell and single channel recordings is complex. Whereas in the 
patched membrane a full opening of one (sometimes two or more) channel can be 
recorded, in the whole cell experiment the overall current is dependent not only on 
the current value recorded at a single channel level but also on the number of 
channels and their opening probability. When comparing whole cell and cell attached 
single channel experiments another consideration has to be taken into account. In the 
former, the intracellular voltage is clamped to the pipette voltage, because there is an 
electrical continuum between the pipette and the interior of the cell. In the latter, the 
voltage across the membrane patch is the difference between the pipette voltage and 
the intracellular voltage (Vr), which is controlled by the electrochemical gradient that 
exists across the entire cell membrane. Another difference is the size of the exposed 
membrane material. Despite being in contact with the toxin, the size of the patch in 
the single channel experiments may be too small for the cell to respond properly. The 
patch is ~0.2 µm2 - considerably smaller than the cell surface area normally exposed to 
toxin in the whole cell experiments, which may be around 300 µm2 (assuming 0.25 µm 
patch radius and 7 µm cell radius). So, even though a high toxin concentration was in 
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the pipette (12 µg/ml), because it was applied only locally, the cell either did not 
detect the damage, detected it but did not react, or detected and tried to repair it but 
because the patch was isolated by the glass it could not. Also, it has been calculated 
that in the single channel experiments with the toxin in the pipette, 0.0085 nM of toxin 
was exposed to the membrane patch of around 0.2 µm2, whereas in the whole cell 
experiments 0.17 nM was exposed to around 300 µm2 (assuming that only half of the 
cell’s surface is exposed to the treatment). This means that in the whole cell 
experiments the surface area of the membrane was ~ 1500 times larger with only 20 
times more toxin molecules in the buffer, increasing the number of toxin molecules 
per surface area in single channel experiments. It may be that in the single channel 
experiments high doses of Cry toxins like PS-3 or Cry1Ca spontaneously inserted in the 
membrane independently of the membrane nature, similarly to experiments in 
artificial lipid bilayers devoid of any protein component, as suggested before (Stumpff 
et al., 2007). Increased conductance was previously observed in excised patches of 
non-susceptible sheep epithelial membranes exposed to Cry1Ab (Stumpff et al., 2007). 
In this study where high toxin dose was used, membrane patches (even in the cell 
attached mode) may represent an environment similar to that in PLB experiments, 
which would explain large conductance values in all of the single channel patch clamp 
experiments. Variation in conductance values between single channel recordings may 
simply reflect how well the toxin inserts into the membrane at a given 
time/experiment resulting in different efficiencies of pore formation. 
To sum up, the data suggest that a substantial single channel activity arose 
most likely as a result of Cry toxin induced pore formation and in non-whole cell 
readings was independent of membrane origin and/or receptor presence most likely as 
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a result of the high doses used. However, due to time constraints single channel 
recordings presented here may not be representative, with two (in some cases only 
one) individual recordings per condition tested. Therefore, conclusions from these 
studies should be approached with caution.  
Single channel activity in planar lipid bilayers 
Planar lipid bilayer technique is another electrophysiological method that allows the 
testing of the activity of pore forming molecules. In this method, first described by 
Mueller and colleagues, an artificial phospholipid bilayer is created separating two 
aqueous solutions (Mueller et al., 1963). The advantage of this method is a more 
simplified environment than at the cell level with a total control over buffer and lipid 
composition. In PLB experiments lipid mixture consisted of PE, PC and cholesterol. PE is 
found in the inner cytoplasmic leaflet, whereas PC is more commonly found in the 
outer leaflet. Cholesterol present in animal cell membranes was added to improve 
membrane integrity and fluidity. No protein components were present.  
All PLB experiments were conducted by Eva Fortea as described in the methods 
section. Briefly, a lipid membrane was painted inside a plastic holder in between two 
chambers named cis and trans. 1 ml of buffer (150 mM KCl, 1 mM CaCl2, 10 mM HEPES, 
pH 7.5) was added to both chambers resulting in symmetrical conditions. Current trace 
was monitored for 30 minutes prior to toxin addition to insure no channel activity, e.g. 
due to contamination. PS-3 (4-8 µg/ml) was added to the cis chamber and activity was 
recorded at different applied voltages. Three experiments were performed. Example 
traces are shown in Figure 64 and Figure 65. 
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Figure 64 Example of a single channel recording in planar lipid bilayer after PS-3 application at positive voltage.  
Single channel activity was recorded at +100 mV (upper and lower traces) from PLB in KCl buffer after addition of 
PS-3 (8 µg/ml) to the cis chamber. Records were filtered at 200 Hz. The trace is representative of three experiments. 
 
 
Figure 65 Example of a single channel recording in planar lipid bilayer after PS-3 application at negative voltage.  
Single channel activity was recorded at - 40 mV (upper and lower trace) from PLB in KCl buffer after addition of PS-3 
(8 µg/ml) to the cis chamber. Records were filtered at 200 Hz. The trace is representative of three experiments. 
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Channel openings were longer and clearer with greater pore stability compared with 
single channel patch clamp recordings, however not always (Figure 65, bottom trace). 
Conductance was calculated to estimate the efficiency of pore formation. 
Around 20-25 current jumps were averaged for each conductance value. Points 
representing similar conductance values were grouped together. Mean conductance 
within a group was read from a slope of a linear regression. Figure 66, Figure 67 and 
Figure 68 present current-voltage relation calculated for each experiment. 
 
Figure 66 Single channel current – voltage relationship for PS-3 in planar lipid bilayers (experiment I). 
Current–voltage (I/V) characteristics of single-channel activity in 150/150 mM KCl (cis/trans) buffer (n=20-25) at 
different voltages after PS-3 (8 µg/ml) was added to the cis side. Conductance was calculated (G=I/V) and data 
points fitted by linear regression. Mean conductance values were deduced as the slopes of the linear regressions on 
the data points as 91, 131, and 220 pS. 
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Figure 67 Single channel current – voltage relationship for PS-3 in planar lipid bilayers (experiment II). 
Current–voltage (I/V) characteristics of single-channel activity in 150/150 mM KCl (cis/trans) buffer (n=20-25) at 
different voltages after PS-3 (8 µg/ml) was added to the cis side. Conductance was calculated (G=I/V) and data 
points fitted by linear regression. Mean conductance values were deduced as the slopes of the linear regressions on 
the data points as 75, 115, and 193 pS.  
 
Figure 68 Single channel current – voltage relationship for PS-3 in planar lipid bilayers (experiment III). 
Current–voltage (I/V) characteristics of single-channel activity in 150/150 mM KCl (cis/trans) buffer (n=20-25) at 
different voltages after PS-3 (8 µg/ml) was added to the cis side. Conductance was calculated (G=I/V) and data 
points fitted by linear regression. Mean conductance values were deduced as the slopes of the linear regressions on 
the data points as 79, 122, and 196 pS. 
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The results from the three experiments were consistent. Multiple conductance levels 
were observed. There was no rectification (non-linear current–voltage relation) as the 
conductance did not change with different voltages applied. Interestingly, there was a 
numerical relation of the two lowest conductance states to the highest conductance 
(roughly two add up to the third). This may result from two separate channel 
populations that open and close independently of each other, but when they open 
simultaneously, the highest conductance is achieved. Alternatively, the results may 
represent different sub-states of a single population of channels, when one channel 
type may have more than one open conformation, which results in different 
conductance values.  
For comparison, in PLB experiments, under symmetrical 150 mM KCl conditions 
at pH 9.0, the main conductance for Cry1Ac was 461 pS, 350 pS for Cry1B, 90 pS for 
Cry1C, and 450 pS for Cry1Aa (Schwartz et al., 1997). Under symmetrical 150 mM KCl, 
pH 9.0 conditions conductance induced by nematocidal Cry5B was 125 pS and less (Kao 
et al., 2011). In 300 mM KCl, pH 9.7 conductance levels for Cry1Ac and Cry3A ranged 
from 200 pS to 4000 pS (Slatin et al., 1990a). In 300 mM KCl, pH 9.5 a 21.5 kDa α-
helical region of Cry1Ac induced a range of conductance values up to 600 pS (Walters 
et al., 1993). A homolog of PS-1 – PS-1Aa2 (Cry31Aa2) formed pores that had several 
levels of conductance: 11, 16 and 21 pS in 150 mM KCl buffer (Gabriel Narvaez, 2014).  
Importantly, incorporation of membrane material from susceptible insects into 
PLBs promoted activity of Cry toxins. In PLBs enriched in brush border membranes, 
conductance induced by Cry1Aa increased 8 fold to 85 - 420 pS (Peyronnet et al., 2001) 
and conductance induced by Cry1C increased from 31 - 76 pS to 50 – 752 pS, reaching 
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as high as 1900 pS (Lorence, 1995) compared to receptor free phospholipid bilayers. 
However in experiments where PLBs were reconstituted with GPI-linked receptor 
complex the conductance by Cry1Ac did not increase and by Cry1Aa even decreased, 
but it took significantly less Cry1Ac and Cry1Aa toxin to trigger channel activity 
compared with non-enriched lipid membranes (Schwartz et al., 1997). 
Comparison of conductance was attempted between PLB and single channel 
inside out recordings in KCl, due to similar buffer composition and detection sensitivity 
levels in these methods. Composition of the membrane was the main difference; with 
artificial membrane being a simple, neutral bilayer, and biological membrane – 
asymmetric, packed with protein components and most likely negatively charged. 
Conductance ranging from 100 to 600 pS was obtained in patch clamp system - values 
being much higher than in PLB experiments (100 – 200 pS). The difference cannot be 
explained by the presence of toxin receptor as high values were observed with PS-3 
exposed to both extracellular and intracellular sides. Bigger conductance values 
observed in single channel patch clamp compared with PLB experiments may be due to 
different lipid composition, presence of the protein component in general, or other 
factors influenced by the biological origin of the membrane. Also, higher toxin dose 
was used in patch clamp (12-30 µg/ml) compared to PLB experiments (4-8 µg/ml). 
Another explanation, mentioned before when comparing whole cell with other single 
channel experiments, is that in PLB experiments the probability of toxin hitting the 
bilayer is much smaller with toxin being in the bath compared with the toxin in the 
pipette in the patch clamp experiments, even though membrane surface in PLB is 
larger than in the patch. Calculations suggest (assuming 50 μm radius of the functional 
painted membrane) that in the PLB experiments the surface area of the membrane 
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was ~ 40,000 times larger with only 13 times more toxin molecules in the buffer. Also, 
the vertical position of PLB painted in the sidewall of the chamber does not promote 
contact with the protein. On the contrary, patch system where the toxin is in the 
pipette is much more sensitive as area is reduced by a patch pipette and toxin is 
concentrated in a very small area by diffusing down directly towards the membrane.  
To study selectivity of channels in the PLB system, concentration of KCl was 
increased from 150 to 450 mM in the cis chamber. Conductance in these asymmetric 
conditions was calculated as previously (Figure 69).  
 
Figure 69 Single channel current – voltage relationship for PS-3 in planar lipid bilayers in asymmetric conditions 
(experiments I, II and III). 
Current–voltage (I/V) characteristics of single-channel activity in 450/150 mM KCl (cis/trans) buffer (n=20-25) at 
different voltages after PS-3 (8 µg/ml) was added to the cis side. Conductance was calculated (G=I/V) and data 
points fitted by linear regression. Mean conductance values were deduced as the slopes of the linear regressions on 
the data points as 90, 113, and 206 pS. 
 
Selectivity (PK+/PCl- value) was calculated using Goldman-Hodgkin Katz potential 
equation (Hodgkin and Horowicz, 1959), which relates ions permeability across the 
-40
-30
-20
-10
0
10
20
30
40
-100-80 -60 -40 -20 0 20 40 60 80 100
C
u
rr
en
t 
(p
A
) 
Voltage (mV) 
Selectivity 
90 pS
113 pS
206 pS
Conductance: 
161 
 
membrane and reversal potential (Table 7). Reversal potential (Vr) calculated below 
represents the potential at which there is no current passing through a pore. 
Table 7 Selectivity and reversal potential calculated in PLB experiments I, II and III with PS-3 in asymmetrical 
conditions. 
Selectivity (PK
+
/PCl-) and reversal potential (Vr) were calculated in planar lipid bilayer experiments I, II and III with 
PS-3 in asymmetrical (450/150 mM KCl cis/trans) conditions. 
 I II III Mean SEM 
Vr (mV) -10.5 -9.5 -12.9 -10.97 1.0 
PK+/PCl- 2.35 2.15 2.93 2.48 0.23 
 
Under asymmetrical conditions the channel conductance remained in the similar pS 
range and the reversal potential shifted to – 10.97 mV (± 1 mV). PK+/PCl- value was 2.48 
(± 0.23) indicating a slight selectivity to cations. Cationic channels in PLBs were also 
observed by Cry1B, Cry1Ac, Cry3A (Schwartz et al., 1997, Slatin et al., 1990b, Walters 
et al., 1993), by monomeric and oligomeric Cry1Ab (Rausell et al., 2004), as well as by 
Cry1Aa and Cry1Ac in M. sexta BBMV (Kirouac et al., 2002). A small PK+/PCl- value is in 
agreement with the general thought that pores created by Cry toxins are weakly 
specific as these proteins did not evolve with the host insect membrane, which is also 
undoubtedly true for cancer cells. 
Channel activity is a stochastic process with probabilities of opening and 
closing. The opening probability can be determined from single channel recordings by 
a simple analysis of the distribution of all the current values plotted as a histogram 
(called all-points histogram or amplitude histogram). A peak at 0 current represents a 
channel at the shut level and a peak at any other value, positive or negative depending 
on the voltage applied, represents a channel at an open level. The area under the peak 
is proportional to the time that a channel spends in each conformation. Amplitude 
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histograms were generated for each of the three experiments (Figure 70, Figure 71 and 
Figure 72).  
 
Figure 70 Amplitude histogram of channel openings obtained in the presence of PS-3 in PLBs in experiment I. 
Data presented in the histogram were collected at +/- 20, 40, 60, and 80 mV in PLBs in the presence of PS-3 (8 
µg/ml) and were not Gaussian fitted. Count (N) represents the number of observed events of channel conductance 
and amplitude represents the value of a current jump in pA. Histogram plots were obtained for 1 minute current 
recordings generated by Clampfit 10.5, using 0.05 bin width. The bars have been removed for clarity. 
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Figure 71 Amplitude histogram of channel openings obtained in the presence of PS-3 in PLBs in experiment II. 
Data presented in the histogram were collected at +/- 20, 40, 60, and 80 mV in PLBs in the presence of PS-3 (8 
µg/ml) and were not Gaussian fitted. Count (N) represents the number of observed events of channel conductance 
and amplitude represents the value of a current jump in pA. Histogram plots were obtained for 1 minute current 
recordings generated by Clampfit 10.5, using 0.05 bin width. The bars have been removed for clarity. 
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Figure 72 Amplitude histogram of channel openings obtained in the presence of PS-3 in PLBs in experiment III. 
Data presented in the histogram were collected at +/- 20, 40, 60, and 80 mV in PLBs in the presence of PS-3 (8 
µg/ml) and were not Gaussian fitted. Count (N) represents the number of observed events of channel conductance 
and amplitude represents the value of a current jump in pA. Histogram plots were obtained for 1 minute current 
recordings generated by Clampfit 10.5, using 0.05 bin width. The bars have been removed for clarity. 
 
All amplitude histograms showed that opening probability at different voltages was 
close to 100%. This was previously observed for oligomeric structures of Cry1Ab 
compared with the monomeric toxin (Rausell et al., 2004), but in general does not 
occur for Bt Cry toxins and implies the creation of very stable pores by PS-3.  
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Amplitude currents were not identical at positive and negative voltages. In 
experiments II and III, channels seemed to pass more current at negative compared to 
positive voltages. This shift was opposite in experiment I, where higher current was 
observed at positive voltages. These data, although not consistent, may point to some 
kind of voltage dependency, however they represent only 1 minute recordings and no 
rectification was observed previously (Figure 66, Figure 67 and Figure 68). Also, by 
comparing current values for the three experiments at a given voltage, it can be 
speculated that the number of pores was different in each experiment as currents are 
not the same, with smaller currents in experiment I and III and larger in II.  
4.8 Estimation of pore size 
The size of pores formed by PS-3 was estimated using various osmoprotectants in an 
assay that measures the release of a big (138 kDa) proteinous marker. Technically, 
pore blocking accomplished by some osmoprotectants should also prevent the release 
of cytotoxic marker to the cell medium leading to decreased luminescence. Reading 
was taken 3 hours after toxin exposure (Figure 73) as prolonged cell exposure to some 
osmoprotectants (especially high MW PEGs after 24 hours) led to cell rounding and 
disintegration reflecting in low viability readings (data not shown). Changes in 
permeability to osmoprotectants over time were not anticipated because 
osmoprotectants added before toxin would prevent swelling and further expansion of 
pores. Nevertheless the experiment was repeated extending toxin exposure time from 
3 to 6 hours to test that (Figure 74). Hydrodynamic radii data were taken from 
references (Scherrer and Gerhardt, 1971, Schultz and Solomon, 1961). 
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Figure 73 The effect of osmoprotectants on HepG2 membrane permeability 3 hours after exposure to PS-3.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate. The next day cells were treated 
with various osmoprotectants (30 mM) or mock (dH2O) for 10 minutes. This was followed by the addition of either 
trypsin activated PS-3 (55 µg/ml) or buffer. Luminescent reading was taken 3 hours later using CytoTox-Glo cell 
assay. All data were plotted as the percentage of digitonin treated cells (12 µg/ml). 
 
 
Figure 74 The effect of osmoprotectants on HepG2 membrane permeability 6 hours after exposure to PS-3.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate. The next day the cells were 
treated with various osmoprotectants (30 mM) or mock (dH2O) for 10 minutes. This was followed by the addition of 
either PS-3 (55 µg/ml) or buffer. Luminescent reading was taken 6 hours later using CytoTox-Glo cell assay. All data 
were plotted as the percentage of digitonin treated cells (12 µg/ml). 
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In the toxin’s presence, the membrane was permeable to the small sugars but mostly 
impermeable to disaccharides and bigger molecules. Osmoprotectants showed little 
toxicity in the absence of PS-3 (assessed as membrane permeability). Swelling was 
assessed visually at the end of both experiments. It was present only in cells treated 
with toxin, toxin and glucose as well as toxin and glucosamine, but not in other 
treatments. Cells treated with digitonin rapidly disintegrated.  
Although CellTiter-Blue reagent cannot indicate cell swelling inhibition (being 
cell permeable), it was used to assess the effect of high MW PEGs on cell metabolic 
activity and whether pore blocking itself could prevent viability decrease (Figure 75).   
 
Figure 75 The effect of high MW PEGs on cell viability in the presence or absence of PS-3.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were pre-incubated for 1 hour with 
30 mM of either PEG 1000, 2000, 4000 or water, before PS-3 (10 μg/ml) or buffer was applied. Cell viability was 
measured 5 hours after toxin treatment using CellTiter-Blue. 
 
PEG 4000 significantly decreased cell viability after 6 hours. High MW PEGs did not 
efficiently protect the cells from PS-3 elicited viability decline, although PEGs 1000 and 
2000 seemed to slightly reduce the activity of the toxin. 
0
20
40
60
80
100
120
1000 2000 4000 1000 2000 4000 -
PEG PEG Mock
Buffer PS-3
%
 v
ia
b
ili
ty
 (
re
la
ti
ve
 t
o
 b
u
ff
er
 o
n
ly
 
tr
ea
te
d
) 
168 
 
4.9 Microscopic observation of susceptible cells 
Cytotoxic effect of PS-3 and morphological changes in HepG2 cells were observed by 
differential interference contrast (DIC) microscopy. This method allows good 
visualization of cell morphology for unstained specimens. Pictures taken during initial 
experiments with non-purified PS-3, presented in Figure 76 and Figure 77, show 
progressive swelling and cell deterioration over time. Figure 78 shows results of a 
similar experiment repeated using lower cell density and lower dose of purified toxin 
in order to better visualise single cell swelling.  
 
Figure 76 DIC microscopic analysis of HepG2 cell morphological changes after PS-3 exposure.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a microscope chamber slide. The next day cells were 
treated with non-purified dialysed trypsin activated PS-3 (100 μg/ml). Pictures were taken at 1, 4 and 6 hour time 
points after treatment using Zeiss Axiovert 200M, 63x DIC objective; scale bar 20 µm.  
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Figure 77 DIC microscopic analysis of HepG2 cellular and nuclear swelling after PS-3 exposure.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a microscope chamber slide. The next day cells were 
treated with non-purified, dialysed trypsin activated PS-3 (100 μg/ml). After 6 hours swelling of plasma membrane 
(indicated by red arrows) and nuclei (blue arrows) were apparent. Picture was taken with Zeiss Axiovert 200M, 63x 
DIC objective; scale bar 20 µm. 
 
Figure 78 DIC microscopic analysis of HepG2 single cell swelling after PS-3 exposure.  
HepG2 cells were seeded at the density of 5 x 10
4
 cells/ml in a microscope chamber slide. The next day cells were 
treated with either buffer or purified trypsin activated PS-3 (5.5 µg/ml). Pictures were taken at different time points 
using Zeiss Axiovert 200M, 63x DIC objective; scale bar 20 µm. 
170 
 
Cell swelling as well as nuclear swelling was clearly observed in toxin treated cells 
within the first few hours. The rate of swelling was dose dependent, but generally 
compromised cells showed first signs of swelling after 20 minutes and the great 
majority of them become swollen within the first hour. By the end of 6 hours after 
exposure to toxin, cell disintegration and accumulation of debris was visible. Buffer 
treated cells showed no cytopathy. Also, cells treated with Cry1Ca (26 μg/ml) exhibited 
no morphological change (data not shown).  
 Interestingly, low temperature precluded PS-3 toxicity. 96-well plate containing 
HepG2 cells was pre-chilled for 30 minutes at 4°C. After that toxin was added (12 
µg/ml) and plate was placed back at 4°C for another 4 hours. Cells were monitored 
during this time and no swelling was observed. When after 4 hours the plate was 
transferred into the 37°C incubator, majority of cells became swollen within an hour 
(data not shown). Longer than 4 hour cell incubation at 4°C damaged the cells and was 
not practiced. Temperature dependent rate of swelling was most likely caused by 
changes in the membrane fluidity affecting toxin interaction with the membrane, 
which was pointed out before in the context of PLB experiments (Stumpff et al., 2007).  
4.10 Analysis of PS-3 cytotoxicity against other cell lines 
The cytotoxic activity of purified trypsin activated PS-3 was tested against several 
human cultured cells. Cell lines and their origins are listed in Table 8. The cell density 
and incubation time with CellTiter-Blue reagent were optimized for each cell line (data 
not shown). 
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Table 8 Cell lines used in viability assays to assess PS-3 toxicity 
Cell lines and their origins used in viability assays for the assessment of PS-3 cytotoxicity. 
Cell line: Origin: 
HepG2 Hepatocyte cancer 
HeLa Uterus cervix cancer 
Mutu1 Burkitt's lymphoma (EBV positive) 
BL31 Burkitt's lymphoma (EBV negative) 
IB4 Lymphoblastoid (B cells transfected with EBV) 
GM12878 Lymphoblastoid (B cells transfected with EBV) 
HL-60 Acute myeloid leukaemia 
B lymphocytes 
PS-3 was tested against several cell lines that have not been examined before, like 
cancerous Burkitt's lymphoma and non-cancerous lymphoblastoid cells (Figure 79). 
Since these cells easily undergo apoptosis when induced by therapeutic drugs (Loni et 
al., 2001), it was of interest to assess if PS-3 would trigger cell death. Susceptible 
(HepG2) and resistant (HeLa) cell lines were tested for comparison. 
 
Figure 79 Viability analysis of various cultured cells after exposure to PS-3.  
Cells were plated at 25 x 10
4
 cells/ml, HepG2 and HeLa - 24 hours before the experiment, the other cell lines - on 
the day of the experiment. Cells were treated with trypsin activated, purified PS-3 (6 or 12 µg/ml), buffer, Cry1Ca 
(12 µg/ml), Triton X-100 (0.01%) or etoposide (100 µg/ml). Cell viability was assessed using CellTiter-Blue after 24 
hour incubation with toxins. 
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The results confirmed narrow toxicity spectrum of PS-3. Only HepG2 cells showed high 
susceptibility towards the toxin. BL31 cells showed some decrease in viability; however 
the effect was relatively smaller compared to HepG2 cells considering the high toxin 
dose used. Moreover, no swelling was observed in PS-3 treated BL31 cells. None of the 
cell lines showed susceptibility towards Cry1Ca. 
HL-60 
Assessment of HL-60 susceptibility was studied in detail since this cell line has been 
previously shown to be the most sensitive to PS-3 with EC50 of 1.25 µg/ml (Yamashita 
et al., 2005). Toxicity of trypsin activated PS-3 was determined on HL-60 cells obtained 
from two independent sources as shown in Figure 80 and Figure 81.   
 
Figure 80 The effect of PS-3 on HL-60 of unconfirmed status.  
HL-60 cells were plated at the density of 25 x 10
4
/ml and treated with purified trypsin activated PS-3 (6 or 12 
µg/ml), Cry1Ca (12 µg/ml), TX-100 (0.01%) or etoposide (100 µg/ml). Cell viability was assessed using CellTiter-Blue 
after 24 hour incubation with toxins. 
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Figure 81 The effect of PS-3 on HL-60 purchased from ECACC.  
HL-60 cells were plated at the density of 25 x 10
4
/ml and treated with purified trypsin activated PS-3 (6 or 12 
µg/ml), Cry1Ca (12 µg/ml), TX-100 (0.01%) or etoposide (100 µg/ml). Cell viability was assessed using CellTiter-Blue 
after 24 hour incubation with toxins. 
 
Surprisingly, the viability of HL-60 cells was not greatly reduced after 24 hours. These 
results correlated with microscopic observation, where only a small percentage of the 
cells were swollen. 
To further assess the toxin’s impact on HL-60, membrane permeability was 
measured in HL-60 cells exposed to PS-3 (Figure 82). HepG2 data were included for 
comparison. To obtain more informative data per well about cell well-being, cytotoxic 
assay was multiplexed with CellTiter-Blue for additional assessment of cell viability 
after 30 hour exposure to toxins (Figure 83). 
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Figure 82 Analysis of membrane permeability in HL-60 and HepG2 cells exposed to PS-3 over 26 hour period.  
Cells were seeded at the density of 25 x 10
4
 cells/ml in the presence of CellTox-Green dye in a black 96-well plate. 
HL-60 cells were seeded on the day of the experiment and HepG2 one day before. Cells were treated with buffer, 
lysis solution (provided by the manufacturer), or purified toxins: trypsin activated PS-3 (12 µg/ml) or Cry1Ca (12 
µg/ml). Fluorescence was measured at different time points after toxin addition using CellTox-Green assay. 
 
 
Figure 83 Viability of HL-60 and HepG2 cells used in the CellTox-Green experiment after 30 hour exposure to PS-3.  
Cells were seeded at the density of 25 x 10
4
 cells/ml in the presence of CellTox-Green dye in a black 96-well plate; 
HL-60 on the day of the experiment and HepG2 one day before. Cells were treated with buffer, lysis solution, or 
purified toxins: trypsin activated PS-3 (1, 6 or 12 µg/ml) or Cry1Ca (12 µg/ml). After membrane damage was 
measured using CellTox-Green assay, CellTiter-Blue reagent was used to assess cell viability 30 hours after toxin 
treatment. 
 
Trypsin activated PS-3 did not affect HL-60 cell viability within 30 hours, nor did it 
compromise membrane integrity. Only a small number of HL-60 cells showed swelling.  
-20000
0
20000
40000
60000
80000
100000
120000
PS-3 Buffer Cry1Ca Lysis PS-3 Buffer Cry1Ca Lysis
HepG2 HL-60
 M
em
b
ra
e 
p
er
m
ea
b
ili
ty
 (
R
FU
) 
1h 2h 4h 5h 6h 26h
0
20
40
60
80
100
120
140
PS-3 (12) PS-3 (6) PS-3 (1) Cry1Ca (12) Lysis
%
 v
ia
b
ili
ty
 (
re
la
ti
ve
 t
o
 b
u
ff
er
 
tr
ea
te
d
) 
HepG2
HL-60
175 
 
 Additionally, Trypan Blue exclusion assay was performed to assess cell viability. 
HL-60 and HepG2 cells were treated with either PS-3 (12 µg/ml) or buffer only for 3 or 
24 hours, followed by the addition of Trypan Blue and cell count. In wells containing 
compromised HepG2, the number of viable cells was drastically reduced after 3 hours. 
In PS-3 treated HL-60 cells the cell count was high after 3 and 24 hours and 
comparable to the 24 hour control wells. Even though some HL-60 cells were swollen 
after 3 and 24 hour treatment, they excluded the blue dye (data not shown).   
HeLa 
As presented in Figure 79 HeLa cells showed resistance to 12 µg/ml toxin treatment, 
and for this reason was used as a negative cell line control in western blot experiments 
in chapter 7. The mechanism of resistance was questioned in an experiment, where 
HeLa cells were treated with high doses of PS-3 (Figure 84).   
 
Figure 84 The effect of high concentration of PS-3 on HeLa and HepG2 cells after 6 hour treatment. 
HeLa were seeded at 15 x 10
4
 cells/ml and HepG2 at 25 x 10
4
 cells/ml density. The next day cells were dosed with 
different concentrations of purified trypsin activated PS-3. Viability was measured 6 hours later using CellTiter-Blue. 
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0.4 mg/ml dose of PS-3 caused a 20% loss of viability in HeLa cells. Moreover some 
swelling was observed in toxin treated HeLa cells that was directly proportional to the 
PS-3 dose. These results indicate that the HeLa resistance can be overcome by 
increasing toxin concentration.  
4.11 Discussion 
Protoxin triggered low levels of cytotoxicity. It was revealed to undergo a proteolytic 
processing by the endogenous proteases present in the crude sample, as including 
protease inhibitors at solubilisation step supressed both protoxin associated viability 
decline and membrane damage in HepG2 cells. The role for native proteases in 
protoxin processing was postulated before for PS-2 (Kim et al., 2000). Experiments 
with PS-2 showed that this toxin was not activated by cellular proteases or by itself 
during the incubation with susceptible HepG2 cells (Kitada et al., 2006). Similarly 
Cry1Aa in the presence of BBMV from M. sexta; once activated, it did not need further 
proteolysis for activity (Kirouac et al., 2006). However there is a strong evidence of 
Cry1Ab cleavage after interaction with membrane receptor BT-R1 (Bravo et al., 2004, 
Gómez et al., 2002). PS-3 protoxin was not activated by HepG2 proteases, but further 
processing of active form of the toxin was not assessed. The presence of DTT greatly 
increased solubilisation yield and was prerequisite for effective activation with trypsin. 
Protease inhibitors considerately slowed down the rate of PS-3 degradation and were 
used at the end of toxin activation.  
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In general HepG2 cells were more sensitive towards toxin activated with 
proteinase K than with trypsin. The results of viability assays with ÄKTA purified trypsin 
and proteinase K activated toxins should not be directly compared with each other 
since different cell density and high toxin dose were used. The difference in toxicity 
between trypsin and proteinase K treated samples is most likely a consequence of 
different proteolytic cleavage by these two enzymes. Smaller size fragments after 
proteinase K digestion correspond with broad proteolytic activity of this enzyme 
compared to narrow substrate specificity of trypsin, which acts only on lysine and 
arginine residues. It is in accordance with the fact that the C-terminally truncated 30 
kDa PS-2 killed CACO-2 and Sawano cells more efficient than the non-truncated 31 kDa 
protein. Also, in HepG2 cells, killing occurred significantly quicker with more processed 
PS-2 (Kitada et al., 2006). Despite proteinase K activating PS-3 more efficiently, 
trypsinization was chosen as a preferred method of activation, because trypsin did not 
degrade toxin at higher concentrations compared with proteinase K. Similarly, PS-1 
digested with a high dose of proteinase K lost cytotoxicity to HeLa, but not when 
activated with a high dose of trypsin (Katayama et al., 2005a). Also, trypsin is one of 
the major proteases contributing to protein digestion in lepidopteran midguts (Terra 
and Ferreira, 1994) and has been widely used to process Cry toxins in vitro.  
ÄKTA purification allowed for separation of the toxin bands. The fact that both 
lower and higher MW proteins (and arisen from digestion with either proteinase K or 
trypsin) showed toxic effect, confirms that all fragments contain the toxic core. For this 
reason bands were not separated for cell assays and size exclusion chromatography 
was used as a preferred method to make stocks of purified toxins.  
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Regardless of the activation method, PS-3 significantly affected cell viability 
within the first few hours. Protoxin caused moderate decrease in viability. There was a 
good correlation between measurement of metabolic activity (CellTiter-Blue assay) 
and ATP levels (CellTiter-Glo) in susceptible cells. EC50 was calculated as 2.17 μg/ml, 
which is similar to 1.86 µg/ml calculated for PS-3 by Yamashita et al. (Yamashita et al., 
2005). Membrane permeability cytotoxic cell assays showed concentration and time 
dependent cytotoxicity of PS-3. After exposure to toxin, membrane became rapidly 
permeable to both small and big size markers. Toxin induced decrease in metabolic 
activity and ATP levels, swelling, and membrane damage followed similar time courses 
in susceptible cells, extensively affecting cells after 2 hours. 
Results from electrophysiology experiments were discussed in detail in section 
4.7. To conclude, a significant increase in the whole cell conductance was observed in 
HepG2 cells exposed to PS-3 (266.9 nS), but not in toxin treated HeLa (18.3 nS) or 
HepG2 exposed to Cry1Ca (9.2 nS) cells. Experiments in planar lipid bilayer system 
ultimately confirmed pore forming nature of PS-3. Toxin induced very stable channels 
with an opening probability close to 1 and conductance ranging between 75 – 220 pS 
with no rectification. The pore was slightly cationic selective and seemed to be voltage 
dependent. In single channel patch clamp experiments multiple conductance levels 
were observed, indicating the presence of different channel populations or different 
sub-states of a single channel population. Membrane activity was recorded after toxin 
exposure to either side of the membrane as well as in the cell attached mode. These 
channels were not seen in the absence of toxin and because of high conductance 
values obtained (100 - 5000 pS) and low conductance levels reported for hepatocytes 
and hepatoma cells, channel activity can be most likely attributed to Cry toxin induced 
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channel formation de novo. Large conductance values observed in all of the single 
channel patch clamp experiments did not reflect differences observed in the whole cell 
experiments between different treatments. The most plausible explanation for that is 
that membrane patches (even in the cell attached mode) do not represent a good 
model that would reflect cells natural susceptibility/resistance due to a high toxin dose 
used, but instead behave similar to PLBs, where any PFT at high enough dose would 
create a pore and increase conductance. 
Experiments with osmoprotectants showed that the compromised membrane 
was permeable to the simple sugars like glucose or glucosamine but mostly 
impermeable to the disaccharides like sucrose or maltose, suggesting the creation of 
small primary lesions with estimated pore diameter <1 nm. This is smaller than 
previously estimated for some Cry toxins. Maximal radius of Cry1C was between 1 - 1.3 
nm (Peyronnet et al., 2002) and that of Cry1Ac 1.2 – 1.3 nm (Carroll and Ellar, 1997). 
However the former experiments were performed in planar lipid bilayers in the 
absence of receptors and the latter with BBMV devoid of cellular content and at 
relatively high pH. Other experiments based on Trypan Blue exclusion method in Ch. 
fumiferana cells resulted in the detection of smaller pores. Channel radii induced by 
var. kurstaki P1 were less than 0.6 nm and vars. aizawai and israelensis between 0.6 - 
1.0 nm (Knowles and Ellar, 1987). The size of PS-3 induced pores was also close to 
other pore forming toxin CyaA, a hemolysin from B. pertussis, which forms pores of 0.6 
- 0.8 nm in diameter (Benz et al., 1994). These results are consistent with PS-3 forming 
discrete pores rather than causing a non-specific detergent-like membrane disruption. 
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Although PEGs in the toxin’s presence inhibited detection of membrane 
damage, they did not fully prevent cells from decreased viability reassuring that - 
contrary to EGTA action (explained in chapter 5) - PEGs did not prevent toxin 
interaction with the membrane but only inhibited swelling arising as a result of 
membrane damage. It also implies that inhibition of swelling itself is not capable of 
fully rescuing HepG2 cell viability after PS-3 treatment. 
Question however remains how a small pore diameter estimated using 
osmoprotectants (<1 nm) can allow for the passage of 138 kDa protease detected 
clearly in CytoTox-Glo assay, if the pore can be blocked by much smaller disaccharides. 
The possibility exists that the CytoTox-Glo substrate diffuses into the cell through toxin 
induced pores before the protease leaks out due to much smaller size. However, the 
manufacturers assure that substrate processing is inefficient inside the cells and 
predict that potential contribution of luminescence from intracellular processing of the 
substrate is small. More likely, primary lesions created by the toxin and cellular 
swelling induced membrane stretching. This in turn may have disrupted toxin 
arrangement in the membrane leading to radial expansion of pores – a process that 
would explain the changes in permeability presented in Figure 47, but would not have 
occurred when cells are protected from swelling by osmoprotectants. 
Untreated HepG2 cells are polygonal in shape, generally arranged in 
monolayers. After toxin administration, the cells swelled and eventually detached from 
the bottom. This is consistent with the insect cells losing the ability to regulate the 
osmotic pressure and lysis due to osmotic shock after exposure to Cry toxins. After 
breaking open, often yellow granules were released from HepG2 cells treated with 
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proteinase K activated PS-3 (data not shown). These may possibly be lipid droplets. The 
literature shows that 15% of HepG2 cells have these dispersed in the cytoplasm 
(Bouma et al., 1989). Also, lipid droplet formation was documented as one of the 
cellular responses to PFTs (Gonzalez et al., 2011b).  
PS-3 was tested against some additional cell lines that have not been examined 
before, like Burkitt's lymphoma and lymphoblastoid cells. None of them showed 
significant susceptibility towards the toxin, confirming narrow toxicity spectrum of PS-
3. Surprisingly, HL-60 cells were mostly unaffected by trypsin activated PS-3. However, 
the same cells were significantly affected by proteinase K activated PS-3 (Souissi et al. 
unpublished), highlighting the role of toxin activation in specificity. Similarly, truncated 
at the C-terminus PS-2 killed Sawano and CACO-2 cells much more efficiently than the 
non-truncated form of the toxin (Kitada et al., 2006).  
Interestingly, high dose of PS-3 (40 µg/ml final) caused a 20% reduction in HeLa 
cell viability, which was accompanied by swelling. These results indicate that the 
resistance of HeLa cells can be overcome by increasing toxin concentration. In fact, 
cytocidal activity of a high dose of PS-3 against HeLa cells has been previously 
documented (Yamashita et al., 2000). The toxin most likely affects HeLa cells by 
spontaneous insertion, similarly to how other Cry toxins can spontaneously form pores 
in artificial lipid bilayers devoid of receptors when present at a high enough dose 
(Schwartz et al., 1993, Slatin et al., 1990b). These results suggest the capacity of PS-3 
for pore formation even in the absence of the receptor. This is also supported by the 
fact that high dose of PS-3 (40 µg/ml) overcame 2 mM protective effect of EGTA, 
inducing cell swelling and lowering viability by 40 % (Figure 88, chapter 5). 
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5. Role of divalent cations in binding and toxicity 
5.1 Introduction 
Ions play many distinct roles both in cellular metabolism and extracellular processes. A 
large number of proteins coordinate cofactors - often metal ions - which facilitate 
specific functions (e.g. enzymatic activity) or help stabilize structures. Moreover, ion 
homeostasis and regulation of ionic gradients are critical for the proper functioning of 
cells. In the case of PFTs, cations not only participate in ionic imbalance created after 
membrane damage (Knowles and Ellar, 1987), but may also control toxin binding and 
pore formation (Kirouac et al., 2006).  
The two most commonly used non-specific chelators of metal ions are EGTA 
and EDTA. They have been widely used to test the roles of extracellular cations in the 
activities of various proteins including Cry toxins. Using this approach Zhang et al. 
showed that in the presence of the EDTA (but not EGTA) the toxicity of Cry1Ab on S5 
cells was prevented (Zhang et al., 2005). EDTA also inhibited pore formation by Cry1Aa, 
Cry1Ac and Cry1Ea in isolated insect BBMV (Kirouac et al., 2006). Ca2+ was shown to be 
indispensable for the activity of PS-1. Cytotoxicity of PS-1 was substantially inhibited 
when HeLa cells were cultured in low-Ca2+ medium. This effect was reversed with the 
addition of Ca2+ but not Mg2+. Extra– and intracellular increases in Ca2+ augmented 
Cry1C toxicity in Sf9 fall armyworm S. frugiperda cells in a dose-dependent manner, 
possibly via a Ca2+ dependent intracellular pathway (Monette et al., 1997). Toxicity of 
Bt var. entomocidus  against the cotton leafworm S. littoralis was enhanced by calcium 
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and zinc salts (Salama et al., 1985). However, experiments with Cry1 toxins showed 
some contradictory results; for example, in osmotic swelling assays using M. sexta 
BBMV, Ca2+ reduced the rate of pore formation by Cry1Ac, but enhanced pore 
formation by Cry1Ca (Fortier et al., 2005). Moreover there are reports of synergistic 
effects of EDTA and Dipel in resistant P. xylostella larvae (Liu and Tabashnik, 1997) 
To test the involvement of divalent ions in PS-3 toxicity, various cell treatment 
methods were developed that involved the use of different chelators and metal salts. 
Experiments with chelators were carried out over a time period of 5 hours as 24 hour 
cell exposure to 2 mM EGTA showed around 20% lowered viability (data not shown). 
There was no loss of viability within the first 5 hours, however it was noted that in the 
presence of >2 mM EDTA or EGTA cells showed some rounding over time (more so in 
case of EDTA than EGTA).  
5.2 Exploration of the protective EGTA effect  
HepG2 cells were pre-incubated with either EGTA or EDTA, followed by toxin 
administration and viability examination. Additionally Ca2+ and Mg2+ salts were added 
to some wells before the toxin to test if the chelator effect could be reversed (Figure 
85). Addition of EGTA, EDTA, CaCl2, MgCl2 separately or a combination of a chelator 
and metal salt did not decrease cell viability within 5 hours (data not shown). 
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Figure 85 The effect of chelating agents on viability of PS-3 treated HepG2 cells.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were pre-incubated with 5mM of 
either EGTA or EDTA or water (mock) for 30 min followed by the addition of toxin (12 μg/ml). CaCl2 or MgCl2 was 
added (5 mM) to some wells 10 minutes before the toxin. The readings were taken 5 hours after toxin addition 
using CellTiter-Blue assay. 
 
Both EDTA and EGTA significantly reduced cytotoxicity of PS-3. Also, no cell swelling 
was observed. In comparison pre-incubation with EDTA or EGTA did not prevent 
cellular damage by 0.01% Triton X-100 (data not shown). Interestingly Ca2+, but not 
Mg2+, restored PS-3 cytotoxicity. Experiments with proteinase K activated toxin yielded 
comparable results (data not shown). It is consistent with EGTA’s high affinity for 
calcium but negligible affinity for magnesium ions. Concentrations of bound and free 
Ca2+ and Mg2+ were calculated in the presence of 2 mM EGTA using the Chelator 
algorithm (Schoenmakers et al., 1992). Results presented in Table 9 show that EGTA 
bound 99.94 % of Ca2+, but only 0.003 % of Mg2+ and point to a paramount role of 
calcium ions in the toxin’s action. 
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Table 9 Calculation of Ca
2+
 and Mg
2+
 concentrations from given total metal concentrations in the EGTA presence. 
Ca
2+
 and Mg
2+
 concentrations were calculated in the presence of 2 mM EGTA at pH = 7.4, 37° C and  0.165 N ionic 
contribution. Total ion concentrations were selected to match ion levels present in DMEM formulation. Calculations 
were performed using Ca/Mg/ATP/EGTA calculator v1, available online: maxchelator.stanford.edu. 
  
Name Total (M) Free (M) Bound (M) % Bound 
Ca2+ 0.0018 9.666e-7 0.001799 99.94 
Mg2+ 0.0008 0.000799 3.160e-8 0.003 
EGTA 0.002 0.000184 0.001815 90.78 
 
Next, the minimal concentration of CaCl2 that can counteract the effect of 2 
mM EGTA was estimated (Figure 86).  
 
Figure 86 Analysis of reversal of the 2 mM EGTA effect by CaCl2. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were dosed with 2 mM EGTA and 20 
minutes later supplemented with various concentrations of CaCl2 for another 10 minutes, followed by PS-3 (10 
µg/ml) administration. Viability was measured 5 hours after treatment using CellTiter-Blue assay. 
 
Addition of ≥1 mM of CaCl2 counteracted the 2 mM EGTA effect.  
 It was assessed whether the addition of CaCl2 after toxin treatment would 
reinstate toxicity as efficiently as when calcium ions were added first (Figure 87). 
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Figure 87 Analysis of PS-3 activity in EGTA treated HepG2 cells with CaCl2 added before or after the toxin.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were pre-incubated with 2 mM EGTA 
35 minutes before the toxin (12 µg/ml) administration. 2 mM CaCl2 was added 30 minutes before or after the toxin. 
Viability was measured 5 hours after treatment using CellTiter-Blue assay. 
 
The presence of calcium ions, regardless of whether they were added before or after 
the toxin, had the capacity to restore PS-3 toxicity in EGTA treated cells.  
 Knowing that 2 mM EGTA is sufficient to block the activity of PS-3 at 12 µg/ml, 
it was hypothesised that adding toxin in excess could inflict damage in the presence of 
EGTA. Cells were treated with 2 mM EGTA and higher PS-3 doses (Figure 88). 
 
Figure 88 The effect of high doses of PS-3 on HepG2 cell susceptibility in the presence of 2 mM EGTA. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with 2 mM EGTA or 
water (mock). 10 minutes later cells were treated with different concentrations of PS-3 or buffer. Viability was 
measured 5 hours after toxin treatment using CellTiter-Blue assay. 
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High concentrations of PS-3 (>30 µg/ml) overcame 2 mM protective effect of EGTA. 
Cells treated with EGTA and >30 µg/ml toxin showed signs of swelling and decreased 
viability. 
An experiment was performed to find out if there is a competition between PS-
3 and EGTA when both of these components are added at the same time and if toxicity 
could be reversed by late EGTA administration (Figure 89). 
 
Figure 89 Administration time-dependent effect of EGTA on PS-3 treated cells. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with 2 mM EGTA at 
different time points: before, at the same time as, or after PS-3 (12 µg/ml). Viability was measured 6 hours after 
toxin addition using CellTiter-Blue. Control cells were treated with water and exposed to PS-3 (12 µg/ml) for 6 
hours.  
 
EGTA was less able to protect the cells when added more than a few minutes after the 
toxin. 
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5.3 Analysis of toxin - membrane interaction in the 
presence of EGTA 
To elucidate whether EGTA acts prior or post membrane damage, membrane 
permeability in EGTA and PS-3 treated cells was assessed using CellTox-Green 
cytotoxicity cell assay (Figure 90) and the whole cell patch clamp technique (Figure 91). 
 
Figure 90 The effect of EGTA on HepG2 membrane permeability after PS-3 treatment.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in the presence of CellTox-Green dye in a black 96-well 
plate. The next day cells were pre-treated with EGTA (5mM) 30 minutes before treatment with PS-3 (12 μg/ml). 
Membrane permeability was measured using CellTox-Green assay at different time points after toxin addition. 
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Figure 91 Whole cell patch clamp recordings from HepG2 cells exposed to PS-3 in the presence or absence of 2 
mM EGTA. 
HepG2 cells were seeded at the density of 5 x 10
4
 cells/ml on the glass coverslip inside the 35 mm petri dish. The 
next day whole cell patch clamp recordings from a single cell were reported 20 minutes after the addition of PS-3 
(12 µg/ml) to the bath in NaCl solution in the presence or absence of EGTA (2 mM). Currents were induced by a 1 
second set of depolarizing potentials from −20 to 140 mV from a holding potential of −20 mV. Error bars indicate 
the standard error of the mean. The lines show the mean currents from three representative experiments from 
three different cells patched. 
 
In EGTA and PS-3 treated cells membrane stayed impermeable to a small cytotoxic 
marker (<1 kDa) for 6 hours. Also, PS-3 was not able to induce large whole cell currents 
in the presence of EGTA within 20 minutes. Mean conductance levels were 12.5 and 
266.9 nS for HepG2 cells treated with PS-3 in the presence and absence of EGTA 
respectively, as also shown in Table 4. Additionally, cells showed no signs of swelling in 
contrast to toxin treated cells in the absence of the chelator. 
 The effect of EGTA was tested on the ability of PS-3 to create channel openings 
in planar lipid bilayers. PLB KCl buffer containing 2 mM EGTA was placed in the cis 
chamber before the toxin was added and traces recorded (Figure 92). 
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Figure 92 The effect of EGTA on PS-3 induced channel activity in planar lipid bilayers. 
Formation of ion channels by PS-3 (8 µg/ml) was tested in planar lipid bilayers in the presence or absence of 2 mM 
EGTA. Representative current traces are shown at + 60 mV applied voltage in the absence (upper trace) and in the 
presence (lower trace) of 2 mM EGTA. Traces were filtered at 120 Hz. 
 
EGTA did not prevent PS-3 induced pore formation in planar lipid bilayers.  
For more clarification on the exact role of EGTA, i.e. whether it impedes the 
toxin binding or subsequent steps in the mode of action (e.g. oligomerization or pore 
formation), cell viability was assessed after transient EGTA and PS-3 treatment. A cell 
washing step after 20 minutes ensured that all non-bound toxin molecules and EGTA 
were removed as shown in experiment’s outline in Figure 93. 
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Figure 93 The effect of transient treatment with toxin and EGTA on HepG2 cell viability. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were pre-incubated with either 5 mM 
EGTA or 5 mM EGTA and 5 mM CaCl2 or water (mock). After 30 minutes PS-3 (12 μg/ml) or buffer was added and 
cells were incubated for further 20 minutes. Then all cells were washed twice with DPBS and re-suspended in 
complete culture medium. Viability was assessed using CellTiter-Blue 24 hours after toxin addition. Results are 
represented as % viability relative to cells washed after treatment with EGTA and buffer. Below results, 
experimental outline is presented graphically. Cells were exposed to toxin and EGTA for 20 minutes, followed by 
washes and addition of DMEM. High viability was recorded 24 hours later.  
 
High viability in cells transiently treated with PS-3 and EGTA indicates that the chelator 
prevented toxin interaction with the membrane within the 20 minute incubation 
period – a time that was sufficient to initiate cytotoxic effect in cells transiently treated 
with PS-3 in the absence of EGTA. For confirmation this experiment was repeated 
three times using lower EGTA concentration (2 mM), each time yielding similar results 
(data not shown). Presence of Ca2+ counteracted EGTA effect and promoted efficient 
PS-3 toxicity within the 20 minute period. Cells were observed under the microscope 
after washing and re-suspending steps as well as after 20 hours. At each of these steps, 
cells treated with EGTA, Ca2+ and toxin as well as with toxin only showed significant 
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swelling (more than >90% of cells), whereas cells treated with EGTA and toxin 
presented little swelling (<10%).  
 It is shown in chapter 6 that PS-3 - as many other PFTs - induced p38 
phosphorylation, a pathway activated by pore formation. It was speculated that if 
EGTA prevents PS-3 making pores, the chelator should also prevent phosphorylation of 
p38. Western blot was carried out to test this hypothesis. Cells were first pre-treated 
with EGTA, followed by toxin administration, cell lysis and detection of dually 
phosphorylated p38 (Figure 94). 
 
Figure 94 Analysis of p38 phosphorylation in EGTA pre-treated HepG2 cells exposed to PS-3. 
HepG2 cells were pre-treated with EGTA (2 mM) or water only for 10 minutes. Next, Cry1Ca (15 µg/ml), sodium 
arsenite (0.5 mM), PS-3 (15 µg/ml) or buffer were added. Cells were lysed in NP-40 15 minutes after toxin 
treatment. 10 µg of proteins were loaded in each lane and after SDS-PAGE proteins were subject to western blot 
analysis for the presence of phosphorylated p38 (p p38) and CD59 (loading control). 
 
Cell pre-incubation with EGTA significantly reduced p38 activation in PS-3 treated cells. 
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5.4 Assessment of possible indirect EGTA actions 
Chelation of metal ions is considered here as a direct effect of EGTA, whereas any form 
of other interactions is considered as indirect. The following direct and indirect effects 
associated with EGTA administration may be resulting in toxicity abolition. 
Direct: 
- EGTA chelates metal ions present in extracellular medium, 
- EGTA – in addition to extracellular ions - chelates metal ions bound to 
membrane proteins. 
Indirect: 
- EGTA binds or interacts with toxin, 
- EGTA binds or affects cell membrane by means different from ion chelation, 
- EGTA induces drop in pH due to H+ release during chelation reaction.  
To test if EGTA was causing the toxin to degrade or precipitate, PS-3 was incubated 
with or without EGTA followed by SDS - PAGE to assess toxin bands (Figure 95).  
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Figure 95 SDS-PAGE analysis of possible protein degradation and precipitation after incubation with EGTA. 
A) 10 µl of activated PS-3 (120 µg/ml) was incubated with either 5 mM EGTA in PBS or appropriate volume of PBS 
for 1 hour at 37°C. After incubation samples were spun and run on a 7.5% SDS-PAGE gel. B) 10 µl of activated PS-3 
(96 µg/ml) was incubated with either 2 mM EGTA in dH2O or appropriate volume of dH2O for 15 minutes at RT. 
After incubation samples were either spun or not and run on a 7.5% SDS-PAGE gel. 
 
The size and quantity of toxin was unaffected by incubation with the chelator under 
different conditions. Also, soluble fraction after spinning did not look any different 
from the control bands indicating no toxin precipitation.   
The possibility exists, although unlikely, that the toxin was bound by EGTA and 
this affected its toxicity. Only some proteins are able to bind EGTA and EDTA, but this 
occurs with very low affinity (Uversky, 2007). To test this possibility PS-3 was incubated 
with EGTA, dialysed and then tested on cells (Figure 96). 
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Figure 96 Assessment of PS-3 activity on HepG2 cells after toxin pre-incubation with EGTA and dialysis. 
PS-3 (12 µg/ml) was incubated at RT for 30 minutes with either EGTA (2 mM) or water. Mixtures were transferred to 
Vivaspin500 desalting columns followed by 4 washes with DPBS buffer to remove unbound EGTA molecules. HepG2 
cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with dialysed retenates and 
viability was measured 5 hours after toxin administration using CellTiter-Blue.  
 
Even though PS-3 had been in contact with EGTA, its toxicity was retained after 
dialysis, indicating that EGTA does not bind the toxin or does not affect its activity.  
To test if EGTA physically affected cell membranes e.g. by binding, PS-3 toxicity 
was assessed in cells treated transiently with EGTA (Figure 97).   
 
Figure 97 Assessment of PS-3 toxicity in HepG2 cells pre-treated transiently with EGTA.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were pre-treated with either EGTA (2 
mM) or water for 30 minutes followed by a cell wash and toxin (12 µg/ml) treatment in complete medium. Viability 
was measured 5 hours after toxin administration using CellTiter-Blue. 
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Cells transiently pre-treated with EGTA remained susceptible to PS-3. Cell washing 
removed EGTA suggesting it did not bind cell surfaces or that binding did not affect the 
activity of PS-3. 
Soon after EGTA is added to the cells phenol red present in the culture medium 
changes colour from red to yellow, indicating a shift towards more acidic pH. It is 
because in distilled water chelators like EDTA or EGTA behave as weak acids. When a 
chelation reaction takes place protons in the chelation are displaced by metal cations 
resulting subsequently in a pH drop (Spencer, 1958). Moreover, pore formation activity 
by Cry1Aa in M. sexta BBMV in the presence of EGTA was shown previously to be 
affected by a pH change; EGTA was inhibitory at pH 10.5 but not 7.4 (Kirouac et al., 
2006). Therefore, the pH of HepG2 cell suspension in complete DMEM was measured 
before and after the addition of 2 mM EGTA. Medium’s pH dropped from 7.4 to 6.8. 
Activity of PS-3 was then assessed in the absence of EGTA in medium with lowered or 
increased pH values (Figure 98).  
 
Figure 98 The effect of medium’s pH on PS-3 activity against HepG2 cells.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day cells were washed 
with DPBS and placed in medium with altered pH. pH of culture medium was adjusted in advance using either 10 
mM NaOH or 1M HCl. PS-3 (10 µg/ml) was added 30 minutes later and cell viability was measured 5 hours after 
toxin addition using CellTiter-Blue.  
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A pH drop in the culture medium to 6.84, which mimicked EGTA induced pH change, 
did not influence PS-3 activity, suggesting that this cannot explain EGTA protective 
effect.    
5.5 Effect of other chelators on PS-3 toxicity 
Effects of chelators other than EGTA or EDTA were tested on PS-3 toxicity (Figure 99). 
DTPA is a membrane impermeable chelator often used in zinc depletion studies. Only 
zinc and to a lesser extent copper, but not calcium or magnesium ions, were able to 
counteract the cytotoxic effect of DTPA in breast cancer cell lines after 48 hour 
exposure (Hashemi et al., 2007), however DTPA has the capacity to bind other ions 
(Byegård et al., 1999). BAPTA is a derivative of EGTA, designed to be more selective for 
Ca2+ over Mg2+ than EGTA, however it forms lower affinity calcium chelates than EGTA: 
6.71 versus 7.18 at pH 7.4 (Bolsover, 1994). Histidine is a chelator of many divalent 
ions including copper and iron but it presents negligible affinity for calcium. For this 
reason it has been used previously alongside EGTA to test the involvement of calcium 
in lymphocyte membrane permeability (Quastel et al., 1981, Segel et al., 1981). 
Contrary to previously mentioned chelators, which bind metals in a 1:1 molar ratio, 
histidine complexes metals in a ratio of 2:1. 
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Figure 99 The effect of different metal chelators on PS-3 toxicity.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in Advanced DMEM. The next day cells were incubated 
for 30 minutes with different concentrations of EGTA, BAPTA, DTPA or histidine before PS-3 (10 µg/ml) was added. 
Viability was measured 5 hours after toxin addition using CellTiter-Blue. Dose response curves were generated using 
Graphpad Prism. 
 
Non-specific chelators like EGTA or BAPTA were most efficient at protecting cells from 
PS-3. It required higher concentration of DTPA to achieve this effect while histidine, 
even at high concentrations, had no significant impact.  
5.6 Role of membrane bound ions in PS-3 toxicity 
In order to better explain the role of extracellular calcium ions in PS-3 activity, titration 
of EGTA was performed in complete DMEM as well as in Ca2+ free DMEM with and 
without FCS - as supplementation with FCS additionally increases extracellular calcium 
pool (Figure 100). Experiments that involved Ca2+ free medium were carried out 
straight after cell seeding because lack of extracellular Ca2+ led to a detrimental fall in 
viability after 24 hours. Although the cells were not attached to the bottom of the 96-
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well plate, the difference in morphology before and after toxin addition (swelling) was 
prominent.  
 
Figure 100 EGTA titration in culture media with different calcium levels and its effect on PS-3 activity.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM, Ca
2+
 free DMEM with FCS, or Ca
2+
 
free DMEM without FCS. Cells in complete DMEM were seeded 24 hours before the experiment and cells in Ca
2+
 
free DMEM on the same day. Cells were treated with different concentrations of EGTA and 30 minutes later with 
PS-3 (12 µg/ml). CellTiter-Blue cell viability assay was used to measure viability 5 hours later. Dose response curves 
were generated using Graphpad Prism. 
 
Cells in DMEM devoid of extracellular Ca2+ were able to resist PS-3 at much lower EGTA 
concentration compared to complete DMEM. When Ca2+ free DMEM was lacking FCS, 
cells resisted PS-3 at even lower chelator dose. Importantly, in the absence of EGTA 
toxin retained its activity in Ca2+ free DMEM (with or without FCS), suggesting that 
EGTA may be chelating extracellular metal ions other than calcium or ions bound to 
cellular membranes. To test this, a similar experiment was conducted measuring 
viability of PS-3 treated cells in DPBS in the presence of different BAPTA concentrations 
as shown in Figure 101 (BAPTA dose-response curve in Advanced DMEM from Figure 
99 is included for comparison).    
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Figure 101 Titration of BAPTA in Advanced DMEM and DPBS and its effect on PS-3 activity.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. BAPTA in DPBS treatment: cells were seeded in 
Advanced DMEM overnight. The next day cells were washed once with DPBS and fresh DPBS was placed in the 
wells. Different concentrations of BAPTA were added and 30 minutes later PS-3 was administered (10 µg/ml). 
Viability was measured 3 hours later using CellTiter-Blue. BAPTA in Advanced DMEM treatment: cells were seeded 
in Advanced DMEM. The next day cells were incubated with different concentrations of BAPTA. After 30 min PS-3 
(10 µg/ml) was added and viability was measured 5 hours later using CellTiter-Blue. Dose response curves were 
generated using Graphpad Prism. 
 
Much less BAPTA was required to abolish PS-3 toxicity in DPBS compared with 
Advanced DMEM. However, in DPBS in the absence of chelator, like previously 
observed in Ca2+ free DMEM, the toxin was still able to cause swelling and decrease 
cell viability, which suggests that cations bound to the membrane play a role in PS-3 
toxicity.   
5.7 Effect of metal ion supplementation on PS-3 toxicity 
Considering that calcium ions counteracted the EGTA effect, it was tested whether 
increasing extracellular Ca2+ levels would increase PS-3 toxicity (Figure 102), like in the 
case of experiments with Cry1C and Sf9 cells (Monette et al., 1997).   
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Figure 102 The effect of increased Ca
2+ 
levels on PS-3 toxicity.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day cells were 
supplemented with various concentrations of CaCl2 for 10 minutes, followed by either toxin (12 µg/ml) or buffer 
administration. Viability was measured 5 hours after toxin treatment using CellTiter-Blue assay. 
 
Adding extra calcium ions did not increase PS-3 toxicity. This is consistent with data 
presented in Figure 86, where the addition of as little as 1 mM CaCl2 counteracted the 
2 mM EGTA effect, whereas the addition of >1 mM CaCl2 did not increase toxicity any 
further. 
To test the effect of calcium and other metal ions on PS-3 activity in the 
absence of extracellular Ca2+, salt supplementation was done in Ca2+ free medium. Low 
toxin dose was used to better visualise changes in toxicity (Figure 103).  
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Figure 103 The effect of metal salts on residual PS-3 toxicity in Ca
2+
 free DMEM.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in Ca
2+
 free DMEM. After 30 minutes cells were 
supplemented with various concentrations of metal salts: CaCl2, MnSO4, ZnSO4, FeSO4, FeCl3, CuCl2 or MgCl2, 
followed by either PS-3 (5 µg/ml) or buffer treatment. Viability was measured 5 hours after toxin treatment using 
CellTiter-Blue assay. Bars with asterisks are significantly different from control cells exposed to PS-3 (5 µg/ml) in 
calcium free DMEM without supplementation (* p < 0.005, Post-Hoc comparison with Bonferroni correction).  
  
In the absence of extracellular Ca2+, low quantities of Mn2+ and Zn2+ enhanced PS-3 
toxicity, as did Ca2+. When similar experiments were conducted in complete and 
Advanced DMEM, so in the presence of normal Ca2+ concentrations, addition of low 
levels of Zn2+ or Mn2+ also enhanced PS-3 toxicity (data not shown).  
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5.8 Effect of metal ion supplementation on EGTA effect 
reversal 
To further clarify which metal cations play a role in toxicity, EGTA and PS-3 treated 
cells were supplemented with different concentrations of metal ions to counteract the 
protective EGTA effect (Figure 104).  
 
Figure 104 The effect of different salts on HepG2 cells exposed to EGTA and PS-3 in Ca
2+
 free DMEM. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in Ca
2+
 free medium followed by treatment with 2 mM 
EGTA or water. 10 min later different concentrations of salts were added followed by either PS-3 (10 µg/ml) or 
buffer treatment. Viability was measured 5 hours later using CellTiter-Blue. Addition of high concentrations (>1 
mM) of ZnSO4 and CuCl2 to cells resulted in decreased viability therefore normalisation was done for the effect of all 
salts. Normalized data was then plotted as a percentage of the EGTA and PS-3 treated cells. Dose response curves 
were generated using Graphpad Prism. 
 
Ca2+, Mn2+ and Zn2+ supplementation most strongly counteracted EGTA effect. It is 
worth noting that as little as 0.5 mM of Mn2+ was able to significantly reinstate toxicity. 
Cu2+ partially restored toxicity, however >1 mM concentrations of ZnSO4 and CuCl2 
were toxic to cells (~35% viability drop in cells treated with 2 mM CuCl2, 15% viability 
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drop in cells treated with 2 mM ZnSO4; data not shown); data were normalized for this 
effect, but it could mask the real contribution of these ions in PS-3 action.  
Unfortunately, addition of extra salts will affect the equilibria of existing EGTA 
chelates, e.g. addition of a large amount of Zn2+ could displace another metal cation 
from EGTA chelate making it available for the cells and facilitating toxicity . To avoid 
the problem of the unknown stoichiometry of each metal ion after supplementation in 
the presence of EGTA, similar experiment was performed where culture medium with 
EGTA was removed before salt and toxin addition in DPBS. Salt supplementation was 
done in DPBS for absolute control of buffer composition (Figure 105). 
 
Figure 105 The effect of PS-3 on HepG2 cells in DPBS with or without Ca
2+
 and Mg
2+
 after transient EGTA 
treatment.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day cells were treated 
with 2 mM EGTA or water for 10 minutes. After that medium was removed from wells and 90 µl of DPBS formulated 
either without or with Ca
2+
 (0.9 mM of CaCl2) and Mg
2+
 (0.5 mM of MgCl2) was added. 5 minutes later either PS-3 
(10 µg/ml) or buffer was added. Viability was measured 4 hours later using CellTiter-Blue.  
 
High viability in PS-3 treated cells in DPBS after EGTA removal suggests that together 
with removed medium all the metal cations needed for PS-3 toxicity have been also 
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removed due to EGTA chelation. When DPBS formulated to include Ca2+ and Mg2+ was 
used instead, swelling and drop in viability was present. These results and previous 
observations about Mg2+ insignificance (Figure 85, Figure 103 and Figure 104) suggest 
that Ca2+ alone is able to distinctly reinstate PS-3 activity. Analogous experiment was 
carried out in DPBS that included more metal salts (Figure 106). 
 
Figure 106 The effect of various salts on PS-3 treated cells in DPBS after EGTA removal.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day cells were treated 
with 2 mM EGTA or water for 10 minutes. After that medium was removed from wells and DPBS was added. 5 
minutes later different concentrations of salts were added followed by either PS-3 (10 µg/ml) or buffer treatment. 
Viability was measured 4 hours later using CellTiter-Blue. Addition of NiSO4 and CuCl2 to cells in DPBS resulted in 
decreased viability therefore normalisation was done for the effect of all salts. Normalized data was then plotted as 
a percentage of the EGTA and PS-3 treated cells. Bars with asterisks are significantly different from control cells 
exposed to PS-3 (10 µg/ml) in PBS without supplementation after transient treatment with 2 mM EGTA (* p < 0.001, 
** p < 0.05, Post-Hoc comparison with Bonferroni correction). 
 
The above results show that addition of CaCl2, MnSO4 and to a lesser extent ZnSO4 not 
only restored but even elevated PS-3 toxicity compared to viability levels of PS-3 
treated cells when water instead of EGTA was used for transient treatment.  
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It was noted that in the routinely used Nunclon surface treated 96-well plates, 
small percentage of adhered cells grow forming layers, with some of them probably 
being hidden from the treatment. Experiment was therefore repeated using a Poly-D-
lysine coated 96 well-plate as it allows for even spreading out of cells, and ensures a 
more even exposure to EGTA (Figure 107). 
 
Figure 107 The effect of various salts on PS-3 treated cells in DPBS after EGTA removal (cells seeded on a Poly-D-
lysine substrate). 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM in Poly-D-lysine coated 96-well 
plates. The next day cells were treated with 2 mM EGTA or water for 10 minutes. After that medium was removed 
from wells and DPBS was added. 5 minutes later different concentrations of salts were added followed by either PS-
3 (10 µg/ml) or buffer treatment. Viability was measured 4 hours later using CellTiter-Blue. Addition of NiSO4 and 
CuCl2 to cells in DPBS resulted in decreased viability therefore normalisation was done for the effect of all salts. 
Normalized data was then plotted as a percentage of the EGTA and PS-3 treated cells. Bars with asterisks are 
significantly different from control cells exposed to PS-3 (10 µg/ml) in PBS without supplementation after transient 
treatment with 2 mM EGTA (* p < 0.001, Post-Hoc comparison with Bonferroni correction). 
 
Results showed similar trend: trace levels of MnSO4 and ZnSO4 restored PS-3 toxicity. 
High levels of CaCl2 (1mM), but less than present in DMEM formulation, not only 
restored but significantly enhanced toxicity of PS-3.   
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5.9 Discussion 
EGTA is thought to be cell impermeant and not metabolised by cells. However, 
undoubtedly high dose and prolonged exposure will have an effect by the virtue of its 
metal-chelating property. Calcium is one of the most abundant metal ions present in 
extracellular fluids, and also in the DMEM formulation (Table 10). The literature has 
shown that removal of extracellular Ca2+ reversibly increases permeability of tight 
junctions, a multi-protein system that mediates cell to cell adhesion and transport in 
epithelial cells, leading to its disruption, cell contraction and reduction of cell-cell 
adhesion (Pitelka et al., 1983). Furthermore, mouse myoblast C2C12 cells treated with 
1.75 mM EGTA for 24 hours showed significant changes in morphology resulting from 
changes in number and distribution of stress fibres and microtubules (Mermelstein et 
al., 2003). For these reasons all chelator experiments were carried out over a short 
time period of 5 hours. Results indicate that indirect interaction between the chelator 
and either cell membrane or the toxin was not responsible for alleviating PS-3 toxicity. 
Also, the EGTA induced fall in pH neither affected cell viability nor was responsible for 
toxicity inhibition. EGTA action appeared to result from the metal ion chelation 
activity.  
Interestingly, high dose of PS-3 (>30 µg/ml) overcame 2 mM protective effect 
of EGTA, perhaps analogous to how other Cry toxins can spontaneously form pores in 
artificial lipid bilayers devoid of receptors when present at high dose (Schwartz et al., 
1993, Slatin et al., 1990b). These results may suggest the capacity of PS-3 for 
spontaneous insertion and pore formation when the receptor is malfunctioned e.g. 
due to chelator action. This is supported by the fact that a high PS-3 dose also lowered 
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viability and initiated swelling in HeLa cells (section 4.10) and high conductance was 
observed in negative controls in single channel patch clamp experiments (section 4.7). 
Experiments showed that the later EGTA was administered relative to toxin 
treatment, the more ineffective it was in cell protection. Gradual decrease in viability 
in wells where EGTA was added, 1, 5, and 15 minutes after PS-3, points to some sort of 
competition between the chelator and toxin. When a chelator like EGTA is added to a 
solution, equilibrium is reached relatively quickly within micro- to milliseconds, 
depending on rate constants and ionic strength. This may indicate that the initial few 
minutes are required for toxin interaction with the membrane. This would be the 
diffusion time it takes for the toxin to reach and bind membranes, but could also 
include oligomerisation. In HepG2 cells treated with PS-2, membrane associated 
oligomers were detected after 10 minute incubation with the signal reaching highest 
intensity after 60 minutes (Abe et al., 2008). Unfortunately, attempts to detect PS-3 
oligomers embedded in HepG2 membranes were unsuccessful (section 7.5). It seems 
that as soon as EGTA is added (after PS-3), it prevents further toxin action but it cannot 
undo the damage already created. This is consistent with study by Kirouac et al. who 
showed that EDTA (and to some extent EGTA) inhibited the rate of pore formation by 
Cry1Aa but did not alter the pores that were already formed (Kirouac et al., 2006).  
The membrane permeability assays showed that in EGTA and PS-3 treated cells 
membrane stayed impermeable to a small cytotoxic marker and a large current flow 
(whole cell patch clamp experiments) implying that EGTA protected cells from 
membrane damage. In agreement with this is the fact that EGTA also prevented p38 
phosphorylation. It has been shown that non-lytic mutants of some PFTs like E. coli 
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Hemolysin A or S. aureus α-toxin failed to activate p38 (Husmann et al., 2006, Kloft et 
al., 2009). Moreover, a study by Ratner et al. demonstrated that EGTA abolished p38 
activation in Pneumolysin treated A549 epithelial cells (Ratner et al., 2006). Lack of p38 
activation in EGTA and PS-3 treated cells could then result either from the lack of 
binding or pore formation. Clarification came from the experiment in which removal of 
toxin and EGTA after transient treatment resulted in high cell viability opposed to low 
viability in control cells transiently treated with toxin only. These results indicate that 
EGTA prevented stable interaction between the toxin and cell membrane and not the 
subsequent steps. Interestingly, EGTA did not prevent pore formation by PS-3 in 
artificial membranes, indicating a biological context of this chelator effect. This may 
also be attributed to single channel recording being a highly sensitive method of 
channel detection. The latter may be true as high conductance values were also 
observed in EGTA and PS-3 treated cells in single channel patch clamp experiments, 
but not in the whole cell patch clamp experiments where macroscopic current from 
the whole cells was measured.  
Chelator titration curves may support the idea of calcium being the cation of 
major importance in PS-3 mode of action. BAPTA which forms lower affinity calcium 
chelates compared to EGTA was somewhat less effective in preventing cell death than 
EGTA. The ability of high concentrations of DTPA to preserve cell viability was most 
likely caused by metal chelation other than zinc. 1.2 mM of DTPA was found to be the 
optimal concentration to chelate zinc in osteoblastic MC3T3-E1 cells (Cho et al., 2007), 
however much smaller concentrations of 0.1 mM were used successfully with MCF-7 
and MDA-MB468 breast cancer cells (Hashemi et al., 2007). In experiments with PS-3, 
even 2 mM DTPA was not able to fully protect the cells from the toxin’s damage. 
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Moreover histidine, which is a poor calcium chelator, did not inhibit PS-3 toxicity even 
at very high up to 10 mM concentration (data not shown). 
PS-3 stayed active in Ca2+ free DMEM and DPBS, even in the absence of 
chelators. Formulation of DPBS contains only potassium and sodium salts in 
concentrations exceeding 2 mM. Moreover both EGTA and BAPTA have negligible 
affinities for K+ or Na+. These results imply that cations bound to the membrane 
proteins and not present in extracellular medium are important for PS-3 activity. If 
protein-metal affinity is weaker than chelator affinity for this metal, it may be pulled 
out of its binding protein partner. 
Nonetheless, caution should be taken when analysing experiments with 
chelating agents like EGTA. Due to the fact that EGTA forms complexes with a large 
number of metallic cations, it is difficult to predict the levels of the un-chelated free 
metal ions available to cells after EGTA treatment in culture medium. EGTA-metal 
equilibria are calculated in a situation when EGTA is fully dissociated (alkaline pH) and 
only with one type of cation present. What is known is that both abundance of metal 
ions (if they are major constituents in DMEM like calcium or magnesium or minor like 
zinc or manganese ions) and their ability to form stable complexes with the chelator at 
experimental pH, highly influence the actual equilibria (Spencer, 1958). Table 10 
presents quantities of major metal ions present in DMEM formulation and stability 
constants of complexes formed by EGTA and these ions.   
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Table 10 Levels of metal ions in complete DMEM and EGTA-metal stability constants.  
Amounts of metal cations were obtained from supplier’s website (Life Technologies). Stability constants were taken 
from Cheng, et al. (K. L.Cheng, 1982). 
Ions Presence in complete DMEM (mM) EGTA-metal absolute stability constant 
Ca2+ 1.8 (in DMEM) 11 
Mg2+ 0.8 (in DMEM) 5.2 
Fe3+ 0.0003 (in DMEM) 20.5 
Fe2+ Trace (in FCS) 11.9 
Mn2+ Trace (in FCS) 12.3 
Zn2+ Trace (in FCS) 14.5 
Cu2+ Trace (in FCS) 17.8 
 
Considering then that the biological levels of Zn2+ and Mn2+ are in micromolar and 
nanomolar range respectively, the addition of large quantities (2 mM) of Zn2+ or Mn2+ 
to the cells most likely created variations in the equilibrium concentrations of all the 
strongly chelated as well as un-chelated ions releasing other ions that formed less 
stable complexes with EGTA. For example, added Zn2+ could displace Ca2+, which when 
released could aid or affect PS-3 action. 
However, despite the above, experiments where EGTA was present with cells 
throughout the experiment, displayed comparable results to experiments where ion 
supplementation was done without EGTA or after its removal, as graphically presented 
in Figure 108. In the absence of EGTA low quantities of Mn2+, Zn2+ and Ca2+ enhanced 
PS-3 toxicity in Ca2+ free DMEM. When EGTA was present continuously with the cells, it 
was also supplementation with Ca2+, Mn2+ and Zn2+ that most strongly counteracted 
EGTA effect. When the cells were only transiently treated with EGTA and cultured in 
DPBS, results showed similar trend: the addition of Ca2+, Mn2+ and Zn2+ not only 
restored but in some cases increased PS-3 toxicity. Therefore Mn2+, Zn2+ and Ca2+ seem 
to play an important role in PS-3 toxicity. 
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Figure 108 Experimental evidence for the role of Zn
2+
, Ca
2+
 and Mn
2+
 in PS-3 toxicity. 
Zn
2+
, Ca
2+
 and Mn
2+
 enhanced PS-3 toxicity in Ca
2+
 free medium (A) and restored PS-3 toxicity after EGTA treatment 
in complete medium (B). Zn
2+
, Ca
2+
 and Mn
2+
 also triggered PS-3 toxicity in DPBS after transient EGTA treatment (C).    
 
There is no unified view on the role of divalent cations in Cry toxin mode of 
action. Some researchers claim they participate in signalling pathways. Zhang et al. 
showed that Cry1Ab toxicity can be abolished with EDTA, but not EGTA. This effect was 
interpreted as Mg2+ depletion based on the fact that EDTA binds Mg2+ more strongly 
than EGTA and because supplementation with magnesium salt restored toxicity (Zhang 
et al., 2005). Contrary to PS-3 experimental results, the chelator did not prevent 
Cry1Ab binding, as evidenced by the monomer and oligomer bands detected by 
western blots. The authors suggested the importance of Mg2+ in post-binding phase, 
specifically in cAMP synthesis and G protein stimulation (Zhang et al., 2005). PS-1 on 
the other hand seems to use changes in  the cytosolic Ca2+ concentration as a 
A                                               B                                               C 
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messenger system (Katayama et al., 2007). After cell injury, the levels of Ca2+ normally 
increase. This can be a rapid increase and may come from extracellular space, 
intracellular organelles that store Ca2+ or both of these (Thastrup et al., 1990). 
Experiments with PS-1 showed that the toxin induced Ca2+ influx from the extracellular 
environment triggering apoptosis. This influx was attributed to trimeric G-protein 
signalling, as suramin, which inhibits this pathway, suppressed both the Ca2+ influx and 
cytotoxicity in PS-1 treated HeLa cells (Katayama et al., 2007). In contrast to PS-1 and 
Cry1Ab, extracellular cations are not required for PS-3, as the toxin was still active in 
Ca2+ free medium or DPBS. Also, EGTA did not inhibit signal transduction pathways 
arising as a result of a post toxin-binding step. Instead it acted at an early stage by 
preventing a permanent toxin interaction with the membrane. However, based on 
experiment with chelators, the possibility of a signalling pathway playing a role in PS-3 
mode of action cannot be excluded.  
Another idea for the role of cations came from Fortier et al. who highlighted 
the importance of divalent cations, ionic strength and pH in the Bt mechanism of 
action (Fortier et al., 2005). It has been postulated that binding and pore formation 
could be influenced by electrostatic interactions between the toxin molecules and the 
membrane. Experiments using membrane potential measurements and osmotic 
swelling assays with BBMV showed that at higher pH values, both ionic strength and 
divalent cations generate a screening of the negative charges at the toxin and 
membrane surfaces increasing their interaction (Fortier et al., 2005). Also, data from 
Kirouac et al. study support the role of metal ions in processes other than signalling 
pathways. The authors showed that EDTA inhibited pore formation by Cry1Aa, Cry1Ac, 
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and Cry1Ea in isolated insect BBMV and so in a system devoid of cellular content 
(Kirouac et al., 2006). 
The results of this study clearly indicate that PS-3 activity is abolished by means 
of chelating membrane bound metal ions. This could be explained by changes in 
conformation or functionality of a membrane receptor(s) as was proposed before to 
explain the EDTA effect on Cry1 toxins (Kirouac et al., 2006). Large conformational 
transition - from a rod-like to globular shape - in cadherin structure occurs upon the 
addition of EDTA (Pokutta et al., 1994). It has been further shown by Candas et al. that 
Ca2+ removal from the medium mediates cleavage of the ectodomain of cadherin BT-
R1 – a target receptor for Cry1A toxin - leading to its destabilisation and proteolytic 
cleavage (Candas et al., 2002). A model is suggested that metal cations facilitate PS-3 
toxicity by promoting receptor’s structure and/or functionality as shown in Figure 109. 
 
Figure 109 A proposed model for the role of divalent cations in PS-3 mode of action. 
PS-3 remained toxic to HepG2 cells in DPBS, implying that extracellular metal cations are not required for toxin’s 
activity. Also, experimental results excluded possible indirect effects of EGTA that could explain chelator’s 
protective action. A model is proposed where metal cations (M
2+
) facilitate PS-3 toxicity by either promoting 
receptor’s functionality, appropriate conformation or its stability.  
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Ca2+, Zn2+ and Mn2+ out of the metal ions tested most prominently restored or 
even enhanced PS-3 toxicity. Interestingly Zn2+ dependent metalloproteases 
(aminopeptidase N APN), Zn2+ binding proteins (alkaline phosphatase ALP) and Ca2+ 
stabilised proteins (cadherin-like proteins) have previously been identified as 
functional Cry toxin receptors in insects (Pigott and Ellar, 2007). The possibility that 
metal cations facilitate PS-3 toxicity in a cooperative fashion cannot be excluded. It 
may be that PS-3 requires two or more toxin receptors, each coordinating different 
metal. This would explain why non-specific chelators like EGTA protected cells better 
than e.g. DTPA. This is not a new idea; in a sequential binding model (mentioned in 
section 1.4) both APN and cadherin receptors have been proposed to be required for 
Cry1Ab toxicity towards M. sexta (Pacheco et al., 2009). Another possibility is that 
identified metals: Ca2+, Zn2+ and Mn2+ show some functional redundancy. Proteins 
often adopt flexible metal binding sites, allowing non-specific interactions with many 
divalent metal cations depending on their bioavailability. However the results of salt 
supplementation experiments do not seem to follow the Irving-Williams rule: Mg2+ and 
Ca2+ < Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+, with Mg2+ and Ca2+ being the weakest 
binding metals and Cu2+ and Zn2+ the strongest (Irving and Williams, 1953).  
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6. Cellular response to PS-3 
6.1 Introduction 
Investigating the mode of action of any toxin should not be limited to the analysis of its 
mechanistic behaviour but should also evaluate cellular response to this insult. 
Ultimately, both of these contribute to the final outcome, being either cell recovery or 
cell death. In this chapter five aspects of cellular response to PS-3 were examined and 
discussed:  
- analysis of caspase 3/7 activation, 
- analysis of ROS formation, 
- analysis of damage permanency, 
- analysis of p38 and ERK 1/2 activation, 
- analysis of PKA activation. 
In general, damaged cells undergo either apoptosis or necrosis. Apoptotic cell death is 
mediated by an intracellular program, with caspases being the main regulators. 
Morphologically apoptosis results in cell shrinkage, membrane blebbing, chromatin 
condensation and formation of apoptotic bodies. Numerous stimuli can trigger 
apoptosis, like intracellular signals when cells are stressed (intrinsic pathway) or 
extracellular ligands binding to the death receptors present in the cell membrane 
(extrinsic pathway). Intrinsic pathway leads to increased mitochondrial membrane 
permeability and extrinsic pathway results in formation of the death inducing signaling 
complex (DISC). In both pathways, regardless of the initial mechanisms, apoptosis is 
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driven by caspase activation. Initiator caspases (2, 8, 9, and 10) activate effector 
caspases (3, 6, and 7) which execute apoptosis by cleaving cellular proteins following 
aspartate amino acid residues (Li and Yuan, 2008). Common caspase targets include 
cytoskeletal proteins, nuclear lamins, DNases and caspases themselves. As mentioned 
in section 1.5, some PFTs are capable of inducing apoptotic pathway, like S. aureus α-
toxin, listeriolysin O, and aerolysin (Guzmán et al., 1996, Imre et al., 2012, Jonas et al., 
1994, Nelson et al., 1999). Cells may udergo apoptosis after exposure to low doses of 
toxin, even when high concentrations prompt necrosis. Activation of apoptosis was 
observed in HepG2 cells treated with PS-2 (from the A1547 strain), but only when a 
sub-lethal toxin dose was used (Ito et al., 2004). Interestingly PS-2 like protein from 
4R2 strain (showing 100% sequence similarity to PS-2 from A1547 strain) induced 
apoptosis at a lethal dose in HepG2 and in various other cell lines (Brasseur et al., 
2015b). Another parasporin - PS-1 - triggered apoptosis in HeLa cells mediated by the 
influx of calcium ions (Katayama et al., 2007). Apoptotic signalling was examined in PS-
3 treated HepG2 cells by looking at caspase 3/7 activation. 
Although, necrotic cell death is often considered accidental and uncontrolled 
(e.g. when caused by gross cell injury, like damage to the plasma membrane), there is 
more data emerging that necrosis can also be facilitated by regulated events, which is 
called programmed necrosis or necroptosis. Programmed necrosis is characterised by 
cell swelling, increase in intracellular Ca2+, rapid ATP depletion, increase in ROS levels, 
inflammatory response and can be induced by a number of extracellular stimuli. The 
key signaling mediators include: receptor interacting protein (RIP) kinases, poly (ADP-
ribose) polymerase-1 (PARP1), calpains and NADPH oxidases. Necrotic stimuli lead to 
RIP kinase activation facilitating excessive ROS production (Baines, 2010). High levels of 
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ROS - which can be NADPH oxidase derived or from a mitochondrial source - leads to 
irreversible damage to the intracellular molecules and cell death. An example of 
programmed necrosis in the context of exposure to PFTs comes from Kennedy et al. 
Clostridium septicum α-toxin induced a multifaceted necrotic cell death in murine 
myoblast cells, involving Ca2+ influx, calpain activation, disruption of mitochondrial 
activity, increased ROS levels, and a drastic drop of ATP levels (Kennedy et al., 2009). 
Some bacterial toxins specifically target mitochondria after entering into the host cells. 
They are predicted to form pores in mitochondrial membranes, ultimately affecting 
ROS levels and cell fate (Jiang et al., 2012). However, under physiological conditions, 
low levels of ROS activate various signaling pathways promoting cell growth and 
survival, such as tyrosine kinase, MAP kinase, NF-κB, Ras proteins, and hypoxia 
inducible factor α (Azad et al., 2009). Production of ROS has also been shown to exert 
antibacterial action (Fang, 2011). Interestingly, a number of pathogens have been 
demonstrated to inhibit ROS production by altering the activity of the NOX2 NADPH 
oxidase in order to increase survival in host cells. For example, listeriolysin O 
prevented NOX2 localization to the phagosomes in primary macrophages, decreasing 
as a consequence ROS production (Lam et al., 2011). Contribution of ROS formation to 
PS-3 cytotoxicity was evaluated by the analysis of H2O2 levels in toxin treated cells. 
Cellular recovery after exposure to PFTs is dependent on many factors, among 
others: cell type, abundance and nature of toxin receptors, toxin concentration, and 
finally the toxin’s mode of action and how it interacts with the membrane. For 
example, if a created pore is stable, cell recovery from such injury will be more 
challenging than if the pore is unstable. It has been demonstrated that heptamerized 
aerolysin is extremely stable (Lesieur et al., 1999) resulting in a slow 8 hour recovery of 
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membrane integrity, whereas SDS sensitive listeriolysin O oligomers generate lesions 
which can be restored within 1 hour (Gonzalez et al., 2011b). Cellular recovery after 
transient exposure to PS-3 was analysed looking at membrane integrity and cell 
viability in HepG2 cells. 
PFTs can lead to the activation of various signalling pathways (section 1.5). p38 
MAP kinase pathway has been well documented to be a conserved cellular response to 
different PFTs, like β-barrel and α-PFTs. A number of PFTs were shown to activate 
phosphorylation of p38 (listed in section 1.5), including Cry toxins. p38 pathway was 
activated in C. elegans treated with Cry5B toxin (Huffman et al., 2004) and M. sexta 
and A. aegypti treated with Cry1Ab and Cry11Aa respectively (Cancino-Rodezno et al., 
2010). In addition to p38 pathway, it was shown that some PFTs like proaerolysin and 
listeriolysin O (Gonzalez et al., 2011b), Mycobacterium tuberculosis secretory protein 
ESAT-6 (Ganguly et al., 2007) and Parasporin-2 Aa1 (Brasseur et al., 2015a) also 
triggered activation of ERK pathway. This chapter covers the assessment of PS-3 
induced activation of p38 and ERK 1/2. 
The role of the PKA pathway in the Bt mode of action (section 1.4), although it 
does not have many supporters, and its work was strongly confronted (Kirouac et al., 
2006), continues to be cited and has become one of the models for Bt Cry toxin action. 
Mainly for this reason, stimulation of this pathway was analysed in PS-3 treated cells, 
which is also presented in this chapter. 
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6.2 Analysis of caspase 3/7 activation 
To find out if PS-3 induces the apoptotic signalling pathway in HepG2 cells, caspase 3/7 
levels were measured 2, 4, 6 and 8 hours after treatment with a lethal toxin dose by 
measuring the luminescent signal produced by caspase cleavage of the substrate 
(Figure 110). Etoposide was used as a positive control, as this drug induces apoptosis in 
HepG2 cells by inhibiting DNA synthesis (Hande, 1998).   
 
Figure 110 Assessment of caspase 3/7 activation and viability levels in PS-3 treated cells over 8 hours. 
HepG2 cells were seeded at the density of 5.5 x 10
4
 cells/ml in a black 96-well plate. The next day cells were treated 
with non-purified, dialysed toxins: protoxin (100 μg/ml), trypsin treated PS-3 (100 μg/ml), proteinase K treated PS-3 
(50 μg/ml), etoposide (100 μg/ml) or buffer. Caspase and viability levels were measured at different time points 
over a period of 8 hours using the ApoTox-Glo Triplex Assay.  
 
Caspase 3/7 levels were not elevated in PS-3 treated cells over the period of 8 hours. 
Etoposide induced caspase 3/7 activation over time. 
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To examine the effects of purified toxins and sub-lethal PS-3 concentrations on 
caspase 3/7 activation, HepG2 cells were treated with various toxin dilutions, followed 
by viability and caspase assessment in a multiplexed experiment (Figure 111).   
 
Figure 111 Assessment of caspase 3/7 activation and viability levels in PS-3 treated cells over 24 hours.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a black 96-well plate. The next day cells were treated 
with trypsin activated purified toxins: PS-3 (1, 2, 4, or 12 µg/ml), Cry1Ca (12 µg/ml), etoposide (100 μg/ml) or buffer. 
Caspase 3/7 levels were measured at different time points over a period of 24 hours using Caspase-Glo 3/7 assay. 
This was multiplexed with viability assessment using CellTiter-Blue assay as described in the methods section. 
 
Low doses of PS-3, as well as Cry1Ca, did not result in elevation of caspase 3/7 levels in 
susceptible cells within 24 hours. The overall results indicate that PS-3 does not induce 
apoptosis at either lethal or sub-lethal doses. 
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6.3 Estimation of ROS levels 
Hydrogen peroxide (H2O2) is a widely used indicator to measure ROS levels. Produced 
from another reactive species – the superoxide anion (O2
-) - it is a convenient marker 
due to its stability and a high diffusion rate across plasma membrane (Lee et al., 2004). 
Some culture media may contain H2O2 - called abiotic ROS - that arises from 
spontaneous oxidation of medium components, (which can be eliminated by cells’ 
intracellular catalase activity during culture). On the other hand pyruvic acid eliminates 
H2O2 abiotically, reacting directly with hydrogen peroxide and reducing any 
background signal. Due to the fact that the ROS-Glo H2O2 assay detects H2O2 regardless 
of its source, assessment of ROS levels in PS-3 treated cells was conducted in medium 
without (Figure 112) and with (Figure 113) sodium pyruvate supplementation. 
Menadione, a drug that causes oxidative stress was used as a positive control.   
 
Figure 112 Estimation of H2O2 levels in PS-3 treated HepG2 cells in the absence of sodium pyruvate.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate in DMEM without phenol red 
and without sodium pyruvate. The next day cells were dosed with H2O2 substrate and incubated with PS-3 (10 or 5 
µg/ml), menadione (50 µM), Cry1Ca (10 µg/ml), digitonin (13 µg/ml) or buffer for indicated amount of time. 
Luminescent signal was measured using ROS-Glo H2O2 Assay.  
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PS-3 at a concentration of 5 or 10 µg/ml did not induce oxidative stress in HepG2 cells 
within 5 hours. In the absence of sodium pyruvate abiotic ROS production was very 
high in all no cell controls (data not shown) with values similar to that obtained for 
cells treated with menadione for 2 hours.  
 
Figure 113 Estimation of H2O2 levels in PS-3 treated HepG2 cells in the presence of sodium pyruvate.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate in complete DMEM (with 
sodium pyruvate). The next day cells were dosed with H2O2 substrate and incubated with PS-3 (10 µg/ml), 
menadione (50 µM), Cry1Ca (10 µg/ml), digitonin (13 µg/ml) or buffer for indicated amount of time. Luminescent 
signal was measured using ROS-Glo H2O2 Assay.  
 
In the presence of sodium pyruvate abiotic ROS production was low and close to the 
levels observed in the presence of buffer treated cells (data not shown). Results in the 
presence of the cells were similar to the ones obtained in the first experiment; ROS 
formation in toxin treated cells was still minimal. 
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6.4 Evaluation of cellular recovery after transient 
exposure to PS-3 
It was assessed whether membrane damage and decrease in viability after brief toxin 
treatment was transient or permanent. This could shed some light on pore stability 
and cells' ability to recover from the damage. HepG2 cells were pulse treated with PS-
3, washed and cultured in a toxin free medium. Another group of cells were incubated 
continuously with the toxin. Membrane damage was detected using a cytotoxic assay 
measuring membrane permeability to a big protease marker. Viability and membrane 
permeability readings were taken at different time points (Figure 114). 
 
Figure 114 HepG2 cell viability and cytotoxicity after transient or continuous exposure to PS-3.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96 well-plate. The next day cells were treated 
with PS-3 (2, 6, 12 μg/ml), Cry1Ca (12 μg/ml) or buffer for 20 minutes, washed twice with DPBS and cultured in a 
toxin free medium (pulse treatment) or continuously in the presence of toxin for 24 hours (continuous treatment). 
Viability was measured using CellTiter-Blue. The reagent was added to all cells at the same time and kept for the 
final two hours of incubation, before the reading. Viability data were DMEM subtracted and plotted as a percentage 
of the buffer treated cells at appropriate time point. Membrane damage was assessed using CytoTox-Glo assay. 
Cytotoxicity data were buffer signal subtracted and plotted as a percentage of the digitonin treated cells (43.7 
μg/ml) at appropriate time point.  
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Viability levels were reduced in cells treated with high doses of PS-3, but there was no 
significant difference between pulse and continuous treatments except 4 hour time 
point at 12 µg/ml toxin dose. The cytotoxic assay results showed dose-dependent 
changes in membrane permeability. In cells treated with high doses of PS-3 (6 and 12 
μg/ml) values increased in the first four hours. After that they slightly declined, 
regardless of the toxin exposure type. Comparing pulse with continuous exposure, cells 
treated with PS-3 continuously showed somewhat greater membrane damage (up to 
20% difference). However, this occurred due to the relatively high cytotoxic signal in 
cells treated transiently with buffer and a low signal in cells treated continuously with 
buffer, that were subtracted from appropriate data, leading to these differences. Cell 
washing step (present in the pulse but not continuous treatment) most likely 
contributed to damage in pulse treated cells. This difference in cytotoxicity seems to 
result from experimental procedure rather than the toxin’s activity. Overall, these 
results suggest that little cellular recovery occurred after transient exposure to toxin.  
6.5 Activation of ERK 1/2 and p38 MAP kinase pathways  
To analyse the involvement of the p38 MAPK pathway, HepG2 cell extracts after 
treatment with PS-3 were examined by western blotting with antibodies specific for 
the dually phosphorylated and non-phosphorylated forms of p38 (Figure 115). Cells 
were lysed in non-ionic NP-40 buffer and NP-40 containing SDS (0.5%). As mentioned 
in section 1.5, following p38 activation, it is translocated to the nucleus. Therefore, to 
make sure all phosphorylated p38 is available for detection, SDS was included to break 
open nuclei. Sodium arsenite, a potent p38 inducer, was used as a positive control.  
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Figure 115 Analysis of p38 activation in PS-3 treated HepG2 cells extracted in NP-40 buffer with or without SDS.  
HepG2 cells were treated with buffer, PS-3 (2 µg/ml), or sodium arsenite (0.5 mM) for 30 minutes. Then cells were 
lysed in NP-40 buffer with or without 0.5% SDS. 15 µg of protein from each sample were loaded in each lane and 
analysed by western blot for the presence of total (t p38) or phosphorylated (p p38) p38. 
 
p38 phosphorylation was elevated in cells treated with an EC50 PS-3 dose (2 µg/ml), as 
well as in the positive control. Cell lysis in the presence of SDS did not yield more p p38 
signal compared to cells lysed in NP-40 only. For this reason and because >0.1% SDS 
interferes with the Bio-Rad Protein Assay used for protein concentration 
measurement, further experiments involved cell lysis in just NP-40. Next, 
phosphorylation of p38 was assessed in cells treated with higher PS-3 concentrations 
(Figure 116).  
 
Figure 116 Analysis of p38 activation in HepG2 cells treated with various PS-3 doses.  
HepG2 cells were treated with buffer, sodium arsenite (0.5 mM), PS-3 (1, 2, 4, 6, 12 μg/ml), or Cry1Ca (2, 12 μg/ml) 
for 15 minutes. Then cells were lysed in NP-40 buffer. 15 µg of protein from each sample were loaded in each lane 
and analysed by western blot for the presence of total or phosphorylated p38. 
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Low doses of PS-3 (1-4 μg/ml) caused p38 phosphorylation in a dose-dependent 
manner. The signal in cells treated with higher doses of PS-3 (4-12 μg/ml) reached a 
plateau. Conversely, neither low nor high doses of activated Cry1Ca produced a signal.  
To characterize the temporality of PS-3 induced p38 phosphorylation, a time 
course from 1-15 min was investigated (Figure 117). 
 
Figure 117 A time course of p38 phosphorylation in PS-3 treated HepG2 cells. 
HepG2 cells were treated with PS-3 (12 μg/ml) for different amounts of time before they were lysed in NP-40 
buffer. 13 µg of protein from each sample were loaded in each lane and analysed by western blot for the presence 
of total or phosphorylated p38. 
 
p38 phosphorylation reached its maximum level at 10 minutes after toxin treatment. 
Assessment of exposures longer than 15 min was not possible with high PS-3 doses 
due to the cells’ swelling and fragility (cell content was lost due to cells breaking open 
during washes). 
SB202190 is a highly selective inhibitor of p38 MAP kinase, with a speciﬁcity 
similar to that of the widely used SB203580 (Davies et al., 2000). It selectively inhibits 
the α and β isoforms by binding within the ATP pocket of the active kinase and was 
successfully used before to inhibit p38 activity in HepG2 cells (Wu et al., 2006). Cell 
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viability was determined after treatment with SB202190 alone or in combination with 
different doses of PS-3 or sodium arsenite as shown (Figure 118).  
 
Figure 118 The effect of p38 inhibitor on HepG2 cell survival after treatment with PS-3.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were incubated with SB202190 
inhibitor (25 µM) or dH2O (mock) for 30 minutes before treatment with either PS-3 (1, 2, 4, 6, 12 µg/ml), sodium 
arsenite (50 µM) or buffer. Cell viability was measured 24 hours after toxin treatment using CellTiter-Blue. A paired 
t-test (2 - tailed) indicated a statistically significant difference (p <  0.05) between mean viability of mock and 
inhibitor treated cells for each treatment with PS-3.  
  
SB202190 moderately reduced the viability of cells treated with low or high doses of 
toxin after 24 hours compared to cells treated with toxin only (the inhibitor showed 
only slight effect after 4 hour incubation with the toxin, data not shown). SB202190 
showed more acute effect on arsenic toxicity. These data suggest that activation of 
p38 may be part of cellular protective responses to the toxin but it cannot efficiently 
lead to cell recovery.   
It was hypothesized that the activation of p38 MAP kinase pathway after toxin 
exposure would vary in different cell lines that possess different degree of 
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susceptibility to PS-3. To test that, p38 phosphorylation was analysed in PS-3 treated 
HeLa (Figure 119) and HL-60 (Figure 120) cells. 
 
Figure 119 Assessment of p38 activation in PS-3 treated HeLa cells. 
HeLa cells were treated with PS-3 (12 μg/ml), buffer, sodium arsenite (0.5 mM), or Cry1Ca (12 μg/ml) for 30 
minutes. Next, cells were lysed in NP-40 buffer. 17 µg of protein from each sample were loaded in each lane and 
analysed by western blot for the presence of total or phosphorylated p38. 
 
Results showed high levels of activated p38 in HeLa cells regardless of toxin exposure. 
The experiment was repeated with the same outcome (data not shown). 
 
Figure 120 Assessment of p38 activation in PS-3 treated HL-60 cells. 
HL-60 cells were treated with trypsin activated PS-3 (12 μg/ml), buffer, sodium arsenite (0.5 mM), or Cry1Ca (12 
μg/ml) for 30 minutes. Next, cells were lysed in NP-40 buffer. 5 µg of protein from each sample were loaded in each 
lane and analysed by western blot for the presence of total or phosphorylated p38. 
 
PS-3 strongly activated p38 in HL-60 cells.  The experiment was repeated producing the 
same results (data not shown).  
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High levels of phosphorylated p38 in HeLa cells seem endogenous and did not 
differ between treatments. Activation of p38 in HL-60 was substantial in PS-3 treated 
cells and insignificant in the negative controls. Even though HL-60 cells showed little 
susceptibility to trypsin activated PS-3 (section 4.10), they were profoundly affected by 
PS-3 activated with proteinase K (Souissi et al. unpublished). Therefore, activation of 
p38 in HL-60 cells may be toxin specific.  
ERK activation was assessed after treatment with PS-3 by western blotting with 
antibodies detecting individually-, dually- or non-phosphorylated forms of ERK 1 and 
ERK 2 (Figure 121). 
 
Figure 121 Analysis of ERK 1/2 phosphorylation in HepG2 cells exposed to PS-3. 
HepG2 cells were treated with PS-3 (12 μg/ml), buffer, sodium arsenite (0.5 mM), or Cry1Ca (12 μg/ml) for 15 
minutes. Next, cells were lysed in NP-40. 10 µg of protein from each sample were loaded in each lane and analysed 
by western blot for the presence of total (t ERK) or phosphorylated (p ERK) ERK 1/2. 
 
Signal of ERK 1/2 activation in PS-3 treated cells was slightly elevated compared to cells 
treated with buffer or Cry1Ca. The experiment was repeated and included more PS-3 
concentrations (Figure 122). Loaded samples came from the same source as samples 
loaded in the experiment presented in Figure 116. 
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Figure 122 Analysis of ERK 1/2 activation in HepG2 cells treated with various PS-3 concentrations.  
HepG2 cells were treated with buffer, sodium arsenite (0.5 mM), PS-3 (1, 2, 4, 6, 12 μg/ml) or Cry1Ca (2, 12 μg/ml) 
for 15 minutes. Then cells were lysed in NP-40 buffer. 15 µg of protein from each sample were loaded in each lane 
and analysed by western blot for the presence of total or phosphorylated ERK 1/2. 
 
Results confirmed that 15 minute cell exposure to PS-3 induced only slight activation of 
ERK 1/2. Similarly to p38, a time course or ERK 1/2 activation was analysed from 1-15 
minutes (Figure 123). Loaded samples came from the same source as samples loaded 
in the experiment presented in Figure 117. 
 
Figure 123 A time course of ERK1/2 phosphorylation in HepG2 cells treated with PS-3.  
HepG2 cells were treated with PS-3 (12 μg/ml) for different amounts of time before they were lysed in NP-40 
buffer. 13 µg of protein from each sample were loaded in each lane and analysed by western blot for the presence 
of total or phosphorylated ERK 1/2.  
 
Similarly to p38, ERK 1/2 phosphorylation reached its maximum level at 10 minutes 
after exposure. Activation of ERK1/2 pathway by PS-3 was evident, however without 
testing specific inhibitors little can be concluded about its role in cellular protection.   
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6.6 Analysis of PKA activation 
The effect of PKA inhibitors was tested on PS-3 activity in a viability assay (Figure 124).  
 
Figure 124 The effect of PKA inhibitors on PS-3 toxicity. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in Advanced DMEM. The next day cells were pre-treated 
with H-89 (10 or 50 µM) or PKi (10 or 50 µM) for 30 minutes. Next, PS-3 was added (12 µg/ml) and viability was 
measured 6 hours later using CellTiter-Blue. 
 
Neither H-89 nor PKi prevented toxin activity. Cell viability was still reduced and 
neither inhibitor rescued cells from PS-3 induced swelling. At 50 µM H-89 significantly 
decreased HepG2 viability in control cells.  
To validate these results, another approach was adopted. After activation, 
catalytic PKA domains diffuse from cytoplasm into the nucleus where they 
phosphorylate many nuclear factors, CREB being the major one (Lodish, 2008). PKA 
activity in PS-3 treated cells was therefore investigated by western blot analysis of 
CREB phosphorylation (p CREB). 8-bromo-cAMP (8-br-cAMP), a cAMP analogue and 
activator of PKA, was used as a positive control and functionality of previously used 
PKA inhibitors was also assessed (Figure 125). 
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Figure 125 Analysis of CREB activation in PS-3 treated cells and analysis of PKA inhibition efficiency.  
HepG2 cells were seeded in complete DMEM. 24 hours before the experiment medium was changed to Advanced 
DMEM. Cells were treated with either PKi (50 µM), H-89 (100 µM) or water for 30 minutes. Next, 8-br-cAMP (0.5 
mM) was added and cells were incubated for another 30 minutes, before cell lysis in NP-40. Another set of cells 
were treated with either PS-3 (15 µg/ml), Cry1Ca (20 µg/ml) or buffer for 15 minutes, before cell lysis in NP-40. 20 
µg of protein from each sample were loaded in each lane and analysed by western blot for the presence of 
phosphorylated CREB (p CREB) or CD59 (loading control). 
 
Control cells showed high endogenous levels of p CREB. There was no significant 
increase in CREB phosphorylation in cells exposed to PS-3. 8-br-cAMP slightly elevated 
p CREB levels, which was evidently inhibited by H-89 but not PKi. To confirm this result 
experiment was repeated using SDS containing RIPA buffer for harsher cell lysis, 
nuclear membrane disruption as well as increased dose of 8-br-cAMP (Figure 126).  
 
Figure 126 Analysis of CREB activation in PS-3 treated cells and analysis of PKA inhibition in RIPA lysed cells.  
HepG2 cells were seeded in complete DMEM. 24 hours before experiment medium was changed to Advanced 
DMEM. Cells were treated with either PKi (50 µM), H-89 (50 or 100 µM) or water for 30 minutes. Next, 8-br-cAMP 
(1 mM) was added and cells were incubated for another 30 minutes, before cell lysis in RIPA. Another set of cells 
were treated with either PS-3 (15 µg/ml), Cry1Ca (15 µg/ml) or buffer for 15 minutes, before cell lysis in RIPA. 10 µg 
of protein from each sample were loaded in each lane and analysed by western blot for the presence of p CREB and 
CD59. 
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In general, p CREB signal was stronger when cells were lysed in RIPA (despite lower 
protein amount loaded per lane), which additionally lysed nuclear proteins. However, 
results showed similar information: p CREB was equally present in cells exposed to PS-
3 or buffer only, and H-89 - but not PKi - inhibited CREB activation. 
6.7 Discussion 
Several methods have been developed to detect apoptosis. Activation of caspase 3/7 is 
widely accepted as a reliable apoptotic indicator since this protease is an important 
effector caspase associated with the initiation of apoptosis. PS-3 did not induce 
caspase 3/7 activation. Even 24 hour exposure to a low toxin dose did not elevate their 
levels. These results indicate that the PS-3 mediated cell death is primarily non-
apoptotic.  
Analysis of ROS results points to a suggestion that formation of reactive oxygen 
species is not part of PS-3 induced cytotoxicity, viewed whether as a marker of 
programmed necrosis or one of cellular protective responses. However, ROS-
independent programmed necrosis cannot be excluded as some cells like 
macrophages, HT-29, and Jurkat cells undergo programmed necrosis independent of 
ROS formation (Moquin and Chan, 2010).  
Formation of oligomeric structures and pore forming activity have been 
demonstrated for some of Cry toxins, reviewed in Bravo et al. (Bravo et al., 2007), but 
stability of created pores was often not assessed in a biological context. For example, 
experiments with ionic currents in artificial lipid bilayers revealed formation of stable 
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channels by oligomeric Cry1Ab (Rausell et al., 2004), but these experiments disregard 
cellular mechanisms leading to membrane resealing. Some of the pioneer research 
work on innate immunity against Cry toxin was done by the Aroian group. Among 
other cellular responses, rapid and efficient membrane resealing was demonstrated in 
vivo in C. elegans after Cry5B exposure via endocytic and exocytic vesicle trafficking 
pathways (Los et al., 2011).  
In an attempt to understand the stability of lesions created by PS-3, viability 
and membrane damage were estimated after transient and continuous treatment with 
PS-3. Viability results were quite erratic over time regardless of the treatment, similar 
to the 24 hour viability time-course experiment (Figure 40), indicating that this type of 
assay may be unsuitable for over time cell viability monitoring. The decline in cytotoxic 
signal after 4 hours in cells treated with high PS-3 concentrations was most likely due 
to the decreased activity of the protease marker released from dead cells. According to 
the manufacturer its half-life is estimated to be around 10 hours (Niles et al., 2007). In 
this situation, where cell death occurred rapidly and the incubation time was greater 
than 10 hours, the degree of cytotoxicity at 12 hours was probably underestimated. As 
mentioned earlier, the differences in the degree of membrane damage in pulse and 
continuous treatments resulted most likely from experimental procedure and should 
not be attributed to the toxin’s action. After the initial 4 hours the cytotoxic curves 
representing pulse and continuous treatments were quite similar with no significantly 
descending trend, suggesting that little recovery of damaged membrane occurred over 
time in pulse or continuous treated cells. It has been suggested that when cells are 
exposed to a high dose of PFT, they die quickly as a result of rapid and irreversible 
membrane damage; and when the dose is sub-lethal, or exposure brief, cells have the 
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ability to respond to the insult and produce signals promoting protection mechanisms, 
like restoring membrane integrity (Gonzalez et al., 2011b). HepG2 cells had no ability 
to repair the membrane within 12 hours even though toxin exposure lasted only 20 
minutes, which indicates permanent membrane damage and implies formation of 
stable pores. This is consistent with experimental results presented in Figure 42, Figure 
43 and Figure 93, where transient exposure to PS-3 resulted in low cell viability. Also, 
formation of stable pores was demonstrated for PS-3 in PLB experiments, and 
inhibition of p38 activity, discussed later, was almost indifferent to cell fate. However, 
alternative methods are needed to assess cellular recovery as cell assays used here 
seem unsuitable. For example, continuous real-time monitoring of viability and 
cytotoxicity using non-toxic reagents would solve the problem of erratic data and time 
constraints due to short half-life of the marker enzyme. 
It is thought that PFTs induce the p38 MAPK pathway via osmotic stress 
following pore formation (Porta et al., 2011, Ratner et al., 2006); however, other 
studies had demonstrated that the p38 activation was not caused directly by osmotic 
stress but by ionic imbalance, specifically loss of intracellular potassium (Gonzalez et 
al., 2011b, Kloft et al., 2009). Despite these differences, the authors of these studies 
agree that membrane damage is a prerequisite for p38 phosphorylation, as defective 
in pore formation mutants did not cause activation of p38 (Kloft et al., 2009, Ratner et 
al., 2006), which was mentioned in section 5.3. In HepG2 cells p38 was phosphorylated 
after exposure to lethal or sub-lethal toxin doses and the maximum signal was reached 
at 10 minutes post-treatment. HepG2 cells did not show any swelling or other 
morphological changes after 10 minute incubation with the toxin (even at the time of 
cell lysis at 15 minutes), indicating that swelling was not the direct cause of p38 
237 
 
activation. Rather, it may depend on the degree of cell susceptibility and membrane 
damage as PS-3 induced p38 activation in HepG2 and HL-60, but not so in HeLa cells. 
This is consistent with the viability results of HL-60 being partially affected and HeLa 
not being affected by 12 µg/ml PS-3 treatment (Figure 81 and Figure 79 respectively).  
Published data suggest a differential role of p38 after attack by PFTs. Neural 
cells exposed to pneumolysin underwent p38 dependent apoptosis (Stringaris et al., 
2002). Inhibition of p38 had a detrimental effect on the ATP recovery in keratinocyte 
cells treated with Staphylococcal α toxin, but had no effect when cells were treated 
with streptolysin O (Husmann et al., 2006). Finally, p38 MAP kinase pathway was 
shown play a pivotal role in C. elegans defence against Cry5B. Two downstream 
transcriptional targets were identified, one of them interestingly being a homolog of a 
human cation efflux transporter (Huffman et al., 2004). Additionally, experiments using 
p38 inhibitor caused hypersensitivity to aerolysin in hamster kidney cells (Huffman et 
al., 2004). The authors speculate that despite a conserved mechanism of p38 
activation, cells have evolved to cope with membrane damage using different 
strategies; depending on pore size and/or its stability. For example, cells would initiate 
exo- and endo-cytosis based repair to deal with large channels but may rely on various 
signalling pathways, p38 being one of them, in response to small pores (Aroian and van 
der Goot, 2007, Husmann et al., 2006).  
p38 MAP kinase pathway, although activated in PS-3 treated cells, does not 
seem to be greatly beneficial as SB202190 only moderately reduced cell viability even 
in cells exposed to sub-lethal toxin doses. Presumably the inhibitor suppressed, to 
some degree, cellular recovery making cells less able to withstand the injury but 
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further studies involving the identification of downstream p38 MAPK targets are a 
prerequisite for better understanding. SB202190 showed a more profound effect on 
arsenite toxicity. Sodium arsenite was demonstrated to induce p38 dependent 
apoptosis in neural cells (Namgung and Xia, 2000). However the mechanism of action 
in HepG2 seems to be different as the inhibitor did not rescue cell viability. This is in 
agreement with a previous study by Qi et al. who showed that SB202190 also 
enhanced cytotoxicity of arsenic species in HepG2 (Qi et al., 2012). Unfortunately, the 
inhibitor’s functionality was not assessed in a western blot as SB202190 prevents p38 
activity but not its activation. Antibodies against downstream p38 targets should be 
used to achieve that.   
Depending on cell type and stimulus ERK 1/2 MAP kinase pathway has been 
shown to control cell survival by regulating the activity of pro- and anti - apoptotic 
transcription factors (Cagnol and Chambard, 2010, Lu and Xu, 2006). PS-2 Aa1 
activated both apoptosis and ERK 1/2 phosphorylation in PC-3 cells (prostate cancer 
cell line) and role of this MAPK pathway in apoptosis was postulated. However, a 
specific ERK 1/2 inhibitor did not protect the cells from toxin induced apoptosis 
(Brasseur et al., 2015a). Another role for the ERK pathway after PFT injury was 
suggested by Gonzalez et al. They suggested that both p38 and ERK pathways play a 
role in the recovery of ion homeostasis as inhibition of either of these significantly 
diminished restoration of intracellular K+ in intestinal human cell line after listeriolysin 
O or aerolysin exposure (Gonzalez et al., 2011b). PS-3 induced ERK 1/2 activation was 
slight but clearly evident at 10 minutes after treatment. Yet, without examining 
signalling events linked to the activation of this pathway and experiments with ERK 
inhibitors, little can be concluded about its role in the cellular response to PS-3.  
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To test whether PKA has a specific role in PS-3 toxicity, the effect of PKA 
specific (PKi) and non-specific (H-89) inhibitors was assessed on the toxin’s action. 
Neither H-89 nor PKi prevented PS-3 activity. Additionally, phosphorylation of CREB - 
one of PKA targets - was analysed. CREB has been shown to be activated by various 
kinases, like: PKA, PKC, CaM KI, CaM K II, CaM KIV and others (Bito et al., 1996). PKi 
specifically inhibits PKA, whereas H-89 inhibits PKA and other kinases like PKC, Casein 
Kinase I, MLCK, CaM KII, Rho Kinase II (Lochner and Moolman, 2006). Western blot 
results clearly indicate that endogenous levels of p CREB arise in HepG2 cells due to 
kinase activity that is inhibited by H-89, but other than PKA, as H-89 but not PKi 
inhibited the signal. These and cell viability results signify that neither PKA nor any 
other kinase mentioned earlier and inhibited by H-89 play a role in the PS-3 mode of 
action. 
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7. In search for the receptor 
7.1 Introduction 
Detailed information about Cry toxin receptors was given in section 1.6. This chapter 
presents experiments based on different strategies used to identify PS-3 receptor; they 
are graphically presented in Figure 127.  
 
Figure 127 Different strategies used in an attempt to identify PS-3 receptor. 
Strategies for the PS-3 receptor identification involved three main types of assays: pull down with directly and 
indirectly (via HA tag) immobilized toxin, ligand and western blots with labelled and non-labelled PS-3 and viability 
cell assays where cells were depleted of a certain membrane component. 
 
Ligand blotting constituted a big portion of experiments aimed at receptor recognition. 
This method has been successfully used before for the detection of Cry toxin receptors 
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as well as to study interactions between receptors and Cry toxins (Budatha et al., 2007, 
Contreras et al., 2013, Hayakawa et al., 2004, Krishnan et al., 2010, Shitomi et al., 
2006). In principle, membrane proteins are separated using SDS-PAGE. The gel is then 
blotted onto a nitrocellulose membrane. This is followed by membrane incubation 
with the toxin, which is often labelled. Providing that the toxin binds to the receptor, 
the complex can be then detected by antibody against the toxin or the tag attached to 
it. PS-3 was labelled with different labels: FITC, biotin, HA tag. Additionally genetic 
engineering was done on the HA-labelled PS-3 to improve its function as a probe. Two 
buffers used for cell lysis included harsh denaturing ionic RIPA and mild non-ionic NP-
40. In later experiments N-octyl glucoside (NOG), a non-ionic detergent frequently 
used for the solubilisation of membrane proteins, was used. 
Pull down is another technique for the identification of protein-protein 
interactions. The advantage of this approach is that both toxin and cellular proteins are 
in their native state (providing that non-denaturing lysis buffer like NP-40 or NOG was 
used for cell lysis). In pull down experiments PS-3 was either directly immobilised to 
the beads via sulfhydryl groups or indirectly via the HA tag. Beads were then exposed 
to the HepG2 cell extract, washed, spun and different fractions were analysed on a gel. 
The nature of the receptor was investigated by manipulating the membrane of 
susceptible cells and observing how it affected PS-3 activity. Lipid rafts are detergent 
resistant domains of the plasma membrane that contain high levels of cholesterol, 
sphingolipids and glycosylphosphatidylinositol (GPI-) anchored proteins, which are 
involved in signal transduction and protein sorting (Simons and Toomre, 2000). Lipid 
rafts are the targets for many bacterial PFTs, including insecticidal Cry toxins (Diep et 
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al., 1998, Giddings et al., 2004, Gordon et al., 1999, Zhuang et al., 2002) and some 
parasporins (Abe et al., 2008). Consequently, cholesterol and GPI-anchored proteins 
are plausible candidates for PS-3 receptors. Especially that they have been identified as 
receptors for PFTs before (Diep et al., 1998, Gordon et al., 1999, Heuck et al., 2010). 
The effect of depletion of these two biological molecules was tested on PS-3 toxicity. 
To study the role of GPI-anchored proteins in cytotoxicity, phosphatidylinositol-specific 
phospholipase C (PI-PLC) was used to enzymatically remove GPI-anchored proteins 
from the cell membrane. In order to reduce membrane cholesterol, cells were pre-
treated with methyl-β-cyclodextrin - MβCD, which increases the solubility of 
membrane lipids. Also, blocking of N-cadherin was attempted with the antibodies 
against that protein. 
7.2 Different anti-Cry antibodies 
Initial attempts to detect PS-3 in western blot experiments involved the use of 
antibodies against other Cry toxins (Figure 128). The probability of PS-3 being 
recognised by any of them was high as antibodies were polyclonal and had been raised 
against three-domain class of Cry toxins. 
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Figure 128 Detection of purified and non-purified PS-3 using antibodies against other three domain Cry toxins. 
Toxin samples were run on 7.5% SDS-PAGE gels: non-purified (580 µg/ml) or ÄKTA purified trypsin activated PS-3 
(50 µg/ml), Cry1Ca (266 µg/ml), Cry1Ac (220 µg/ml). After transfer membranes were cut and incubated overnight 
with appropriate primary antibody diluted 1:2000 v/v. The next day the membranes were incubated with secondary 
antibody and detected with ECL.  
 
Most antibodies were able to detect the non-purified form of PS-3, except the 
antibody raised against Cry3Aa (data not shown). None of the antibodies bound to 
purified PS-3, which may indicate that antibodies were binding to some impurity in the 
non-purified form of the toxin and that there is no specific binding to the toxin itself, 
especially that these antibodies were raised against not highly purified proteins that 
had been cut out of SDS gel. Bands detected in PS-3 and Cry1Ca lanes exposed to anti-
Cry1Ca or anti-Cry4Aa antibodies were almost identical. Explanation may come from 
the fact that both recombinant Cry1Ca and PS-3 were produced in the same Bt strain. 
Due to the fact that only one of two PS-3 bands was detected and only in non-purified 
form, the above mentioned antibodies were not used in further experiments.  
244 
 
7.3 Anti-PS-3 antibody and its purification 
Preparation of immunogen 
Trypsin activated PS-3 with ricin domain deleted (ricin ∆ PS-3) was purified by size 
exclusion chromatography and concentrated to be used as immunogen (Figure 129). 
Ricin ∆ PS-3 was chosen - and not PS-3 - to obtain one band after protease cleavage. 
More importantly, presence of the ricin B lectin domain was found in many other 
carbohydrate binding proteins (Hazes, 1996), and so antibodies raised against the non-
truncated PS-3 could bind directly to the cell extract increasing non-specific 
background. 
 
Figure 129 Purification of ricin ∆ PS-3. 
Trypsin activated ricin ∆ PS-3 was purified and concentrated into four stock samples. Protein concentration was 
measured and samples were run on a 7.5% SDS-PAGE gel: 0.7, 0.4, 0.3 and 0.4 mg/ml. 1 and 0.5 mg/ml BSA samples 
are included for intensity comparison. 
 
Purified samples were sent to Dundee Cell Products for delivering rabbit polyclonal 
affinity purified antibodies against ricin ∆ PS-3.     
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Western and ligand blots using anti-PS-3 antibody  
Affinity purified anti-PS-3 antibody was obtained at a concentration of 5 mg/ml. Its 
cross-reactivity with cell extract proteins was analysed in a western blot (Figure 130).  
 
Figure 130 Western blot analysis of the cross-reactivity of anti-PS-3 antibody with cellular proteins. 
HepG2 cells were treated with either non-purified trypsin activated PS-3 (81.7 μg) or buffer for 20 minutes before 
being lysed with NP-40. Samples were run on 7.5% SDS-PAGE gels followed by western blot with anti-PS-3 antibody 
(PS-3 IgG). Purified trypsin activated PS-3 was included as a control. 11 μg of protein per well were loaded in lanes 
with cell extracts; 0.3 μg of purified toxin. Membrane on the left was incubated with anti-PS-3 antibody (0.7 μg/ml) 
overnight at 4°C, whereas membrane on the right for 1.5 hours at RT. 
 
Both upper and lower toxin bands of trypsin activated PS-3 were detected by the 
antibody. No additional bands were spotted in the lanes with cell extract treated 
previously with toxin compared to cells treated with buffer. Finally, there was a high 
non-specific binding in the lanes with cell extract and various conditions were 
investigated to decrease it: 
 Blocking solution: milk or BSA (various concentrations: 3-7%), 
 Blocking time (1 hour at RT – overnight at 4°C), 
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 Concentration of PS-3 in ligand blot experiments (2.4 – 12 µg/ml),  
 Incubation time with PS-3 (1 hour at RT – overnight at RT), 
 Concentration of anti-PS-3 antibody (0.5- 2.5 µg/ml), 
 Incubation time with anti-PS-3 antibody (1 hour at RT– overnight at 4°C), 
 Concentration of secondary antibody (0.25 – 0.5 µg/ml),  
 Washing buffer: PBST or TBST (Tween-20: 0.02 - 0.1%). 
However despite changing the above, the non-specific background signal remained 
visible. Cross-reactivity was independent of the lysis buffer used (RIPA, NP-40 or NOG) 
and was also high for HeLa cell extracts (data not shown).  
To ensure total protein analysis, debris pellets formed after centrifugation of 
the lysates were resolved on a gel alongside soluble protein fractions in a ligand blot 
experiment with PS-3 and anti-PS-3 antibody (Figure 131).   
 
Figure 131 Ligand blot analysis of pellet and soluble HepG2 protein fractions with PS-3 and anti-PS-3 antibody.  
HepG2 cells were lysed with RIPA. Soluble fractions (SN) and pellets after lysis were run on a 7.5% SDS-PAGE gel. 11 
μg of protein per well were loaded in lanes with cell extracts. After transfer membrane was cut and pieces were 
incubated with 12, 2.4 or 0 µg of purified PS-3 in PBS followed by incubation with anti-PS-3 antibody (1 μg/ml) and 
ECL detection. 
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Proteins present in the pellet, similarly to soluble fractions, did not specifically 
associate with the toxin. Cross-reactivity with anti-PS-3 antibody was high. Increasing 
the amount of PS-3 during membrane-toxin incubation step increased membrane 
darkening without exposing new bands. 
Purification of anti-PS-3 antibody using HA-PS-3 
To reduce cross-reactivity, additional purification of anti-PS-3 antibody was attempted 
using HA-protoxin and anti-HA resin (Figure 132). HA-protoxin was used instead of 
activated PS-3 due to instability of the tag after processing, explained in section 7.5. 
 
Figure 132 Purification of anti-PS-3 antibody using HA-PS-3 and anti-HA resin. 
Pull down assay was performed using anti-HA resin. 50 µl of pelleted washed resin was incubated with purified HA-
tagged protoxin (73 µg). Samples were incubated for 1 hour at RT rotating. Next, 150 µl of anti-PS-3 antibody was 
added and mixture was incubated for another hour at RT rotating. Antibody-HA-PS-3 complex was eluted with 
glycine and samples were run on a 7.5% SDS-PAGE gel: SN – supernatant collected after incubation with antibody, 
samples of three washes before and after elution; HA-protoxin and anti-PS-3 antibody (IgG) were run for 
comparison. 
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A portion of anti-PS-3 antibody was successfully eluted with the HA tagged protoxin. 
Purified antibody was then used in a western blot experiment (Figure 133). Even 
though the eluted antibody was complexed with HA-protoxin, the experiment was 
performed mainly to assess whether or not purification would solve the high cross-
reactivity problem.   
 
Figure 133 Western blot analysis of cross-reactivity of resin purified anti-PS-3 antibody. 
NOG lysed HepG2 and HeLa cells were run on a 7.5% SDS-PAGE gel. 25 and 31 μg of protein per well were loaded in 
lanes with HepG2 and HeLa cell extracts respectively. After transfer membrane was cut and incubated with non-
purified (1 µg/ml), resin purified (2 µg/ml) anti-PS-3 antibody (IgG) or PBS only. Membranes were incubated with 
secondary antibody and ECL detection reagent. 
 
Purification of anti-PS-3 antibody lessened to a certain degree the cross-reactivity 
problems, but not sufficiently enough.  
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7.4 Biotin labelled PS-3 
Characterisation of biotin-PS-3 
Biotinylation is the process of covalently attaching biotin (244.3 Da) to a protein of 
interest, which then can be detected with a labelled avidin or streptavidin. Trypsin 
treated PS-3 was biotinylated as described in the method section. Western blot was 
performed to confirm biotin attachment (Figure 134).  
 
Figure 134 Western blot analysis of the efficiency of PS-3 biotinylation.  
Non-purified, dialysed, trypsin activated PS-3 was biotinylated according to manufacturer’s instruction. Biotinylated 
toxin fractions were run on a 7.5% SDS-PAGE gel: 0.7 µg and 1.6 µg of protein were loaded in respective lanes. 
Proteins were detected with streptavidin conjugated to HRP and ECL detection.  
 
Western blot confirmed successful toxin labelling. Next, labelled PS-3 was purified and 
its toxicity assessed on HepG2 cells (Figure 135). 
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Figure 135 Analysis of the effect of biotinylated PS-3 on HepG2 cell viability.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. Next day cells were treated with non-purified PS-3 
before biotinylation (32 μg/ml), or after biotin attachment (28 μg/ml), purified biotinylated toxin (3.4 μg/ml), or 
purified PS-3 (2.5 µg). Cell viability was measured 24 hours later using CellTiter-Blue. 
 
Biotinylation hardly affected PS-3 toxicity e.g. by sterically blocking binding.  
Ligand blots using biotin-PS-3 
Next, biotin-PS-3 was used in ligand blot experiments (Figure 136). 
 
Figure 136 Ligand blot analysis of HepG2 cell extracts using biotinylated PS-3 as a probe.  
HepG2 cells lysed with NP-40 or RIPA were resolved on a 7.5% SDS-PAGE gel. 15 µg or proteins were loaded in each 
lane. After transfer membrane was incubated with biotinylated, purified PS-3 (0.5 μg in PBS-T) and detected by 
streptavidin-HRP and ECL detection.  
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Two bands were detected in each lane, with 66 and 126 kDa calculated band sizes. To 
test if the signal was due to non-specific binding the experiment was repeated with 
appropriate controls (Figure 137).  
 
Figure 137 Ligand blot analysis of HepG2 and HeLa cell extracts using biotinylated PS-3 or buffer as a probe.  
HepG2 and HeLa cell extracts lysed with NP-40 or RIPA (20 µg of protein loaded per lane) and biotinylated purified 
toxin (34 µg/ml) were resolved by 12% SDS-PAGE gels. After transfer and blocking membrane was cut. One piece 
was incubated with biotinylated purified PS-3 (0.5 μg in PBS-T) and the second one in with buffer only (PBS-T). This 
was followed by incubation with streptavidin-HRP and ECL detection.  
 
The same two bands were detected whether or not the membrane was probed with 
biotinylated PS-3, indicating that streptavidin bound non-specifically to some proteins 
both in HeLa and HepG2 cell extracts. No other bands, unless masked by the present 
bands, were visible on the membrane exposed to the toxin probe that could 
potentially point to a specific interaction. Western blot was repeated with proteins 
resolved on a 7.5% SDS-PAGE gel. The same non-specific bands were obtained (data 
not shown).  For this reason, further experiments did not involve biotinylated toxin and 
alternative ways of PS-3 tagging were sought.  
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7.5 HA tagged PS-3 
HA (human influenza hemagglutinin) is a surface glycoprotein of the human virus 
involved in infectivity. The HA tag has been developed from its epitope (amino acids 
98-106) and since then it has been widely used as a general tag in expression vectors 
(Wilson et al., 1984). 
HA tag (amino acid sequence: YPYDVPDYA) was chosen for PS-3 labelling as it 
does not contain Arg or Lys residues, that could otherwise be cleaved off during trypsin 
activation. Its localisation was designed to be within the core protein sequence that 
would not undergo enzymatic processing, but at the same time exposed and easily 
accessible for detection by antibodies. For these reasons HA tag was integrated into 
the cry41Aa gene after the DNA sequence coding for the domain III in ORF2 but before 
the ricin domain. By specifically designed PCR primers, HA tag was attached and ricin 
domain deleted at the same time (Etherington et al., unpublished). A sequence 
alignment of PS-3, HA tagged PS-3 and ricin ∆ PS-3 was performed using Clustal Omega 
software (Sievers et al., 2011), which is presented in Figure 138. 
 
Figure 138 Clustal Omega sequence alignment of PS-3, HA-PS-3 and ricin ∆ PS-3.  
The following C-terminal sequences were aligned in Clustal Omega: PS-3 full length (FL), ricin ∆ PS-3 (DelR) and HA 
tagged ricin ∆ PS-3 (DelR-HA). Ricin domain is highlighted in green, HA tag in yellow.  
 
DelR-HA      GGPIWIDKIEFIPLSPIPELPVYPGTYQIVTALNNSSVVTSEEFCMGIGLTTYPYDVPDYA 
FL           GGPIWIDKIEFIPLSPIPELPVYPGTYQIVTALNNSSVVTSEEFCMGIGLTTRCGVNLWSN 
DelR         GGPIWIDKIEFIPLSPIPELPVYPGTYQIVTALNNSSVVTSEEFCMGIGLTTRS------ 
             ****************************************************         
 
DelR-HA      ----------------------------------------------------------- 
FL           NGNTLQKWRFVYNGDQNAFQIKSTPNEDLVLSGSNSGTSVTAETNQNRPNQYWLIEEAGN 
DelR         ------------------------------------------------------------ 
                                                                          
 
DelR-HA      -------------------------------------------- 
FL           GYVYLRSKGNPNLVLDVAGTSTANGTNIILWNYNGSTNQKFKLS 
DelR         -------------------------------------------- 
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Characterisation of HA-PS-3 
Western blot was performed to detect the presence of the HA tag attached to PS-3 
using anti-HA antibody (Figure 139).  
 
Figure 139 Western blot analysis of the HA tag attachment to PS-3.  
HepG2 and HeLa cells were lysed with either RIPA or NP-40. Cell extracts and purified trypsin treated HA-PS-3 were 
resolved on a 7.5% SDS-PAGE gel. 8 µg of protein were loaded in lanes with cell extract and 1.28 µg of protein in the 
toxin lane. Membrane was incubated with anti-HA antibody and appropriate HRP-conjugated antibody followed by 
ECL detection.  
 
HA tagged toxin was successfully detected as a single band of around 60 kDa (due to 
lack of the ricin domain). Although anti-HA antibody showed high non-specific signal in 
the lanes with cell extracts, background noise was significantly improved by using 5% 
skimmed milk in PBS-T at blocking and antibody incubation steps (data not shown).  
Next, the toxicity of purified HA-PS-3 was assessed on HepG2 cells. Results 
presented in Figure 140 showed that HA-tagging slightly affected PS-3 toxicity. 
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Figure 140 Analysis of the effect of HA tagged PS-3 on HepG2 cell viability.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with trypsin activated 
HA-PS-3 before (53 μg/ml), or after (12.8 μg/ml) purification. Non-purified (33 µg/ml) and purified PS-3 (12 μg/ml) 
were tested for comparison.  
Western and ligand blots using HA-PS-3 
Figure 141 and Figure 142 show results of ligand blot experiments with HA-PS-3, where 
HepG2 protein samples were resolved using SDS-PAGE or a native gel respectively.  
 
Figure 141 Ligand blot analysis of HepG2 cell extracts run on an SDS-PAGE gel using HA-PS-3 as a probe.  
HepG2 cells were lysed with either NP-40 or RIPA. Samples were run on a 12% SDS-PAGE gel. After transfer 
membrane was cut and incubated with either HA-PS-3 in PBS-T (5.3 μg/ml) or PBS-T. In lanes with cell extract: 7.5 
µg of protein were loaded and in the toxin lane: 2.6 µg of trypsin activated HA-PS-3. Both membranes were then 
incubated with HRP conjugated anti-HA antibody followed by the ECL detection. 
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Figure 142 Ligand blot analysis of HepG2 cell extracts run on a native PAGE gel using HA-PS-3 as a probe.  
HepG2 cells were lysed with either NP-40 or RIPA. Samples were run on a native 7.5% PAGE gel. 11 µg of protein 
were loaded in each lane. After transfer and blocking the membrane was cut into two pieces, one incubated with 
HA-PS-3 in PBS-T (2.5 µg/ml), second with PBS-T. Both membranes were then incubated with HRP conjugated anti-
HA antibody followed by the ECL detection. 
 
No bands were detected that would suggest any kind of interaction with the labelled 
toxin. The same results were obtained when different percentage gel or higher HA-PS-
3 concentration was used (data not shown). Exposing membrane to a very high toxin 
dose resulted in excessively dark background, even when film exposure was shortened 
to a minimum (data not shown). Diluting HA-PS-3 in other buffers like: PBS without 
Tween-20, 5% milk in PBS-T, 3% BSA in PBS-T, or a binding buffer (0.01% BSA, 0.1% 
Tween-20 in PBS) successfully used for Cry1Ab in toxin-receptor binding assays 
(Pacheco et al., 2009), did not improve the results (data not shown). The same was 
true about shortening or lengthening incubation time that membrane was in contact 
with HA-PS-3 (data not shown).   
The next set of western blot experiments involved HepG2 cells that had been 
exposed to HA-PS-3 for 20 minutes before being lysed. Since the interaction between 
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the cells and the toxin most definitely had occurred and because of denaturing 
conditions of SDS-PAGE, a band of molecular weight close to HA-PS-3 or higher (toxin 
oligomers) was expected in lanes with toxin treated-cell extracts as a result of toxin 
dissociation from the receptor (Figure 143). The same cell extract samples were also 
tested in a native PAGE western blot experiment (Figure 144). 
 
Figure 143 Western blot analysis of extracts from HepG2 cells treated with or without HA-PS-3.  
HepG2 cells were treated with either purified HA-PS-3 (10 μg/ml) or buffer for 20 minutes before being lysed with 
either NP-40 or RIPA. Samples were run on a 7.5% SDS-PAGE gel. After transfer the membrane was incubated with 
anti-HA antibody. Non-purified and purified HA-PS-3 was included as a control. 15 μg of protein per well were 
loaded in lanes with cell extracts; 1.2 μg of purified and 5.3 μg of non-purified trypsin activated toxin.  
 
If the toxin did not form stable oligomers after 20 minutes of treatment, the band 
around 60 kDa representing the monomer units should be expected as boiling and SDS 
treatment should detach the toxin from the receptor and produce a signal. If the toxin 
produced SDS-resistant oligomers within this time, these should be represented as 
high molecular weight bands, similarly to experiments done with Parasporin-2 (Abe et 
al., 2008). However, there was no difference between extracts from cells previously 
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treated with or without HA-PS-3. It could be that the toxin concentration in protein 
samples was too small for detection. Non-specific signal was observed around 60 kDa 
in all lanes containing cell extract. The lack of signal in lane with purified HA-PS-3 was 
probably due to its low concentration or - discussed later – HA tag cleavage.  
 
Figure 144 A native PAGE western blot analysis of extracts from HepG2 cells treated with or without HA-PS-3.  
HepG2 cells were treated with either purified HA-PS-3 (10 μg/ml) or buffer for 20 minutes before being lysed with 
either NP-40 or RIPA. Samples were run on a 7.5% native PAGE gel. After transfer the membrane was incubated 
with anti-HA antibody. Non-purified and purified HA-PS-3 was included as a control. 15 μg of protein per well were 
loaded in lanes with cell extracts; 1.2 μg of purified toxin and 5.3 μg of non-purified trypsin activated toxin.  
 
HepG2 cells exposed to either buffer or HA-PS-3 before lysis showed the same non-
specific signal on the native gel. HA-PS-3 could not be detected in lanes with the cell 
extract using native conditions, probably due to small amounts or tag cleavage.  
Experiments with Parasporin-2 showed that oligomerization is time and 
temperature dependent, occurring efficiently at 37°C but not at 4°C. As the signal for 
the monomeric PS-2 decreased with time, the oligomeric band appeared stronger, 
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starting from 30 minutes after cell exposure to toxin (Abe et al., 2008). Oligomerization 
may also increase the chemiluminescent signal as the stability of oligomeric toxin 
complexes in the membrane is thought to be greatly enhanced compared with 
monomeric protein binding, as was demonstrated clearly for aerolysin (Lesieur et al., 
1999). Since 20 minute treatment with HA-PS-3 may not have been enough to 
promote oligomerization, cells were pulse treated with HA-PS-3 for 20 minutes, 
washed and then incubated for another 40 minutes at 37°C, followed by protein 
extraction. In addition, to ensure saturation at binding sites on the cell surface, cells 
were exposed to increased toxin dose (60 μg/ml). Since Cry1Ab oligomers were 
temperature sensitive at 100° C (Gómez et al., 2014), boiled and non-boiled samples 
were compared using the western blot technique (Figure 145). 
 
Figure 145 Western blot of heat-denatured and non-denatured extracts from cells exposed to high HA-PS-3 dose. 
HepG2 cells were treated with non-purified, concentrated trypsin activated HA-PS-3 (60 μg/ml) or with buffer for 20 
minutes before being washed 3 times with PBS. DMEM collected after 20 minutes containing unbound toxin 
(unbound) and PBS collected after the first cell wash (wash) were also run. Then fresh cell medium was added and 
cells were incubated at 37°C for additional 40 minutes. After that time most of the medium was gently removed and 
cells were lysed with NP-40. Samples were run on a 12% SDS-PAGE gel followed by membrane incubation with anti-
HA antibody. Samples were boiled (B) or not boiled (NB) with sample loading buffer prior to loading. HA-PS-3 
diluted in NP-40 was included as a control. 9 μg of protein per well were loaded in lanes with cell extracts and 4.8 μg 
of HA-PS-3 in toxin lanes.  
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The expected 60 kDa toxin band in the lane with denatured cells pre-exposed to HA-
PS-3 was absent. The 50 kDa band strongly present in non-boiled samples most likely 
represents non-specific binding since it originated from the culture medium (present in 
unbound fraction), not the cells. Signal in the toxin control lane was low. Similar bands 
were obtained when experiment was repeated with toxin and buffer treated cells 
lysed in RIPA (data not shown). 
The low signal observed for HA-PS-3 indicated that HA tag may have been lost 
during proteolysis. To test that, the HA-protoxin was digested with different proteases. 
Digested toxins were analysed by western blotting using anti-HA antibody (Figure 146) 
and additionally visualized on an SDS-PAGE gel (Figure 147). 
 
Figure 146 Western blot assessment of proteolytic cleavage of the HA tagged protoxin. 
HA tagged protoxin was digested with different proteases: trypsin (0.5 or 1 mg/ml), chymotrypsin (0.5 or 1 mg/ml), 
proteinase K (0.005 or 0.01 mg/ml) or pepsin (1 mg/ml). Samples were run on a 7.5% SDS-PAGE gel (as shown in 
Figure 147) and western blotted using anti-HA antibody. 
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Figure 147 SDS-PAGE analysis of proteolytic cleavage of the HA tagged protoxin. 
HA tagged protoxin was digested with different proteases: trypsin (0.5 or 1 mg/ml), chymotrypsin (0.5 or 1 mg/ml), 
proteinase K (0.005 or 0.01 mg/ml) or pepsin (1 mg/ml). Samples were run on a 7.5% SDS-PAGE gel. 
 
Regardless of the protease used, signal of activated HA-protoxin was weak compared 
to the protein yield observed by SDS-PAGE, indicating loss of the tag. Since activated 
HA-PS-3 was immunodetected before (Figure 139, Figure 142), various HA-PS-3 
samples were tested in a dot blot experiment to investigate this issue (Figure 148).   
 
Figure 148 Dot blot analysis of HA tag cleavage in activated HA-PS-3 samples. 
Denatured and non-denatured samples of HA-PS-3 trypsinized previously (old) and on the same day (fresh) were 
spotted on a nitrocellulose membrane (5 µg of protein spotted). HA tagged protoxin and activated Cry1Ca were 
spotted for comparison. This was followed by membrane incubation with anti HA antibody and ECL detection. 
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The dot blot and previous results suggest that proteolytic cleavage and the length of 
sample storage increase instability of the tag. For this reason HA tagged protoxin was 
used in subsequent experiments.  
To increase the efficiency of membrane protein extraction, NOG buffer was 
used for cell lysis. It is a non-denaturing, mild detergent frequently used for the 
solubilisation and isolation of membrane proteins. Figure 149 shows a ligand blot 
experiment with HepG2 cells lysed with NOG and HA-protoxin used as a probe at 
membrane incubation step (to ensure the presence of the tag). 
 
Figure 149 Ligand blot analysis of HepG2 and HeLa cell extracts using HA-protoxin as a probe. 
HepG2 and HeLa cells were lysed in NOG buffer. Cell extracts were run on 12% SDS-PAGE gels (32 µg of protein 
were loaded in HepG2 lanes and 31 µg in HeLa lanes). Non-purified and purified HA-protoxin (2.9 and 0.5 μg of 
protein respectively) was run as a control. After transfer membrane was blocked and cut vertically. One piece was 
incubated with HA-protoxin in PBS (17 µg/ml) and the second one with trypsin activated PS-3 in PBS (18 µg/ml) for 1 
hour at RT. Membranes were washed, incubated with anti HA antibody and signal was detected with ECL. 
 
Interestingly, prominent high MW bands were observed in HepG2 and HeLa lanes 
incubated with HA-protoxin. Purified HA-PS-3 protoxin resulted in a strong band as 
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expected. Experiment was repeated resulting in similar bands although less intensive 
(data not shown).   
To investigate the possibility of the HA tag being the binding component in the 
HA-PS-3 protein, the following experiment was performed. Cell extracts from three 
different cell lines were run on an SDS-PAGE gel. After blocking the membrane was cut 
into two, with one piece incubated with HA-protoxin and the other with HA peptide at 
the concentration matching that of a toxin (Figure 150).  
 
Figure 150 Ligand blot analysis of false positive bands using an HA peptide as a probe. 
HepG2, HL-60 and HeLa cells were lysed in NOG buffer. Cell extracts were run on a 10% SDS-PAGE gel (25.7 µg of 
protein were loaded in HepG2 lanes, 23.7 µg in HL-60 and 31 µg in HeLa lanes). After transfer membrane was 
blocked, washed and cut vertically. One piece was incubated with HA peptide in PBS (0.037 µM) and the second one 
with ÄKTA purified HA-protoxin in PBS (0.0375 µM - equivalent roughly to 3 µg/ml) for 1 hour at RT. Membranes 
were washed, incubated with anti HA antibody and detected with ECL. 
 
Similar bands present in both membranes indicate that the previously observed signal 
is due to the HA tag reactivity rather than specific toxin binding.   
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Pull downs using HA-PS-3 
The next method used to identify the receptor was a co-immunoprecipitation assay. 
HA tagged PS-3 (the bait protein) was captured by anti-HA antibody coupled to resin. 
This complex was then incubated with a cell lysate to identify binding partners. The 
proteins of interest were eluted from the beads with appropriate buffers and the 
samples were analysed using SDS-PAGE. Since the verification of proteolytic HA tag 
cleavage, HA tagged protoxin was used in the majority of pull down experiments. 
Initial experiments tested the binding efficiency of the resin (Figure 151).  
 
Figure 151 Analysis of elution efficiency in a pull down using HA-tagged protoxin. 
Pull down assay was performed using anti-HA resin. 50 µl of pelleted washed resin was incubated with HA-tagged 
protoxin (145 µg). Samples were incubated overnight at 4°C, eluted with glycine and run on a 7.5% SDS-PAGE gel: 
SN–supernatant collected after overnight incubation (for estimation of binding efficiency), samples of three washes 
before and after elution, HA-protoxin – toxin used in the experiment.  
 
Toxin band was successfully detected in the fractions eluted with glycine. The same 
result was achieved when HA-protoxin was eluted with 3 M NaSCN (data not shown). 
Pull down with trypsin activated HA tagged PS-3 did not produce the toxin band in the 
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elution fractions consistent with the tag being cleaved during proteolysis (data not 
shown). The amount of eluted toxin was very similar whether incubation was carried 
out at 4°C or at RT (data not shown).  
Next, presence of the HA tag in eluted samples was confirmed in a western blot 
experiment (Figure 152). 
 
Figure 152 Western blot analysis of the presence of the HA tag in eluted fractions. 
HA-tagged PS-3 crude (crude), HA-protoxin, supernatant collected after incubation with toxin (SN) and fractions 
eluted with either NaSCN (1) or glycine (1 and 2) were resolved on a 7.5% SDS-PAGE gel. Membrane was blocked 
and incubated with anti-HA HRP-conjugated antibody followed by ECL detection.  
 
Western blot confirmed the presence of the tag in eluted fractions. The subsequent 
experiments involved incubating resin first with HA-protoxin, and then with a cell 
lysate. Figure 153 presents experiment with RIPA lysed cell extract; Figure 154 NOG 
lysed cells. Analysis of false positive pulldown interactions involved: no toxin (Figure 
153) and no HA tag (Figure 154) controls. 
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Figure 153 SDS-PAGE analysis of a pull down experiment with HA-PS-3 protoxin and RIPA lysed cell extract. 
50 µl of pelleted washed anti-HA resin was incubated with HA-protoxin (87 µg). Samples were incubated for 1 hour 
at RT. After that RIPA lysed cell extract was added (164 µg) and mixture incubated for another hour rotating at RT. 
Resin was washed three times. Protein was eluted with glycine and samples run on a 7.5% SDS-PAGE gel: SN-
supernatant collected after incubation with cell extract, first wash before and three washes after elution, HA-
protoxin – toxin used in this experiment. Pull down was also performed in the absence of toxin (lanes on the right). 
 
 
Figure 154 SDS-PAGE analysis of a pull down experiment with HA-PS-3 protoxin and NOG lysed cell extract. 
50 µl of pelleted washed anti-HA resin was incubated with HA-protoxin (58 µg). Samples were incubated for 1 hour 
at RT. After that NOG lysed cell extract was added (322 µg) and mixture incubated for another hour rotating at RT. 
Resin was washed three times. Protein was eluted with glycine and samples run on a 7.5% SDS-PAGE gel: SN – 
supernatant collected after incubation with cell extract, first wash before and three washes after elution, HA-
protoxin – toxin used in this experiment. Pull down was also performed in the presence of non-labelled ricin ∆ PS-3. 
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Unfortunately no direct protein-protein interactions were demonstrated using the pull 
down method. No non-specific interactions occurred either. Pull down experiments 
with incubation at 4° C or using NP-40 lysed cells resulted in similar data. Running 
elution samples on a 12% SDS-PAGE gel resulted in very faint low MW bands, but these 
results were inconsistent (data not shown). 
7.6 HA tagged PS-3 (K688A) 
Previous results showed that HA tag was cleaved after protease treatment. It was 
suspected that trypsin cleaves PS-3 at the C-terminus not as previously thought at 
arginine (R) at position 713 but at lysine (K) at position 668 (Souissi et al., unpublished). 
For these reasons a mutagenesis experiment was designed to create a substitution at 
position 668 changing lysine into alanine (K668A) in HA tagged ricin ∆ PS-3 (PS-3-∆R-
HA). In this way the HA tag could be available for detection in western blotting or pull 
down assay after trypsin treatment. The PS-3-∆R-HA ORF2 protein sequence with the 
mutation site is presented below. 
 
MNQNCNNNGYEVLNSGKGYCQPRYPFAQAPGSELQNMGYKEWMNMCTSGDPTVLGEGYSADVRDAVI
TSINIASYLLSVPFPPAGVAAGILGALLGLLWPTNTQAVWEAFMNTVEALINQKLDEYARSKAISELNGLKNV
LELYQDAADDWNENPGDLRNKNRVLTEFRNVNGHFENSMPSFAVRNFEVNLLPVYAEAANLHLLLLRDAV
KFGEGWGMSTDPGAERDDMYRRLRSRTEIYTDHCVNTYNQGLQQAKSLQANVSDYSRYPWTQYNQSGG
FSYREAKGEYRGTENWNLYNAFRRDMTILVLDIIAQFPTYDPGLYSRPVKSELTREVYTDIRGTTWRSDANLN
TIDAIENRMVGSRQLQLFTWLTEMKFYIRNTGSITSYTHGDLMVGLEKKIRKTNDNDQWLPLEGQNTSYTRI
DRPGIELGKNYWYYARTQQWFETRLLQLWANTDVLSLNAGTVGNEFWVRDVPDYRNIYARSTRNHFIEN
HRLSWIKFEPVRDNCPFAWPGYKQLSALLFGWTHNSVDLNNIISQYRITQIPAVKAYWNRGAFSVIRGPGST
GGNLVQLGTGGEVSVKVRPEQTGSDWYRVRIRYAAGSRGRLNVKKYVSSIHASVTYDYNMTMSSSTQGTY
NSFQYLDVYNFRLAEPEFEVWLTNESGGPIWIDKIEFIPLSPIPELPVYPGTYQIVTALNNSSVVTSEEFCMGIG
LTTYPYDVPDYA 
 
Blue – conserved block number 5         Yellow – HA tag         Red – amino acid changed 
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DNA mutagenesis 
DNA from Bt pSVP2741Aa-∆R-HA strain was purified and PCR was set up overnight as 
described in the methods section. The PCR product was run on a gel (Figure 155). 
 
Figure 155 Site-directed mutagenesis of Cry41Aa-∆R-HA.  
DNA from Cry41Aa-∆R-HA strain was purified using QIAprep kit and PCR was set up overnight with primers to 
substitute lysine at position 668 into alanine. PCR product containing the substitution was run on 1% agarose gel 
next to a 1 kb ladder (M).  
 
PCR product was digested with DpnI to remove methylated template DNA. DNA after 
digestion was purified and run on a gel (Figure 156). 
 
Figure 156. PCR product after digestion with DpnI and purification.  
After mutagenesis PCR product was digested with DpnI and purified using QIAquick kit and run on 1% agarose gel 
next to a 1kb ladder (M). 
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After digestion with DpnI, purified DNA was ligated overnight. This DNA was used in a 
transformation into E. coli DH5α. Four colonies after transformation named: 1, 2, 3, 
and 4 were picked and grown. Plasmids were extracted by DNA purification and 
digested with HaeIII to confirm the right constructs. HaeIII digested DNAs were run on 
a gel (Figure 157).    
 
Figure 157 HaeIII DNA digest after transformation into E. coli DH5α.  
Purified DNAs after 1
st
 transformation into E. coli DH5α named 1, 2, 3, and 4 were digested with HaeIII and run on a 
1% agarose gel. 
 
Banding patterns of digested DNAs were compared to a predicted digest performed 
using NEBcutter (Figure 158). This provides information about the presence or absence 
of restriction sites at the expected position within the plasmid and initially confirms 
correct insert sequence.   
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Figure 158 Predicted DNA banding pattern of HaeIII digested mutated plasmid sequence.  
Virtual HaeIII digest was performed on the plasmid sequence: Cry41Aa ∆R-HA containing the K668A mutation using 
NEBcutter. 
 
Comparing banding patterns it is clear that sample 3 is missing 558 bp band and 
sample 4: 1895 and 879 bp bands. Therefore next steps were done with samples 1 and 
2. DNAs 1 and 2 were transformed into E.coli GM216 strain to produce non-
methylated DNA. After transformation, colonies were scraped from ampicillin plates, 
purified and digested with HaeIII. DNAs were run on a gel (Figure 159). 
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Figure 159 HaeIII digest of DNAs 1 and 2 obtained after transformation into E.coli GM2163. 
DNAs 1 and 2 after transformation into E.coli GM2163 were purified using QIAprep kit, digested with HaeIII and run 
on a 1% agarose gel. 
 
Banding pattern after HaeIII digest initially verified correct DNA. DNAs 1 and 2 were 
sequenced to confirm the mutations. Sequencing results were aligned with the non-
mutated template (Cry41Aa-∆R-HA) and presented in Figure 160 and Figure 161. 
 
Figure 160 Sequence alignment of non-mutated Cry41Aa-∆R-HA and DNA 1 after transformation into E.coli 
GM216. 
DNA 1, obtained after transformation into E.coli GM216, and Cry41Aa-∆R-HA (DelR-HA) non-mutated sequence 
were aligned in Clustal Omega. Mutation site is depicted in red and partial HA tag sequence in yellow. Figure shows 
C-terminal sequence fragments. 
 
1         TTTGAAGTATGGCTTACTAATGAAAGTGGCGGGCCTATTTGGATTGACGCAATTGAATTC 
DelR-HA   TTTGAAGTATGGCTTACTAATGAAAGTGGCGGGCCTATTTGGATTGACAAAATTGAATTC 
          ************************************************..********** 
 
1         ATTCCGCTAAGTCCGATTCCGGAACTACCAGTATATCCTGGTACCTATCAAATCGTGACA 
DelR-HA   ATTCCGCTAAGTCCGATTCCGGAACTACCAGTATATCCTGGTACCTATCAAATCGTGACA 
          ************************************************************ 
 
1         GCTTTAAATAATAGTAGTGTTGTAACTAGCGAGGAGTTTTGTATGGGTATTGGCTTAACC 
DelR-HA   GCTTTAAATAATAGTAGTGTTGTAACTAGCGAGGAGTTTTGTATGGGTATTGGCTTAACC 
          ************************************************************ 
 
1         ACTTATCCAACATGACAATGTCAAGTTCTACACA---GGGGACTTATAATTCGTTTCAGT 
DelR-HA   ACTTATCCATATGATGT--TCCAGATTATGCTTAAaggtgtgcaacta-tccctgactaa 
          *********:.: .: :    **..**.*.*: *   * * .*::.** * * * :*:.: 
 
271 
 
 
Figure 161 Sequence alignment of non-mutated Cry41Aa-∆R-HA and DNA 2 after transformation into E.coli 
GM216. 
DNA 2, obtained after transformation into E.coli GM216, and Cry41Aa-∆R-HA (DelR-HA) non-mutated sequence 
were aligned in Clustal Omega. Mutation site is depicted in red and full HA tag sequence in yellow. Figure shows C-
terminal sequence fragments. 
 
Both DNAs contained the desired mutation, but DNA 1 did not contain an intact HA tag 
sequence; therefore DNA 2 was used in the next step. DNA 2 was transformed into Bt 
4D7. After transformation cells were picked from two separate Bt colonies (labelled α 
and β) and DNA was purified. DNAs α and β were transformed back into E.coli DH5α. 
After transformation colonies were prepped, DNA extracted and sent for sequencing. 
Sequences α and β were compared with non-mutated Cry41Aa ∆R-HA (Figure 162 and 
Figure 163). Both constructs contained the mutation and the intact HA tag sequence.  
 
Figure 162 Sequence alignment of non-mutated Cry41Aa-∆R-HA and DNA α after transformation into E.coli DH5α.  
DNA α, obtained after transformation into E.coli DH5α (HAK_alpha), and Cry41Aa-∆R-HA (DelR-HA) non-mutated 
sequence were aligned in Clustal Omega. Mutation site is depicted in red and full HA tag sequence in yellow. The 
figure shows C-terminal sequence fragments. 
 
2         TTTGAAGTATGGCTTACTAATGAAAGTGGCGGGCCTATTTGGATTGACGCAATTGAATTC 
DelR-HA   TTTGAAGTATGGCTTACTAATGAAAGTGGCGGGCCTATTTGGATTGACAAAATTGAATTC 
          ************************************************..********** 
 
2         ATTCCGCTAAGTCCGATTCCGGAACTACCAGTATATCCTGGTACCTATCAAATCGTGACA 
DelR-HA   ATTCCGCTAAGTCCGATTCCGGAACTACCAGTATATCCTGGTACCTATCAAATCGTGACA 
          ************************************************************ 
 
2         GCTTTAAATAATAGTAGTGTTGTAACTAGCGAGGAGTTTTGTATGGGTATTGGCTTAACC 
DelR-HA   GCTTTAAATAATAGTAGTGTTGTAACTAGCGAGGAGTTTTGTATGGGTATTGGCTTAACC 
          ************************************************************ 
 
2         ACTTATCCATATGATGTTCCAGATTATGCTTAAAGGTGTGCAACTATCCCTGACTAACAT 
DelR-HA   ACTTATCCATATGATGTTCCAGATTATGCTTAAaggtgtgcaactatccctgactaacat 
          ************************************************************ 
 
 
DelR-HA        TGGCGGGCCTATTTGGATTGACAAAATTGAATTCATTCCGCTAAGTCCGATTCCGGAACT 
HAK_alpha      TGGCGGGCCTATTTGGATTGACGCAATTGAATTCATTCCGCTAAGTCCGATTCCGGAACT 
               **********************  ************************************ 
 
DelR-HA        ACCAGTATATCCTGGTACCTATCAAATCGTGACAGCTTTAAATAATAGTAGTGTTGTAAC 
HAK_alpha      ACCAGTATATCCTGGTACCTATCAAATCGTGACAGCTTTAAATAATAGTAGTGTTGTAAC 
               ************************************************************ 
 
DelR-HA        TAGCGAGGAGTTTTGTATGGGTATTGGCTTAACCACTTATCCATATGATGTTCCAGATTA 
HAK_alpha      TAGCGAGGAGTTTTGTATGGGTATTGGCTTAACCACTTATCCATATGATGTTCCAGATTA 
               ************************************************************ 
 
DelR-HA        TGCTTAAaggtgtgcaactatccctgactaacatatacattta 
HAK_alpha      TGCTTAAAGGTGTGCAACTATCCCTGACTAACATATACATTTA 
               ******************************************* 
 
272 
 
 
Figure 163 Sequence alignment of non-mutated Cry41Aa-∆R-HA and DNA β after transformation into E.coli DH5α.  
DNA β, obtained after transformation into E.coli DH5α (HAK_beta), and Cry41Aa-∆R-HA (DelR-HA) non-mutated 
sequence were aligned in Clustal Omega. Mutation site is depicted in red and full HA tag sequence in yellow. The 
figure shows C-terminal sequence fragments. 
Characterisation of HA-PS-3 (K668A) 
HA-PS-3 (K668A) α was grown and harvested. Protein sizes and levels were compared 
with the full length PS-3 before and after activation (Figure 164). 
 
Figure 164 SDS-PAGE analysis of HA-PS-3 (K688A) protein levels and sizes compared to PS-3. 
Equal amounts of crude PS-3 and mutant HA-PS-3 (K688A) were solubilised for 1 hour at 37°C in 50 mM sodium 
carbonate (pH 10.5) in the presence of 5 mM DTT and activated with trypsin (1 mg/ml) for 1 hour at 37°C. Samples 
at different stages of activation were run on a 7.5% SDS-PAGE gel.  
 
DelR-HA       GGCGGGCCTATTTGGATTGACAAAATTGAATTCATTCCGCTAAGTCCGATTCCGGAACTA 
HAK_beta      GGCGGGCCTATTTGGATTGACGCAATTGAATTCATTCCGCTAAGTCCGATTCCGGAACTA 
              *********************  ************************************* 
 
DelR-HA       CCAGTATATCCTGGTACCTATCAAATCGTGACAGCTTTAAATAATAGTAGTGTTGTAACT 
HAK_beta      CCAGTATATCCTGGTACCTATCAAATCGTGACAGCTTTAAATAATAGTAGTGTTGTAACT 
              ************************************************************ 
 
DelR-HA       AGCGAGGAGTTTTGTATGGGTATTGGCTTAACCACTTATCCATATGATGTTCCAGATTAT 
HAK_beta      AGCGAGGAGTTTTGTATGGGTATTGGCTTAACCACTTATCCATATGATGTTCCAGATTAT 
              ************************************************************ 
 
 
DelR-HA       GCTTAAaggtgtgcaactatccctgactaacatatacattta 
HAK_beta      GCTTAAAGGTGTGCAACTATCCCTGACTAACATATACATTTA 
              ******************************************      
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SDS-PAGE showed successful expression and confirmed predicted MW differences in 
size between the full length PS-3 and the mutant protein. Solubilised mutant migrated 
around 75 kDa and its trypsin activated form - around 60 kDa, similar to sizes observed 
before for HA tagged PS-3 (Figure 147 and Figure 141). Mutant protein was stable after 
trypsin proteolysis indicating that mutation had no major structural impact. 
 A dot blot was performed to confirm the presence of the tag in solubilised and 
trypsin activated HA-PS-3 (K688A) (Figure 165). 
 
Figure 165 Dot blot analysis of the presence of the HA tag in HA-PS-3 (K688A). 
HA-PS-3 (K688A) and PS-3 crude solutions were solubilised and digested with trypsin similar to samples presented in 
Figure 164. Samples at each stage were spotted on a nitrocellulose membrane, blotted with anti-HA antibody, 
followed by ECL detection. 
 
Signal from the HA tag was detected in all mutant samples.  
Next, toxicity of trypsin activated HA-PS-3 (K688A) was established. When 
tested at high concentration, the mutant retained cytotoxic activity (Figure 166). 
274 
 
 
Figure 166 Analysis of the effect of HA-PS-3 (K688A) on HepG2 cell viability.  
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with non-purified 
trypsin activated toxins: PS-3 (46 μg/ml), or HA-PS-3 (K688A) (46 μg/ml). Viability was measured 24 hours later using 
CellTiter-Blue.  
Ligand blot using HA-PS-3 (K688A) 
Trypsin activated HA-PS-3 (K688A) was used in a ligand blot experiment (Figure 167).  
 
Figure 167 Ligand blot analysis of HepG2 cell extracts using HA-PS-3 (K688A) as a probe.  
HepG2 cells were lysed with NOG. Samples were run next to the protein marker on a 12% SDS-PAGE gel (15.6 µg of 
protein were loaded). After transfer membrane was blocked, washed and cut vertically into four pieces. Membranes 
were incubated for 1 hour at RT with non-purified trypsin activated toxins in PBS: HA-PS-3 (K688A) (either 20 or 40 
µg/ml), PS-3 (18.4 μg/ml) or PBS only. Membranes were washed, incubated with anti-HA antibody and signal 
detected with ECL. 
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HA-PS-3 (K688A) used as a probe produced no detectable signal in this experiment. 
Pull down using HA-PS-3 (K688A) 
Pull down assays were performed using trypsin activated HA-PS-3 (K688A) in the 
presence or absence of NOG lysed HepG2 cells (Figure 168). 
 
Figure 168 SDS-PAGE analysis of a pull down experiment with activated HA-PS-3 (K688A) in the presence or 
absence of NOG lysed HepG2 cell extract. 
50 µl of pelleted washed anti-HA resin was incubated with trypsin activated HA-PS-3 (K688A) (52 µg) in a doublet. 
Samples were incubated for 1 hour at RT rotating. After that, to one of the tubes, NOG lysed cell extract was added 
(257 µg) and the mixture was incubated for another hour rotating at RT. Proteins were eluted with glycine and run 
on a 7.5% (pull down with HA-PS-3 K688A on the left) and a 12% (pull down with HA-PS-3 K688A and NOG cell 
extract on the right) SDS-PAGE gel: SN – supernatant collected after resin incubation with toxin (gel on the left) or 
cell extract (gel on the right), samples from washes before and after elution.  
 
The binding efficiency of trypsin activated HA-PS-3 (K688A) to anti-HA resin was poor 
compared with pull downs with HA-protoxin (Figure 151). No specific binding between 
the mutant toxin and the proteins present in the NOG cell extract was observed.  
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7.7 FITC labelled PS-3 
Characterisation of FITC-PS-3 
Trypsin activated PS-3 was labelled with FITC as described in the methods section. The 
labelling was confirmed by measuring fluorescence of labelled toxin and control 
samples at different stages of labelling (Figure 169). 
 
Figure 169 Analysis of FITC labelling efficiency. 
Trypsin activated, purified and concentrated PS-3 (1.15 mg/ml) and sodium carbonate (pH 8.5) were labelled with 
FITC as described in the methods section. Fluorescent properties of flow-through (1-5) and retenate samples were 
assessed by spotting 10 µl of each sample in a 96-well plate and measuring fluorescent signal 15 minutes later using 
blue optical filter Ex 490 nm/Em 510-570 nm (FITC Ex/Em wavelength: 494/518 nm). 
 
PS-3 retained fluorescent properties after labelling and excess dye removal.  
Labelled toxin was then used in a live cell imagining experiment. Cells were 
exposed briefly to FITC labelled PS-3 for 10 minutes, followed by two washes with 
DPBS. Fresh DMEM was added and cells were observed using FITC and bright-field 
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channels in a wide-field configuration using Zeiss Axiovert 200M microscope. However, 
despite observing clear cytotoxic effects, fluorescence was very week. Signal appeared 
more as faint spots rather than the cell outline and did not differ from non-labelled PS-
3 or no toxin controls (data not shown).  
Next, FITC-labelled toxin was used in a cell assay, where the cells were exposed 
continuously or briefly to dialysed samples: FITC-PS-3 or FITC-buffer (Figure 170).     
 
Figure 170 Analysis of fluorescent signal from cells treated transiently or continuously with FITC-PS-3. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml. The next day cells were treated with either dialysed 
FITC-PS-3 (115.2 µg/ml) or dialysed FITC-buffer (sodium carbonated pH 8.5). Toxin was applied either permanently 
(continuous), transiently (for 2, 10 or 20 minutes followed by cell wash and fresh medium addition) or continuously 
with medium transferred from the well treated transiently for 20 minutes (Medium transferred). Cells treated with 
FITC-buffer after transient and continuous (medium transferred) exposure are included as a control. Fluorescent 
signal was measured 1 hour after toxin addition using blue optical filter Ex 490 nm/Em 510-570 nm. 
 
Similarly to live imaging experiment, the cells treated transiently with FITC-PS-3 did not 
retain fluorescence although all of them showed extensive swelling. Cells treated 
continuously with FITC-PS-3 presented high fluorescence and showed extensive 
swelling. Interestingly, medium with FITC-PS-3 transferred after 20 minutes to a new 
0
20000
40000
60000
80000
100000
120000
2 min 10 min 20 min
Continuous Transient Medium
transferred
Transient Medium
transferred
FITC-PS-3 FITC-Buffer
R
FU
 
278 
 
set of cells contained very well conserved fluorescein, similarly to the results obtained 
in a viability assay where one toxin dose transferred nine times retained its full activity 
(Figure 43). FITC-labelled Cry1Ca or FITC alone (concentration matched to FITC bound 
to PS-3) did not induce swelling (data not shown).  
The ability of anti-FITC antibody for immunodetection of the labelled toxin was 
tested in a dot blot experiment (Figure 171).  
 
Figure 171 Dot blot analysis of FITC-PS-3 labelling. 
5 µl of trypsin activated PS-3 prior and post FITC labelling (5.7 μg of protein); PBS and FITC (appropriately diluted to 
match FITC concentration bound to PS-3) were spotted on a nitrocellulose membrane, blotted with anti-FITC 
antibody followed by ECL detection. 
 
FITC was successfully detected in FITC-PS-3. To sum up, despite successful toxin 
labelling, no significant binding to HepG2 cells was detected using cell culture assays.   
Ligand blot using FITC-PS-3 
Next, FITC-labelled toxin was used as a probe in a ligand blot experiment (Figure 172). 
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Figure 172 Ligand blot analysis of HepG2 cell extracts using FITC-PS-3 as a probe.  
Cells were lysed with NOG, RIPA or NP-40. Samples were run on a 12% SDS-PAGE gel (20 µg of protein were loaded). 
After transfer membrane was blocked, washed and cut. One piece was incubated with FITC-PS-3 (17.2 µg/ml) and 
the other one with PBS. Membranes were washed, incubated with anti-FITC antibody and detected with ECL. 
 
FITC-PS-3 did not associate with any of the proteins. 
7.8  PS-3 immobilization via sulfhydryl groups 
SulfoLink Coupling Resin was used to allow covalent attachment of toxin to beaded 
agarose via sulfhydryl (-SH) groups. Iodoacetyl groups present on the resin interact 
with a protein that contains reduced cysteine residues forming covalent thioether 
bonds that permanently attach protein to the resin. Cysteine linkage was chosen for a 
reason. The -SH group, being less common than e.g. -NH2, would ensure that labelling 
occurs at a specific amino acid position limiting the possibility of the linkage blocking 
or adversely affecting toxin’s structure and function. Distribution of cysteines in the 
structure of PS-3 protoxin was examined (Figure 173) using a model generated by 
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Phyre2 (Kelley et al., 2015) and viewed using UCSF Chimera 1.10.1 (Pettersen et al., 
2004). 
 
Figure 173 Distribution of cysteines in PS-3 protoxin sequence. 
A model of PS-3 protoxin was generated by Phyre
2 
and viewed using UCSF Chimera 1.10.1. PS-3 protoxin structure is 
in yellow, positions of cysteines are marked in green with blue labels.  
 
Cysteines at position 5 and 20 are cleaved off during N-terminal activation by trypsin. 
Cysteines at position 705 and 714 lie within the C-terminus and are also most likely 
cleaved during proteolysis, while Cys244 and Cys507 are probably not exposed. Cys46 
is exposed and appeared to be a good candidate residue for coupling. 
Characterisation of PS-3 coupled resin 
Trypsin activated PS-3 was coupled to SulfoLink resin as described in the methods 
section. Coupling efficiency was analysed using SDS-PAGE (Figure 174).  
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Figure 174 SDS-PAGE analysis of PS-3 immobilization to resin via sulfhydryl groups. 
Purified trypsin activated PS-3 was coupled to SulfoLink resin. Samples at different stages of this process were run 
on a 7.5% SDS-PAGE gel: ÄKTA purified and concentrated PS-3 used for coupling (168 µg/ml), SN – supernatant 
collected after coupling (for estimation of binding efficiency), three washes after coupling, and coupled resin. 
 
The weak toxin band in the resin lane may indicate that coupling efficiency was poor. 
However the crosslinking acts by covalently immobilizing sulfhydryl-containing 
proteins; hence the coupled toxin may have not entered the gel, despite boiling and 
SDS treatment, due to a large size of resin beads. Next, toxin coupled resin was tested 
in a dot blot experiment for PS-3 detection using anti-PS-3 antibody (Figure 175).   
 
Figure 175 Dot blot analysis of PS-3 coupled resin. 
5 µl of trypsin activated PS-3 prior and post coupling (0.84 μg of protein) as well as non-coupled resin were spotted 
on a nitrocellulose membrane, blotted with anti-PS-3 antibody, followed by ECL detection. 
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PS-3 coupled resin produced a signal confirming successful attachment of the toxin. 
Coupled resin was incubated with adhered HepG2 and HepG2 cells in suspension (after 
cell trypsinization) to establish cell swelling, however even when the cells were in 
suspension they did not stay in contact with relatively larger resin beads. Swelling was 
not observed most likely due to insufficient physical contact between the immobilized 
toxin and the cells (data not shown).     
Pull down using PS-3 coupled resin 
Figure 176 presents results of a pull down experiment performed with PS-3 coupled 
resin and NOG lysed HepG2 cells.  
 
Figure 176 SDS-PAGE analysis of a pull down experiment using PS-3 coupled resin and NOG lysed cell extract. 
50 µl of pelleted washed SulfoLink resin was incubated with ÄKTA purified trypsin activated PS-3 (74 µg) or buffer 
only as described in the methods section. After incubation non-specific binding sites were blocked with L-cysteine-
HCl buffer in both samples. Resins were washed and incubated with NOG lysed HepG2 cell extracts (260 µg). 
Samples were analysed on a 7.5% SDS-PAGE gel: washed resin after incubation with toxin or buffer and NOG cell 
extract, SN – supernatant collected after resin incubation with toxin and NOG cell extract, samples from three resin 
washes after incubation with toxin and NOG cell extract. 
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Despite covalent bond between resin and the toxin, this experiment was performed in 
hope that denaturing conditions of SDS-PAGE would release any proteins bound to PS-
3. The presence of the same bands in lanes with resin incubated with or without the 
toxin indicates non-specific binding of cell extract proteins to the resin. Strong intensity 
of the bands in resin lanes compared with the supernatant lane indicates high affinity 
of the HepG2 proteins for the beads despite resin blocking with L-cysteine-HCl. PS-3 
band could not be detected, which may be due to its covalent immobilization to resin. 
Due to time constraints this method was not optimised further.  
7.9 Analysis of N-cadherin blocking on PS-3 activity 
Antibodies may be utilized to block a surface protein in the cell culture. Through 
administering a specific antibody that binds to the protein of interest, physical 
interactions of that protein with other proteins can be inhibited. Expression levels of 
different cadherins were analysed in HepG2 cells using the Human Protein Atlas 
representing human proteome database (Uhlén et al., 2015). One, identified at both 
the mRNA and protein level, was N-cadherin or cadherin-2 (CDH2). Its sequence was 
analysed and in the membrane proximal extracellular domain, a sequence 
694SILRVKV700 was identified, similar to 1336SILTVTV1342 present in cadherin repeat 11 in 
M. sexta BT-R1 and identified as Cry1A binding site (Gómez et al., 2003). A rabbit 
polyclonal anti N-cadherin antibody was purchased (synthetic peptide used as an 
immunogen corresponded to 701-714 amino acid sequence of the extracellular 
domain in the human N-cadherin). Functionality of antibody was assessed in a western 
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blot. Expression levels of N-cadherin were analysed in HepG2, HeLa and HL-60 cells 
(Figure 177).  
 
Figure 177 Expression levels of N-cadherin in different cell lines. 
HepG2, HeLa and HL-60 cells were lysed in NOG buffer. Cell extracts were run on a 10% SDS-PAGE gel. 25 µg of 
protein were loaded in each lane. Samples were analysed by western blot for the presence of N-cadherin or CD59. 
 
The antibody successfully detected N-cadherin in HepG2 cells and the levels of 
expression for the three cell lines correlated well with the data deposited online in the 
Human Protein Atlas for each of the cell line (data not shown). 
Next, PS-3 toxicity was examined in HepG2 cells pre-incubated with anti N-
cadherin antibody (Figure 178). 
 
Figure 178 The effect of HepG2 cell pre-incubation with anti N-cadherin antibody on PS-3 activity. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day medium was changed 
to Advanced DMEM without FCS and antibiotics and cells were treated with anti N-cadherin antibody (23.8 µg/ml) 
or 50:50 glycerol: DPBS (v/v). 24 hours later either PS-3 (12 µg/ml) or buffer was administered. Viability was 
measured 24 hours after toxin addition using CellTiter-Blue.  
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Activity of PS-3 was unaffected by pre-incubation with the anti N-cadherin antibody, 
however the binding between the antibody and N-cadherin was not analysed.  
7.10 Assessment of cholesterol depletion and GPI-linked 
protein cleavage on PS-3 toxicity 
HepG2 cells were sequentially adapted to medium containing 0% serum by passaging 
cells in decreasing amount of FCS. This was done because serum components may 
interfere with enzyme activity through binding or even degrading molecules added to 
the medium. FCS was decreased in four passages from 10%, 7.5%, 5%, 2.5% to 0%. The 
change from 2.5% to 0% FCS was too stressful for cells as they did not attach to the 
flask. PI-PLC experiment was attempted using cells cultured in 2.5% FCS as these cells 
stayed connected to the flask and showed similar morphology to HepG2 cultured in 
10% FCS. However, when cells were washed with DPBS prior to PI-PLC addition, the 
majority of the cells detached from the plate. Moreover, cell viability assayed by 
Trypan Blue was only 50% (data not shown). Because of these obstacles, PI-PLC and 
MβCD assays were performed using cells cultured in 10% FCS, with medium changed 
to Advanced DMEM (without FCS supplementation) prior to enzyme treatment. 
Cholesterol or GPI-anchored proteins were depleted from the membrane with 
MβCD and PI-PLC enzyme respectively. After a wash with DPBS, the cells were 
incubated with or without PI-PLC or MβCD in the culture medium without serum, 
followed by PS-3 treatment. Cytotoxicity of PS-3 against these cells was then evaluated 
in a viability assay (Figure 179) and by a visual inspection of cell morphology. 
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Prolonged incubation with 5 mM MβCD or PI-PLC caused some cell detachment and 
death therefore viability was measured after 2 hours. Removal of PI-PLC or MβCD 
before PS-3 addition resulted in cell detachment, hence was aborted (data not shown). 
 
Figure 179 Analysis of PS-3 activity in HepG2 cells pre-treated with PI-PLC or MβCD. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in complete DMEM. The next day cells were washed 
with DPBS and medium changed to Advanced DMEM without FCS and antibiotics. Next, cells were pre-incubated 
with 5mM of MβCD for 30 minutes or PI-PLC (250 mU per 2.25 x 10
4 
cells) for 1 hour at 37°C. After that PS-3 (12 
μg/ml) or buffer was added. CellTiter-Blue reagent was added 20 minutes later and the readings were taken 2 hours 
after toxin addition. 
 
The results showed that 5 mM MβCD and a high dose of PI-PLC were not able to 
reduce PS-3 activity with PI-PLC somewhat affecting cell viability. No difference was 
noted in the degree of cell swelling in the toxin treated wells with or without enzyme 
pre-treatment as observed 20 minutes after PS-3 addition.  
To confirm the effectiveness of the PI-PLC treatment, the amount of GPI-
anchored CD59 - a membrane glycoprotein present on the cell membrane - was 
studied by immunoblotting with anti-CD59 antibody. The cells were incubated in the 
absence or presence of PI-PLC, then washed and lysed. Cell extracts were analysed by 
western blotting (Figure 180). 
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Figure 180 Western blot analysis of CD59 cleavage from the cell membrane after PI-PLC treatment.  
HepG2 cells were seeded in a 6-well plate. The next day cells were washed with DPBS and culture medium changed 
to Advanced DMEM. 25 x 10
4
 cells were treated with PI-PLC (500 mU) or buffer for 1 hour at 37°C, followed by cell 
lysis with RIPA. 15 µg of protein were loaded in each lane. Samples were analysed by western blotting with 
antibodies against CD59 or total p38 (t p38 - loading control) including supernatant (SN) collected after PI-PLC 
treatment and before cell lysis.  
 
The presence of CD59 band in the pellet fraction of the cells pre-treated with PI-PLC 
indicates that the cleavage of the phosphodiester bond in the GPI-anchored proteins 
was ineffective. Experiment was repeated with enzyme treatment performed in a 
different buffer called PI-PLC buffer (Figure 181), which consisted of: 10 mM tris-HCl, 
144 mM NaCl, 0.05% BSA, pH 7.4. 
 
Figure 181 Western blot analysis of CD59 cleavage in the supernatant and pellet fractions using PI-PLC buffer. 
HepG2 cells were washed with DPBS twice and trypsinized. 25 x 10
4
 cells were re-suspended in either Advanced 
DMEM or PI-PLC buffer +/- 116 mU of PI-PLC. Cells were incubated at 37°C for 1 hour with occasional gentle 
shaking. After that cells were spun. Supernatant and RIPA lysed pellets were analysed by a western blot using anti 
CD59 antibody. 15 µg of protein were loaded in each lane. 
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Performing the digest in PI-PLC buffer allowed the enzyme to cleave some of CD59. 
The strong CD59 signal in the lysed cellular pellet suggests that the cleavage was only 
partial or that it represents an intracellular pool of CD59. 
The effect of GPI-anchored protein cleavage and cholesterol depletion on PS-3 
toxicity was re-assessed using the PI-PLC buffer and a kinetic viability cell assay (Figure 
182 and Figure 183 for PI-PLC and MβCD assay respectively).  
 
Figure 182 Analysis of PS-3 activity in HepG2 cells pre-treated with PI-PLC in PI-PLC buffer. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate in PI-PLC buffer in the presence 
of viability reagents. Next, cells were incubated with various amounts of PI-PLC (U) for 60 minutes, before the toxin 
(10 µg/ml) was added. Luminescent readings were recorded at different time-points after toxin addition using 
RealTime-Glo cell viability assay.  
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Figure 183 Analysis of PS-3 activity in HepG2 cells pre-treated with MβCD in PI-PLC buffer. 
HepG2 cells were seeded at the density of 25 x 10
4
 cells/ml in a white 96-well plate in PI-PLC buffer in the presence 
of viability reagents. Next, cells were incubated with various concentrations of MβCD (mM) for 30 minutes, before 
the toxin (10 µg/ml) was added. Luminescent readings were recorded at different time-points after toxin addition 
using RealTime-Glo cell viability assay.  
 
Cell pre-treatment with PI-PLC and MβCD in the simple buffer had no significant effect 
on PS-3 toxicity, correspondingly to previous viability assay results (Figure 179). The 
above results may indicate that GPI-linked proteins and cholesterol do not play a 
significant role in toxin’s mode of action.  
7.11 Discussion 
Ligand blot experiments did not identify any proteins that PS-3, used as a probe, would 
bind to specifically. Lanes with HepG2 cells - supposedly containing molecules critical 
for high susceptibility to the toxin - did not present a band profile different from 
resistant HeLa cells. The reasons why receptor was not identified may be many. The 
simplest being, that it may not be a protein. PS-3 receptor could have a lipid nature. 
Glycolipids have been identified as binding partners for Cry14A and Cry5B in C. 
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elegance before (Griffitts et al., 2005). Even if it is proteinous, denaturing conditions of 
SDS-PAGE used in the majority of western blot experiments may have destroyed 
discontinuous epitopes that the toxin may require for binding. PS-3 may have not been 
able to recognize continuous epitopes even if they represent the receptor. Another 
possibility is that the non-specific bands could have masked specific signal due to low 
resolution of the SDS-PAGE. However, with so many methods of detection used and 
different MW sizes of non-specific bands depending on the method used, it is very 
improbable. Results presented in Figure 43 and Figure 170 suggest that PS-3 
interaction with the membrane is weak and/or involves a small amount of toxin 
molecules and may be beyond detection using a western blot system. Yet another 
possibility, although unlikely, is that there is no receptor and the mode of action is in 
this respect different from other Cry toxins.  
Strong cross-reactivity of cellular proteins with either labelled toxin or 
antibodies was evident. Anti-PS-3 antibody resulted in a high degree of non-specific 
binding with the resolved proteins that could not be improved despite laborious 
method optimization. Epitope mapping, where immuno-reactive regions of the antigen 
are recognized to improve protein-protein interaction could be highly beneficial. 
However, the polyclonal character of this antibody may be the issue. It is thought that 
only 0.5 – 5% of the antibodies in a polyclonal mixture recognize the target antigen 
(Bradbury and Pluckthun, 2015). Additional purification of anti-PS-3 antibody using 
anti-HA resin and HA-PS-3 did not improve the background signal. Antibodies against 
other Cry toxins also bound non-specifically, but only to the non-purified form of PS-3 
and could not detect the purified toxin.  
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Streptavidin too produced non-specific binding interactions. Biotin is a vitamin 
derived from diet and intestinal bacteria, important for fatty acid metabolism. It 
functions as a cofactor facilitating transfer of carbon dioxide during the action of 
certain carboxylases and decarboxylases (Wood and Warnke, 1981). Liver, among a 
few other tissues, is relatively abundant in biotin-containing enzymes (Dakshinamurti 
and Mistry, 1963, Wood and Barden, 1977). Experiments of intracellular distribution of 
biotin in liver cells showed that about 50% of biotin bound enzymes are present in a 
cytosolic fraction, especially in mitochondria and nuclei (Dakshinamurti and Mistry, 
1963). Furthermore, streptavidin itself contains a tripeptidyl sequence that shows high 
resemblance to the binding sequence of fibronectin and other adhesion molecules, 
increasing the non-specific binding of streptavidin to cell surface (Alon et al., 1990, 
Alon et al., 1993). High auto fluorescent background observed in experiments with 
biotin labelled PS-3 may be due to these reasons. 
The HA-PS-3 did not display a significant cross-reactivity with resolved proteins, 
except for when HepG2 cells were lysed with NOG buffer. This non-specific binding 
was through the HA tag and not anti-HA antibody or PS-3. Instability of the HA tag 
after trypsin digest was problematic to detect as freshly activated toxin contained the 
tag. The HA tag degraded along with the increasing length of sample storage. HA 
tagged protoxin was detected better by the antibody, but did not contribute to protein 
receptor identification. Protoxin binding to the receptor may have been impaired due 
to the lack of the N-terminal processing. HA-PS-3 (K688A) mutant, engineered to solve 
this problem, offered the presence of a stable tag, but did not facilitate any specific 
binding. 
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There are many possibilities to explain the lack of fluorescence in FITC-PS-3 
treated cells. Toxin may have not been labelled efficiently or fluorescence quenched 
after interaction with the membrane. More likely, only a minute amount of toxin is 
required to trigger toxicity, which was also concluded from results of another viability 
assay (Figure 43). Moreover, this could explain why HA-PS-3 was not detected by anti-
HA antibody in cells exposed to the high toxin dose prior to cell lysis, even when 
exposure time was extended to increase the chances of presumable oligomerisation. 
Pull down assays were performed using either HA tagged toxin or toxin 
immobilised on beads. Efficiency of toxin-resin binding varied. Satisfactory binding was 
obtained for HA-protoxin. Surprisingly, HA-PS-3 (K688A) showed reduced binding 
compared to HA-protoxin. Binding efficiency of PS-3 coupled to resin via sulfhydryl 
groups was difficult to assess due to its covalent immobilization and lack of a proper 
elution buffer. In all cases, pull downs did not identify any proteins binding specifically. 
Due to the negative results and time constraints these methods were not optimised 
further. 
Cadherin-like proteins have been identified as functional Cry toxin receptors in 
insects with toxin binding regions located near the membrane proximal extracellular 
domain and adjacent cadherin repeats (Pigott and Ellar, 2007). Cadherin functional 
blockage with antibodies was successfully performed in vivo (Gänzler-Odenthal and 
Redies, 1998) and in vitro (Qian et al., 2004). Based on the information about human 
N-cadherin mentioned earlier, a blocking assay was performed to evaluate the role of 
N-cadherin as a potential PS-3 receptor. Cell pre-incubation with anti- N-cadherin 
antibody did not affect the activity of PS-3, however the binding between the antibody 
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and N-cadherin was not analysed. Providing that the binding took place and 
association with other molecules - like PS-3 - was impaired, it can be assumed that N-
cadherin does not facilitate PS-3 binding to the cell membrane. 
Western blot analysis after PI-PLC treatment indicated a strong influence of the 
buffer on the activity of this enzyme. PI-PLC was capable of releasing some of CD59 in 
the presence of a basic physiological buffer, but not in the serum free medium. After 
PI-PLC treatment, CD59 was detected also in the pellet, which may represent an 
intracellular pool of CD59. In fact, Amet et al. already demonstrated that human 
hepatocytes expressed high levels of intracellular CD59 (Amet et al., 2012), which 
makes CD59 not an ideal marker for PI-PLC cleavage in these experiments. MβCD is 
frequently used to efficiently deplete cells of cholesterol. The amount of the 
membrane cholesterol after treatment with MβCD was not quantified, however 5 mM 
MβCD was documented previously to cause ∼40% reduction of total cholesterol pool 
in HepG2 cells (Guo et al., 2011). Viability assays showed that a high dose of neither 
MβCD nor PI-PLC were able to prevent reduced viability and swelling after toxin 
application. Although the protein and the lipid levels after depletion were not assessed 
in details, the results may indicate that GPI-linked proteins and cholesterol do not play 
a significant role in the toxin’s mode of action.  
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8. General discussion 
Bt based pesticides have been widely used for over 50 years with no harmful effects on 
humans (Koch et al., 2015). Parasporins represent a group of Bt toxins that can 
specifically kill certain human tumour cells in vitro and their application in anti-cancer 
therapy was suggested. Some parasporins, like PS-3, are closely related in structure to 
Bt toxins commercially used as bio-pesticides, however at the moment parasporin 
activity cannot be predicted based on a toxin’s sequence. This research was conducted 
to elucidate the mode of action of PS-3.  
Results of the experiments performed in this study are consistent with PS-3 
being a pore forming toxin. Similar to insecticidal Cry toxins, proteolytic activation of 
PS-3 was necessary for toxicity. Two different size fragments resulting from proteolytic 
activation showed after chromatographic separation cytotoxicity towards HepG2 cells, 
indicating partial cleavage sites most likely at the C-terminus. Rapid swelling was 
microscopically observed in susceptible cells, analogous to insect cells losing the ability 
to regulate osmotic pressure after exposure to Cry toxins (Knowles and Ellar, 1987). PS-
3 significantly and rapidly decreased cell viability and ATP levels, and did not induce 
activation of caspases or oxidative stress, consistent with ROS-independent necrotic 
cell death. The EC50 of PS-3 was 2.17 μg/ml, similar to the previous calculation 
(Yamashita et al., 2005). Cell exposure to PS-3 resulted in membrane rapidly becoming 
permeable, allowing the detection of both a small and a large size cytotoxic marker. 
This effect was both time and dose dependent. The size of primary lesions was 
estimated <1 nm. In the absence of intracellular content and membrane proteins PS-3 
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induced channel formation in PLBs as well as in biological membrane patches of 
various origins. PLB experiments ultimately confirmed the pore forming nature of PS-3.  
Pre-treatment of HepG2 cells with EGTA inhibited PS-3 toxicity by means of 
metal ion chelation. Further investigation indicated that EGTA acts early in the toxin’s 
mechanism of action by preventing stable interaction with the membrane and the 
subsequent steps of membrane damage and p38 phosphorylation. More clarification 
came from the experiments involving different chelators, ionic buffer composition, ion 
supplementation and PLBs. EGTA exerted its protective effect by chelating cations 
bound to plasma membrane components, most likely candidates being: Ca2+, Mn2+ and 
Zn2+, which may work in a co-operative fashion. The exact function of these cations is 
unknown. Ca2+ and Zn2+ dependent proteins represent some well-known, functional 
receptors of Cry toxins in insects (Pigott and Ellar, 2007). Therefore a role of cations in 
facilitating a receptor’s structure or enzymatic activity may provide a plausible 
explanation (Kirouac et al., 2006). 
Another aspect of the PS-3 mode of action was analysed from the viewpoint of 
cellular responses to the toxin, although the investigation was limited to a few 
signalling pathways. Activation of p38 MAPK is a conserved cellular response to PFTs 
(Porta et al., 2011). Consistently with PS-3 being a PFT, activation of p38 MAPK was 
clearly evident in susceptible cells and reached its maximum before cell swelling 
ensued. Inhibition of p38 activity did not rescue cell viability, agreeing with the belief 
that this pathway is not universally protective following PFT attack (Husmann et al., 
2006, Stringaris et al., 2002, Aroian and van der Goot, 2007). It is also consistent with 
little membrane recovery observed in cells transiently treated with PS-3. Moreover, 
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PS-3 also activated ERK 1/2 MAPK but its role was not assessed. One model of Cry 
toxin’s action invokes the involvement of adenylyl cyclase and PKA signalling pathway 
(Zhang et al., 2006), which was addressed in this study. Western blot results and 
experiments with PKA inhibitors clearly indicated that PKA and various other kinases 
do not play a role in the PS-3 mode of action. 
PS-3 is active against a very narrow cell type range. Five cell lines not examined 
before (2 lymphoblastoid, 2 Burkitt’s lymphoma and CHOK1 cells) did not show 
susceptibility towards a high toxin dose; however it seems that cells’ resistance can be 
overcome by increasing toxin concentration, e.g. HeLa cells (Yamashita et al., 2000). 
Why PS-3 targets some cancer cells remains unknown. Similar to insecticidal Cry toxins, 
specificity and selectivity of parasporins indicate the involvement of a specific receptor 
in toxicity. Also, an increasing number of membrane bound proteins that are specific 
for cancer cells are being discovered (Grimm et al., 2011). Many attempts were made 
aimed to identify a PS-3 receptor. Experiments, based on the assumption that the 
receptor is proteinaceous in nature, proved unsuccessful for various reasons described 
in chapter 7. Additional experiments with membrane depletion of certain components 
excluded for the moment cholesterol and GPI-linked proteins from being significant 
players in the PS-3 mode of action. Results also suggest that the toxin-membrane 
interaction is weak or involves a small amount of toxin. Nevertheless, the presence of a 
receptor in the membranes of susceptible cells is still anticipated and will undoubtedly 
be the subject of future analyses. 
The application of parasporins in the medical field was suggested based on 
their preferential activities against cancer cells (Ohba et al., 2009). The concept of drug 
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targeting is not new (Fahmy et al., 2005). Nanoparticle drug delivery system is a well-
known component of that, but not exclusive. There are other efficient systems of 
targeted therapy like oncolytic viruses, which are modified not to target non-dividing 
and differentiated cells resulting in selective infection and lysis of cancer cells 
(Kaufman et al., 2015). Recently, the utilization of CRISPR/Cas9 - a genome editing 
method – for targeted gene therapy is underway (Sachdeva et al., 2015). The high 
specificity of PS-3 is definitely an advantage. However, despite many other drawbacks 
and pharmacological concerns, a big protein size poses a risk of immunogenicity, 
especially if the region required for toxicity cannot be narrowed down to a drug size 
molecule, which is the case for the three domain Cry toxins, where each structural 
domain is required for action. Also, the health risks that parasporins pose on humans 
are unknown. In this study, PS-3 was demonstrated to act like a PFT in vitro.  
Future research will focus on receptor identification to gain a deeper 
understanding about PS-3 specificity and to evaluate a potential application of this 
knowledge in the medical field. Methods like thin layer chromatography, photo-
reactive crosslinking or carbohydrate blocking may prove useful in achieving that. Also, 
comparative transcriptome analysis of susceptible and resistant HepG2 cells is already 
underway (Souissi et al., unpublished). More patch clamp experiments using smaller 
toxin dose would help to establish if channel activity is affected by the side of exposed 
membrane and its origin. It would be also interesting to test if EGTA blocks toxicity of 
PS-3 activated with proteinase K in HL-60 cells and if the same cations restore its 
activity, which would suggest the presence of similar receptors in HepG2 and HL-60 
cells. High throughput analysis of kinase phosphorylation profiles could be used to 
simultaneously detect other proteins/pathways involved in cellular response. 
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